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The development of the central nervous system is dysregulated in 
neurodevelopmental disorders such as intellectual disability, autism spectrum 
disorder, and epilepsy. These three disorders have different clinical features, yet 
there is high comorbidity between them. They can be difficult to study due to their 
highly complex aetiologies, however there are various monogenic diseases that can 
cause all of them, including SYNGAP1 haploinsufficiency where the synaptic 
guanosine triphosphatase (GTPase)-activating protein (SYNGAP) protein levels are 
highly reduced; Fragile X syndrome where the fragile X mental retardation protein 
(FMRP) is no longer translated; and DNM1 epileptic encephalopathy where 
mutations in the Dynamin1 gene alter the protein function. These monogenic 
conditions are synaptopathies as the proteins affected play important roles in synapse 
stability and neurotransmission.  
 
Because of the high comorbidity between these disorders, it is hypothesised that 
there may be a common mechanism underlying them. We hypothesise that a deficit 
in presynaptic vesicle recycling may be part of a common mechanism underlying 
intellectual disability, autism spectrum disorder, and epilepsy especially in SYNGAP1 
haploinsufficiency, Fragile X syndrome, and DNM1 epileptic encephalopathy. Using 
various fluorescent presynaptic activity reporters including synaptic pHluorins, 
tetramethylrhodamine dextran and calcium dyes to compare presynaptic activity in in 
vitro models of these monogenic conditions, we found differences in synaptic vesicle 
(SV) endocytosis in the genetically altered conditions compared to wildtype controls.  
 
We observed various SV endocytosis defects in clathrin-mediated endocytosis 
(CME) or activity-dependent bulk endocytosis (ADBE) in our models. We observed 
enhanced CME in SynGAP1 KO mouse hippocampal neurons. This enhanced SV 
endocytosis was accompanied by decreased SV cargo on the plasma membrane. Rat 
SynGAP1 KO hippocampal neurons did not display enhanced SV endocytosis, nor 
15 
 
did neurons with the GTPase-activating (GAP) domain of SynGAP deleted. This was 
perhaps due to the altered time course of development between these rodent species. 
In mouse and rat models of Fragile X syndrome, CME was not altered compared to 
wildtype controls. However, in a rat model, we observed fewer nerve terminals 
undergoing ADBE which is the dominant SV endocytosis mode during elevated 
neuronal activity. De novo epileptic encephalopathy-associated mutations in DNM1 
had differential effects on SV recycling through both CME and ADBE. Mouse 
hippocampal neurons overexpressing Dyn1R237W, Dyn1I289F and Dyn1H396D all 
showed less CME compared to overexpression of Dyn1WT. Moreover, fewer nerve 
terminals overexpressing Dyn1H396D were found to undergo ADBE. We also found 
that a large-conductance potassium (BK) channel opener can accelerate clathrin-
mediated endocytosis and thus may be able to rescue the impaired SV endocytosis 
caused by these mutants. 
 
Although there is not yet a common underlying pathway at the presynaptic level 
between these conditions, SV recycling dysfunction is present across all of these 
models. Furthermore, we propose an axis of pathophysiology model where optimal 
SV endocytosis is required for optimised neural performance. We propose that either 
decreased or increased SV endocytosis can lead to the synaptic dysfunction observed 





Neurodevelopmental disorders are a group of disorders that disrupt brain 
development. Intellectual disability, autism spectrum disorder and epilepsy are 
complex neurodevelopmental disorders that can present themselves together. They 
can be difficult to study as they can have multiple genetic and environmental causes. 
SYNGAP1 haploinsufficiency, Fragile X syndrome and DNM1 epileptic 
encephalopathy are common genetic causes of these disorders. In SYNGAP1 
haploinsufficiency, SYNGAP protein levels are highly reduced. In Fragile X 
syndrome, the fragile X mental retardation protein (FMRP) is absent. In DNM1 
epileptic encephalopathy, mutations in the protein dynamin-1 alter its function. 
These single-gene disorders impair neuronal function as the affected proteins all play 
important roles in communication across nerve cells.  
 
In this project we looked at synaptic vesicle recycling in the brain of mouse and rat 
models of these three conditions. Synaptic vesicles are little membrane packages that 
contain the transmitter that is used for communication between nerve cells. Synaptic 
vesicles undergo cycles: with the appropriate stimulation, they fuse with the cell 
membrane to release their content, then parts of the cell membrane are taken back up 
again to form new synaptic vesicles. Individual vesicles can be taken up from the cell 
membrane in a process called clathrin-mediated endocytosis (CME). During higher 
levels of neuronal activity, a large portion of the membrane can be taken up to form a 
large membrane compartment from which individual synaptic vesicles can then be 
formed. This process is activity-dependent bulk endocytosis (ADBE).  
 
We found defects in synaptic vesicle recycling, particularly impaired membrane 
retrieval in each model. In a mouse model of SYNGAP1 haploinsufficiency, we saw 
enhanced membrane retrieval and less protein stuck on the cell membrane. We did 
not observe this in our rat model. This may be due to differences in development 
across mice and rats. In both mouse and rat models of Fragile X syndrome, we 
17 
 
observed that there was no difference in membrane retrieval through CME. However, 
in a rat model, we observed that there were fewer nerve structures that could undergo 
ADBE at high neuronal activity. For our DNM1 epileptic encephalopathy model, we 
expressed human mutations into mouse neurons and observed that some of these 
mutations impaired membrane retrieval through CME, while others impaired 
membrane retrieval through both CME and ADBE. Interestingly, we also found a 
drug which had been developed for stroke treatment that could enhance membrane 
retrieval through CME and thus may be able rescue the impaired CME that we 
observe in this model.  
 
Although there is not yet a common deficit between these conditions, SV recycling 
dysfunction is present across all of these models. Furthermore, we propose a model 
where optimal membrane retrieval is required for optimised neural performance. We 
propose that either decreased or increased membrane retrieval may lead to the 
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1.1. Neurodevelopmental disorders 
Neurodevelopmental disorders are a heterogeneous group of disorders of nervous 
system development. There are various genetic factors and epigenetic modifications 
that are associated with neurodevelopmental conditions, some of which are yet to be 
elucidated or fully understood (Sontheimer, 2015; van Loo and Martens, 2007). 
There is a complex interplay between genes and prenatal or postnatal environmental 
factors that can give rise to these disorders, making them difficult to study (van Loo 
and Martens, 2007).  
 
The incidence of neurodevelopmental disorders is approximately 1 in 30 live births 
(Sontheimer, 2015). In the United States, the economic cost of neurodevelopmental 
disorders is $81.5–167 billion per year (Schettler, 2001; Szpir, 2006). Although these 
disorders are very common and present an important economic burden, very little is 
still known about them and how to treat them.  
 
The pathophysiology underlying neurodevelopmental disorders remains poorly 
understood. The cellular dysfunction appears to be vastly different within and across 
different neurodevelopmental disorders due to their complex aetiologies. This makes 
it difficult to develop new drugs and treatment strategies. The one thing these 
disorders do have in common is that they impair the correct development of the brain 
(Andreae and Burrone, 2017; Hulbert and Jiang, 2017; Krol and Feng, 2017; Moretto 




In this work we have chosen to study three highly comorbid neurodevelopmental 
disorders: intellectual disability (ID), autism spectrum disorder (ASD) and epilepsy 
to determine whether there is any convergence across their pathophysiology.  
 
1.1.1. Intellectual disability (ID) 
ID, previously mental retardation (American Psychiatric Association and American 
Psychiatric Association. Task Force on DSM-IV, 1994), is characterised by deficits 
in intellectual and adaptive functioning across conceptual, social and practical 
domains (American Psychiatric Association and American Psychiatric Association. 
DSM-5 Task Force, 2013). Individuals can experience varying degrees of these 
deficits. Intelligence quotient (IQ) tests allow for the diagnosis of ID in late 
childhood or early adulthood (IQ< 70). The IQ score also permits the severity 
classification of affected individuals (Mefford et al., 2012). However, these scores 
cannot assess the extent of adaptive functioning deficits in social skills and personal 
independence which are better indicators of treatment and care options (American 
Psychiatric Association and American Psychiatric Association. DSM-5 Task Force, 
2013; Mefford et al., 2012).  
 
Despite ID diagnosis only occurring in late childhood, ID can be identified in early 
childhood from developmental delays across motor, cognitive, and speech functions 
(Mefford et al., 2012). It is a highly prevalent disorder that affects 2-3 % of the 
global population (Leonard and Wen, 2002; Ropers and Hamel, 2005). This is due to 
the broad definition of symptoms of the disorder which allows it to encompass 
various phenotypes that can be due to both syndromic and non-syndromic causes.  
 
As with other neurodevelopmental disorders, there are a multitude of genetic and 
non-genetic factors that can cause intellectual disability. Different single-gene 
mutations, both autosomal and X-linked, have been shown to give rise to the disorder 
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(Mefford et al., 2012). This heterogeneity of risk factors may underlie some of the 
diversity of the phenotypes associated with ID. Multiple psychiatric and 
neurodevelopmental disorders present themselves with lower intellectual 
functioning, suggesting that there may be some similar underlying mechanisms 
across these disorders.  
 
1.1.2. Autism spectrum disorder (ASD) 
ASD is characterised by difficulties in social communication and social interaction, 
and restricted, stereotyped, repetitive behaviours or fixed interests (American 
Psychiatric Association and American Psychiatric Association. DSM-5 Task Force, 
2013). These behaviours can vary in severity across the autism spectrum. ASD is 
often comorbid with other neurodevelopmental disorders including attention deficit 
hyperactivity disorder (ADHD) (Leyfer et al., 2006; Simonoff et al., 2008; Joshi et 
al., 2010), anxiety (Simonoff et al., 2008), ID (McCarthy, 2007) and epilepsy 
(Mazarati et al., 2017). ID is present in 50-70 % of individuals with ASD (Mefford et 
al., 2012) and epilepsy is present in 4-38 % of individuals with ASD (S. Thomas et 
al., 2017).  
 
The disorder was first observed in children displaying obsessive behaviours and 
impaired affective and social interactions (Kanner, 1943). Individuals are diagnosed 
with ASD around 3 years of age using a battery of psychological questionnaires 
(Johnson et al., 2007), behavioural observations, and interviews with caregivers 
(American Psychiatric Association and American Psychiatric Association. DSM-5 
Task Force, 2013). This age is when autistic behaviours become apparent, however 
certain symptoms of the behaviour can be observed at an earlier age, including 




The prevalence of ASD has increased throughout the past 30 years. Currently, 1 in 
68 children in the United States (Developmental Disabilities Monitoring Network 
Surveillance Year 2010 Principal Investigators and Centers for Disease Control and 
Prevention (CDC), 2014), and 3.8:1000 boys and 0.8:1000 girls in the United 
Kingdom (B. Taylor et al., 2013) are diagnosed with ASD. It is unclear whether this 
increase in prevalence is due to more accurate diagnostic tests, a change in diagnostic 
criteria, more awareness of these disorders or a higher incidence rate (Charman, 
2002).  
 
ASDs have a complex aetiology with several known and unknown genetic, 
epigenetic, and environmental causes (Banerjee et al., 2014). They have an important 
heritable component as shown by multiple twin studies (Folstein and Rutter, 1977; 
Ritvo et al., 1985; Rosenberg et al., 2009). These multiple causes give rise to 
different autistic phenotypes of differing severity. Unsurprisingly, there is no 
treatment for this disorder, however certain associated symptoms including epilepsy 
and anxiety can be partially relieved by appropriate medication.  
 
The increased excitation and decreased inhibition model (Rubenstein and Merzenich, 
2003) was developed to attempt to explain how so many different genetic causes 
produce the same autistic phenotypes. This model proposes that there is an 
excitatory/inhibitory imbalance that underlies most behavioural, social and cognitive 
impairments observed in ASD. This model also postulates that the severity of the 
excitatory/inhibitory imbalance determines the severity of ASD phenotypes. This 
imbalance can be due to increased excitation or decreased inhibition or a 
combination of both in different circuits (Rubenstein and Merzenich, 2003). Studies 
have lent support to this model by showing that increasing excitation/inhibition ratio 





Epilepsy is characterised by repeated seizures due to bursts of neuronal hyperactivity 
(Avanzini and Franceschetti, 2003; Bozzi et al., 2012). These events of spontaneous 
neuronal firing can be contained to a specific region of the brain or spread across 
both hemispheres, with the most epileptogenic regions being the cortex and the 
hippocampus (Avanzini and Franceschetti, 2003; Pitkanen and Sutula, 2002). 
Recurrent seizures can result in changes in synaptic plasticity due to neuronal loss, 
neurogenesis, axonal branching and glial proliferation (reviewed in Pitkanen and 
Sutula, 2002).  
 
Epilepsy is a common neurological disorder (Sander and Shorvon, 1996) affecting 
7.3:1000 individuals in the United Kingdom (J. Wright et al., 2000). The prevalence 
of epilepsy increases with age (J. Wright et al., 2000). In certain cases, however, it is 
considered a neurodevelopmental disorder because it is due to the disruption of 
prenatal neuronal proliferation and migration, and postnatal circuit remodelling 
during developmental critical periods (reviewed in Bozzi et al., 2012).  
 
1.2. Monogenic causes of neurodevelopmental disorders 
Neurodevelopmental disorders have highly complex aetiologies and most of their 
pathophysiology is still not well understood. ID, ASD, and epilepsy are highly 
comorbid, suggesting a common mechanism underlying these disorders. Since 
monogenic conditions allow for study of tractable model systems, this work focusses 
on three monogenic conditions causing ID, ASD and epilepsy: SYNGAP1 




1.2.1. SYNGAP1 haploinsufficiency 
SYNGAP1 haploinsufficiency is due to mutations in the SYNGAP1 gene resulting in 
loss of function of the brain-specific synaptic guanosine triphosphatase (GTPase)-
activating protein (SYNGAP). Most described patient mutations are deletions or 
missense mutations leading to dysfunctional proteins (reviewed in Parker et al., 
2015). Since the first mutations in SYNGAP1 were characterised (Hamdan et al., 
2009), SYNGAP1 haploinsufficiency has been identified as an important cause of 
non-syndromic ID (NSID) (C. F. Wright et al., 2015). The ID caused by SYNGAP1 
haploinsufficiency is highly comorbid with epilepsy and ASD (Parker et al., 2015). 
There is also some evidence suggesting that loss of SYNGAP may also lead to 
syndromic ID in a subset of patients who display distinct facial features, typical 
myoclonic, absence, and drop attack seizures, hyperexcitability, sleep disturbances 
and aggressive behaviour (Parker et al., 2015).  
 
SynGAP is a highly abundant protein enriched at excitatory postsynaptic densities 
(PSDs) (H. J. Chen et al., 1998; Kim et al., 1998). SynGAP was identified in a cDNA 
screen as a novel protein that could interact with the PDZ domains of the PSD-95/ 
synapse-assiciated protein (SAP) 102 family of proteins (Kim et al., 1998). The 
N-terminal of the protein contains a pleckstrin homology (PH) domain, a C2 domain 
and a Ras-GTPase activating (RasGAP) domain (Kim et al., 1998). The GAP and C2 
domains of SynGAP can also act as a RapGAP (Krapivinsky et al., 2004; Pena et al., 
2008). Its C-terminal contains a phosphorylation site for Ca2+/calmodulin-dependent 
protein kinase II (CaMKII) (H. J. Chen et al., 1998; Walkup et al., 2015). 
Phosphorylation of SynGAP1 by CaMKII, cyclin-dependent kinase 5 (Cdk5) or 
polo-like kinase 2 (PLK2) increases its RasGAP and RapGAP activity to different 
extents (Krapivinsky et al., 2004; Lee et al., 2011; Walkup et al., 2015).  
 
SynGAP can be alternatively spliced to produce multiple isoforms with distinct 
N-termini and C-termini (Figure 1.1) (Kim et al., 2003; W. Li et al., 2001; A. C. 
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McMahon et al., 2012). SynGAP has five isoforms with distinct C-termini: α1, α2, 
β1/2, β3/4, γ, with the α1 and β isoforms being the most abundant in the brain (W. Li 
et al., 2001). These isoforms have different distribution patterns across the forebrain. 
The α1 isoform colocalises with PSD-95 at excitatory synapses in rat hippocampal 
neuron cultures and β isoforms preferentially colocalises with gephyrin in culture 
suggesting their presence at inhibitory synapses (Moon et al., 2008). The SynGAPα1 
isoform is tightly associated with synaptic structures, whereas the β isoforms formed 
more extra-synaptic clusters in dendrites (Moon et al., 2008). Additionally, there is 
evidence of SynGAPβ isoforms in the nucleus of cultured hippocampal neurons 
(Moon et al., 2008). There are also three alternative spice variants of the N-terminus: 
A, B, C (Kim et al., 2003; W. Li et al., 2001) due to the use of different promoters 
(A. C. McMahon et al., 2012).   
 
 
Figure 1.1 SynGAP isoforms and domain structure 
Adapted from McMahon et al. (2010) 
SynGAP is composed of a pleckstrin homology (PH) domain, a C2 domain and a GTPase 
activating (GAP) domain in its N-terminus. SynGAP can be alternatively spliced to produce 
multiple isoforms with distinct N-termini (A, B, C) and C-termini (α1, α2, β1/2, β3/4, γ).  
 
The different SynGAP isoforms have distinct effects on synaptic function (A. C. 
McMahon et al., 2012). SynGAP Aα2 expressed in forebrain neurons decreased mini 
excitatory postsynaptic current (mEPSC) amplitude whereas SynGAP Bα2 and Cα2 
increased mEPSC amplitude. Thus, SynGAPα2 can regulate mEPSC amplitude in an 
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N-terminus splice variant-dependent manner (A. C. McMahon et al., 2012). 
SynGAP Bα2 isoforms also showed increased mEPSC frequency which may suggest 
an increased release probability of presynaptic neurotransmitter. SynGAP Aα1 
showed decreased mEPSC frequency (A. C. McMahon et al., 2012). Overexpression 
of GFP-SynGAP was also found to decrease mEPSC frequency (Rumbaugh et al., 
2006). No other isoforms tested produced any effect on mEPSC frequency compared 
to control (A. C. McMahon et al., 2012). This suggests that SynGAP can both 
positively and negatively impact synaptic strength depending on isoform expression.  
 
Activation of SynGAP can regulate extracellular signal-regulated kinase (ERK) 
signalling downstream of N-Methyl-D-aspartic acid receptors (NMDARs) 
(Komiyama et al., 2002) which in turn leads to inhibition of protein translation 
(Barnes et al., 2015; Rumbaugh et al., 2006; C. C. Wang et al., 2013). Short 
interfering RNA (siRNA)-mediated knock-down of SynGAP in cortical networks 
leads to increased protein synthesis (C. C. Wang et al., 2013). SynGAP regulates the 
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) content 
of the plasma membrane by suppressing AMPAR synthesis through inhibition of the 
mitogen-activated protein kinase (MAPK)/ERK pathway (C. C. Wang et al., 2013). 
Altering the number of AMPAR at the plasma membrane directly impacts synaptic 
strength (reviewed in Anggono and Huganir, 2012).  
 
As previously stated, SynGAP, particularly the SynGAPα1 isoform, can bind any of 
the three PDZ domains of PSD-95 (Kim et al., 1998). This competitive binding of the 
PDZ of PSD-95 can regulate AMPAR docking and synapse structure by preventing 
neuroligins, leucine-rich repeat transmembrane proteins (LRRTMs) and 
transmembrane AMPA receptor regulatory proteins (TARPs) from binding (Walkup 
et al., 2016). Phosphorylation of SynGAP by CaMKII or PLK2 reduces its binding to 
PSD-95, thus allowing modification of the PSD structure. This modification of PSD 
structure includes more insertion of AMPAR in the plasma membrane through 
binding of TARPs with the PDZ domains of PSD-95 (Walkup et al., 2016). In a 
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mouse model of SynGAP1 haploinsufficiency, there was altered protein composition 
of the PSD with increased LRRTM, TARP and neuroligin-2 associated with PSD-95 
(Walkup et al., 2016). This altered composition of the synapse may, in part, mediate 
some of the deficits in synaptic plasticity observed in models of SynGAP1 
haploinsufficiency.  
 
Mice with homozygous deletion of SynGAP die within 5 days of birth (Komiyama et 
al., 2002) due to increased apoptosis measured by caspase-3 activation (Knuesel et 
al., 2005). Caspase-3 is a key degradative enzyme in apoptosis and can be used to 
measure of amount of apoptosis occurring (Rami, 2003). Interestingly neuronal 
apoptosis appears to be inversely correlated with SynGAP expression levels 
suggesting a role for SynGAP in the apoptosis pathway (Knuesel et al., 2005). 
However how SynGAP regulates apoptosis is not well understood. 
 
Mice with heterozygous deletion of SynGAP1 (SynGAP1 Het) show impaired 
synaptic plasticity during critical periods of synapse formation (Aceti et al., 2015; 
Clement et al., 2012). SynGAP’s pattern of expression would suggest a role in 
development, with expression peaking by post-natal day (PND) 14. SynGAP levels 
then decrease in adulthood (Kim et al., 1998; Porter et al., 2005; Clement et al., 
2012). There is already evidence for premature maturation of hippocampal synapses 
in SynGAP1 Het mice by PND 7 (Aceti et al., 2015) with significantly increased 
hippocampal neurotransmission at PND 14 associated with an increase in the 
AMPA/NMDA currents (Clement et al., 2012). The maturation of excitatory 
synapses requires a change in glutamate receptors inserted into the plasma 
membrane. An increase in AMPA/NMDA currents is suggestive of a more mature 
synapse where AMPAR-mediated neurotransmission is dominant (Hall et al., 2007). 
mEPSC frequency and amplitude are increased in SynGAP1 Het dentate gyrus 
granule neurons (Clement et al., 2012). Dendritic spine density is unchanged 
between Het and WT neurons, however spine morphology was different in Het 
32 
 
neurons with more mushroom-type spines and fewer stubby-type spines at PND 14. 
This phenotype persists into adulthood (Clement et al., 2012). 
 
At PND 21, SynGAP1 Het cortical pyramidal neurons were bigger and displayed 
more dendritic branching and longer dendrites. They appeared to be more similar to 
adult neurons and were already undergoing pruning which is characteristic of mature 
neurons (Aceti et al., 2015). However, during adulthood, there is no longer any 
difference between WT and SynGAP1 Het neuron gross morphology in the cortex 
(Aceti et al., 2015).  
 
Temporally inducing SynGAP haploinsufficiency during adulthood did not alter 
AMPA/NMDA current ratio (Clement et al., 2012). This suggests an important role 
for SynGAP in controlling dendritic spine maturation during development. 
Furthermore, using a Cre-Lox system to express SynGAP during adulthood was not 
able to rescue the impaired behavioural phenotypes including decreased anxiety, 
(more time spent in the open arm the elevated plus maze) and hyperactivity (more 
locomotion in an open field), suggesting a critical role of SynGAP during circuit 
formation (Clement et al., 2012).  
 
SynGAP also plays an important role in circuit connectivity. Hippocampal slices 
from SynGAP1 Het mice display enhanced protein synthesis-dependent metabotropic 
glutamate receptor- mediated long-term depression (mGluR-LTD) (Barnes et al., 
2015). This exaggerated mGluR-LTD is due to dysregulated ERK1/2 signalling 
leading to enhanced protein synthesis.  
 
Thus, SynGAP is necessary for correct synapse formation and circuit connectivity 
during development. This critical role in development makes SYNGAP1 
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haploinsufficiency an important model for elucidating underlying mechanisms for 
neurodevelopmental disorders.  
 
1.2.2. Fragile X syndrome (FXS) 
FXS, also known as Martin-Bell Syndrome (Martin and Bell, 1943), is one of the 
most common monogenic causes of ID and ASD, accounting for 5 % of all cases 
(Mefford et al., 2012). Epilepsy is also present in 10-20 % of cases of FXS (Berry-
Kravis, 2002). 
 
FXS syndrome is caused by the loss of the Fragile X mental retardation 1 (FMR1) 
gene product fragile X mental retardation protein (FMRP) (Pieretti et al., 1991). 
Most cases of FXS, are caused by a CGG trinucleotide expansion in the 5’ 
untranslated region of the FMR1 gene on the X chromosome. This expansion leads to 
hypermethylation of the promoter, repressing the transcription of FMR1 (Bell et al., 
1991; Sutcliffe et al., 1992; Verkerk et al., 1991). This trinucleotide repeat gives rise 
to a constricted and elongated “fragile” appearance of the X chromosome during 
metaphase (Hecht and Bixenman, 1990). The allele is classed as normal (up to 40 
repeats), a pre-mutation (40 to 200 repeats) or a full mutation (over 200 repeats) 
depending on the number of CGG repeats (Fu et al., 1991). Loss of FMRP can also 
be due to large intragenic deletions in FMR1 (Hirst et al., 1995; Lugenbeel et al., 
1995; Meijer et al., 1994) or single point mutations (Collins et al., 2010; Gronskov et 
al., 2011). There has also been one report of FXS in a patient with present though 
non-functional FMRP present (De Boulle et al., 1993). Genotyping revealed a single 
missense point mutation I304N (De Boulle et al., 1993). This mutation was found to 
prevent FMRP from associating with polyribosomes (Feng et al., 1997).  
 
FMR1 is segregated in an X-linked manner with reduced penetrance in females 
(Rousseau et al., 1995). It affects 1:5000 males (Coffee et al., 2009) and 1:6000-8000 
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females (Hagerman, 2008). Alongside the ASD, ID and epilepsy-associated 
cognitive disabilities, individuals with FXS also present a distinct physical 
appearance that aids in the diagnosis of the syndrome. These include large prominent 
ears, macroorchidism and hyperextensible metacarpophalangeal joints (Lachiewicz 
et al., 2000).  
 
FMRP is expressed ubiquitously with high expression throughout the brain and in the 
testes (Gholizadeh et al., 2015; Tamanini et al., 1997). In the brain, expression peaks 
within the first postnatal week and plateaus in adulthood (Gholizadeh et al., 2015; 
Till et al., 2012; Till et al., 2015).  
 
FMRP acts as an mRNA-binding protein that represses the translation of its target 
mRNAs downstream of mGluRs. FMRP can directly inhibit protein translation 
during the initiation or elongation phase. It forms an inhibitory complex with 
cytoplasmic FMRP-interacting protein-1 (CYFIP1) and eukaryotic translation 
initiation factor 4E (eIF4E) to inhibit translation initiation in an activity dependent 
manner (Napoli et al., 2008). FMRP can also supress the translation of its estimated 
748 target mRNAs by directly binding polyribosomes (Feng et al., 1997) to stall their 
translocation (Darnell et al., 2011).  
 
FMRP is also present in the presynapse in discrete granules, Fragile X granules 
(FXGs), in axons in certain regions of the mouse brain (Christie et al., 2009). The 
expression pattern of FXGs is correlated with periods of rich synaptic plasticity and 
circuit remodelling (Akins et al., 2012; Christie et al., 2009). These FXGs can 
associate with ribosomes and mediate the translation of specific mRNAs depending 




FMRP is important regulator of protein synthesis-dependent synaptic plasticity. In 
fact, hippocampal mGluR-LTD is exaggerated in Fmr1 KO mice (Huber et al., 
2002). FMRP does not play a role in the other common LTD form, NMDAR-LTD 
(Huber et al., 2002). In WT, activation of Group 1 mGluRs leads to the rapid 
increase in FMRP synthesis and thus the suppression of target mRNA translation 
(Hou et al., 2006; Weiler et al., 1997). During mGluR-LTD, FMRP is rapidly 
degraded by the ubiquitin-proteasome pathway (Hou et al., 2006). After degradation, 
there is an increase in levels of proteins whose transcripts are targets of FMRP (Hou 
et al., 2006).  
 
In Fmr1 KO mouse hippocampal slices, both synaptic stimulation-induced and 
chemically-induced (using the Group 1 mGluR agonist 3,5-dihydroxyphenylglycine, 
DHPG) mGluR-LTD is enhanced (Hou et al., 2006; Huber et al., 2002; Zhang et al., 
2009). Although mGluR-LTD is translation-dependent in WT, in KO, mGluR-LTD 
is resistant to both the inhibition of protein synthesis and the inhibition of the ERK 
signalling cascade (Hou et al., 2006; Nosyreva and Huber, 2006). This suggests that 
this form of plasticity is protein-synthesis independent in this syndrome. Thus, 
different mechanisms underlie mGluR-LTD in the presence or absence of FMRP.  
 
The altered dendritic spine morphology observed in FXS may also underlie some of 
the impaired synaptic plasticity. Although there is a discrepancy in terms of dendritic 
spine phenotype reported in FXS, most post mortem studies of mouse brains show 
age and region-specific differences in dendritic spine morphology. Dendritic spines 
play an important role in network connectivity as they receive input from most 
excitatory synapses (Alvarez and Sabatini, 2007). Defects in spine morphology in 
FXS include an age-specific increase in length and density compared to wild type 
(WT) (Galvez and Greenough, 2005) and higher density of filopodia and thin spines 
in spiny stellate neurons with fewer mushroom spines in Fmr1 KO mice (Till et al., 
2012). A region-specific immature spine morphology can also be observed in the 
hippocampus of Fmr1 KO mice (Levenga et al., 2011). More recently, stimulated 
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emission depletion (STED) microscopy was used to obtain better spatial resolution 
for the imaging of dendritic spines. This study revealed that there were only subtle 
differences in spine development or morphology in Fmr1 KO mouse brains during 
development compared to WT (Wijetunge et al., 2014).  
 
FMRP can promote maturation of synapses and cell-to-cell connections between the 
third and fifth postnatal weeks (Patel et al., 2014; Zang et al., 2013). Furthermore, 
FMRP can also regulate connectivity of cortical circuits during critical periods of 
connection possibly by promoting the pruning of unnecessary connections through 
the elimination of synapses in an activity-dependent manner (Patel et al., 2014; 
Pfeiffer et al., 2010; Zang et al., 2013).  
 
The mGluR theory of FXS was proposed based on the phenotypes observed in 
models of FXS and described above. This theory suggests that the core deficits in 
FXS can be explained by overactive signalling by group 1 mGluRs (Bear et al., 
2004). As previously described, mGluRs work in opposition to FMRP to regulate 
protein translation. In the absence FMRP, there is excessive translation of these 
proteins by group 1 mGluRs activation of the ERK signalling cascade (Osterweil et 
al., 2010). The increased levels of basal protein synthesis (Osterweil et al., 2010) and 
protein expression (Darnell and Klann, 2013; Klemmer et al., 2011; Tang et al., 
2015; Zalfa et al., 2003) then mediates the different phenotypes reported in FXS 
from exaggerated hippocampal mGluR-LTD to altered circuit connectivity (Bear et 
al., 2004; Dolen and Bear, 2009). Several studies lend support to this theory and have 
shown that genetically (Dolen et al., 2007) or pharmacologically (de Vrij et al., 2008; 
A. M. Thomas et al., 2012; Yan et al., 2005) reducing mGluR5 activity corrects 
multiple phenotypes of Fmr1 KO mice (reviewed in Robertson, 2013). Furthermore, 
treatments regulating the ERK signalling pathway, downstream of group 1 mGluRs, 
have also been shown to rescue the behavioural, protein synthesis and cellular 




Figure 1.2 The mGluR theory of FXS 
Figure adapted from Dolen and Bear, 2009. 
FMRP works in opposition to mGluRs to negatively regulate mRNA translation. In the 
absence of FMRP, as is the case in FXS, there is no negative regulation of translation, thus 
the translation of mGluR-associated transcripts is upregulated. 
 
It is important to note however that modulating group 1 mGluR activity cannot 
correct all of the deficits observed in mouse models of FXS, suggesting that FMRP 
may play another protein translation-independent role. In the presynapse, FMRP 
plays important roles in mediating ion channel gating in a protein synthesis-
independent manner (reviewed in Ferron, 2016). It is hypothesised that the 
presynaptic phenotype in FXS models is independent of its role in protein translation 
(Deng and Klyachko, 2016), despite 30.4 % of the presynaptic proteome’s mRNAs 
being targets of FMRP (Darnell et al., 2011). FMRP can regulate action potential 
(AP) duration by directly binding to large conductance voltage and Ca2+-gated big 
potassium (BK) channel to modulate their gating (Deng et al., 2013; Myrick et al., 
2015). FMRP also directly binds Slack sodium channels (Brown et al., 2010) and 
controls their gating. These channels are involved in maintaining neuronal firing 
during sustained neural activity (Bhattacharjee and Kaczmarek, 2005). FMRP can 
also control the density of N-type calcium channels on the plasma membrane to 
regulate [Ca2+]i (Ferron et al., 2014).  
 
There is increasing evidence that some of the impairments in neurotransmission and 
synaptic plasticity have presynaptic origins. At Fmr1 KO CA3-CA1 hippocampal 
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synapses there is increased synaptic response to high frequency stimulation due to 
increased Ca2+ influx in these conditions (Deng et al., 2011). Baseline synaptic 
transmission is not affected at CA3-CA1 synapses, however (X. S. Wang et al., 
2014). These synapses also display reduced short-term depression (STD) at high 
frequency stimulation due to faster synaptic vesicle (SV) recycling as determined by 
faster FM1-43 destaining and enlarged SV pools. In fact, both the size of the readily 
releasable pool (RRP) and reserve pool are increased in this model (Deng et al., 
2011). Additionally, during repetitive activity, there is an increased release 
probability at the CA3-CA1 synapses, but quantal size remains the intact (X. S. 
Wang et al., 2014).  
 
In WT conditions, FMRP regulates the short-term plasticity described above by 
directly interacting with BK channels (Deng et al., 2013; Deng and Klyachko, 2016; 
Myrick et al., 2015). FMRP can regulate AP duration and thus regulate 
neurotransmitter release. It does this through binding the β4 regulatory subunit of the 
BK channel and modulating its Ca2+ sensitivity (Deng et al., 2013). Loss of FMRP 
causes reduced channel activity and excessive AP broadening which in turns leads to 
increased presynaptic Ca2+ influx, increased synaptic transmission and the deficits in 
short-term plasticity (Deng et al., 2013). Furthermore, genetically (Deng and 
Klyachko, 2016) or pharmacologically (Hebert et al., 2014) enhancing BK channel 
activity in the absence of FMRP is sufficient to rescue multiple synaptic and 
behavioural phenotypes associated with FXS. Therefore, deficits in presynaptic 
activity observed in Fmr1 KO mice can be mediated by BK channel activity.  
 
In the peripheral nervous system, dorsal root ganglion (DRG) neurons display 
increased SV exocytosis at high frequency stimulation with unchanged rate and 
amount of endocytosis with short hairpin RNA (shRNA) mediated knock-down (KD) 
of FMRP (Ferron et al., 2014). This enhanced SV exocytosis may be due to increased 
presynaptic Ca2+ currents observed with FMRP KD. FMRP can directly interact with 
N-type voltage gated Ca2+ channels to regulate their density on the plasma membrane 
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(Ferron et al., 2014). FMRP can regulate N-type Ca2+ channel expression through 
directly binding them and targeting them for proteasomal degradation (Ferron et al., 
2014). This suggests, that in the absence of FMRP, there is increased channel density 
which mediates the increased presynaptic Ca2+ influx and altered neurotransmission. 
 
The loss of FMRP results in impaired synaptic and circuit function at both the 
postsynapse and the presynapse which is why FXS is characterised as a 
synaptopathy. The various presynaptic and postsynaptic phenotypes caused by the 
loss of FMRP make this a very robust model for studying synaptic dysfunction in 
neurodevelopmental disorders.  
 
1.2.3. Dynamin1 (DNM1) epileptic encephalopathy 
Epileptic encephalopathies comprise a group of childhood-onset severe seizure 
disorders where the epilepsy contributes to a disrupted cerebral functioning which 
can progress and worsen with time (Berg et al., 2010). De novo mutations in synaptic 
transmission genes including CDKL5, KCNQ2, STXBP1, DNM1, SLC1A2 and 
CACNA1A can give rise to epileptic encephalopathies (Asinof et al., 2015; Asinof et 
al., 2016; Boumil et al., 2010; Dhindsa et al., 2015; Epi4K Consortium et al., 2013; 
Epi4K Consortium, 2016; Fahrner et al., 2016; Nakashima et al., 2016). Two 
common disorders included in epileptic encephalopathies are infantile spasms and 
Lennox-Gastaut syndrome (Epi4K Consortium et al., 2013). Lennox-Gastaut 
syndrome is characterised by drug-resistant seizures of multiple types including 
tonic, atonic, and atypical absences, abnormal brain wave activity reported by 
electroencephalography (EEG) study and ID (Asadi-Pooya, 2017). De novo 
mutations in DNM1 account for approximately 2 % of cases of infantile spasms or 




Dynamin-1 (dyn1), the gene product of DNM1, was first described as a 
mechanochemical enzyme that could regulate microtubule bundling in a nucleotide-
dependent manner (Obar et al., 1990; Paschal et al., 1987; Shpetner and Vallee, 
1989). The first evidence of dyn1’s involvement in endocytosis came from the 
Drosophila melanogaster shibire temperature sensitive mutant (shibirets). The 
shibire gene encodes multiple forms of dynamin (M. S. Chen et al., 1991; van der 
Bliek and Meyerowitz, 1991). These proteins play an essential role in SV 
endocytosis, as the shibirets mutant exhibited muscle paralysis at restrictive 
temperatures, due to depletion of SVs at the neuromuscular junction because of 
impaired SV endocytosis (Grigliatti et al., 1973; Poodry and Edgar, 1979).  
 
There are three genes that encode different dynamin isoforms in mammals. Dyn1 is 
selectively expressed in the brain at high levels throughout postnatal development 
and adulthood (Cao et al., 1998; Cook et al., 1996; Faire et al., 1992; Nakata et al., 
1991). Dyn2 is ubiquitous, but expressed at lower levels in the brain where it may 
play a housekeeping role (Raimondi et al., 2011). Dyn3 is also expressed in the 
brain, however in lower levels that dyn1 (Cao et al., 1998; Cook et al., 1996). There 
is thought to be some functional overlap between the proteins as revealed by the 
generation of Dnm KO animal models (discussed below) (Ferguson et al., 2007; 
Raimondi et al., 2011). 
 
Dyn1 is composed of a GTPase domain (G domain) responsible for guanosine 
triphosphate (GTP) hydrolysis, a bundle signalling element (BSE) composed of a 
three-helix bundle and required for correct folding of the protein, the stalk through 
which dyn1 can dimerise, a PH domain where phosphoinositides can bind, a GTPase 
effector domain (GED) that regulates GTPase activity, and a proline-rich domain 
(PRD) which mediates its interactions with the Src homology 3 (SH3) domains of 





Figure 1.3 Domain structure of dyn1 
Adapted from Faelber et al. (2011) 
The G domain of dyn1 comprises a bundle signalling element (BSE) and G domain and it 
mediates GTP hydrolysis. The middle domain comprises a BSE and the stalk through which 
dyn1 can self-assemble. The pleckstrin homology (PH) domain is where phosphoinositides 
bind. The GTPase effector domain (GED) of dyn1 comprises a stalk domain as well as a 
BSE, this domain mediates GTPase activity. The PRD domain can mediate dyn1’s binding 
with SH3 domains.   
 
Dyn1 plays an important role in SV endocytosis. Dyn1 is recruited to invaginating 
membranes where it forms a helical “collar” structure around the neck of budding 
vesicles (Sweitzer and Hinshaw, 1998; Takei et al., 1995). This step is independent 
of GTP-binding (Shnyrova et al., 2013). Upon GTP hydrolysis, and conformational 
change, there is constriction and subsequent fission of the plasma membrane and 
formation of SVs (Damke et al., 2001; Marks et al., 2001; Sweitzer and Hinshaw, 
1998). At least two-rungs of dynamin are required for fission to occur (Shnyrova et 
al., 2013).  
 
Evidence obtained from Dnm1 KO mice suggests that dyn1 may not be essential for 
plasma membrane SV endocytosis. Dnm1 KO mice appeared normal at birth, 
however they died within 2 weeks. There were fewer and heterogeneously-shaped 
SVs present in cortical neurons as revealed by electron microscopy. SV recycling 
was impaired during stimulation, leading to an accumulation of interconnected 
clathrin-coated buds at cortical synapses (Ferguson et al., 2007; Hayashi et al., 2008). 
Additionally, endocytic capacity was saturated at a lower frequency stimulus load in 
Dnm1 KO neurons compared to WT, suggesting dyn1 plays a critical role in SV 
endocytosis (Ferguson et al., 2007; Hayashi et al., 2008). There was still some SV 
occurring in this model due to the functional overlap of dyn1 and dyn3 (Raimondi et 
al., 2011). The Dnm3 KO mouse did not appear to have any SV recycling deficits, 
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however Dnm1/3 double KO (DKO) mice died within hours of birth, suggesting a 
more severe effect of the DKO compared to Dnm1 KO or Dnm3 KO (Ferguson et al., 
2007; Raimondi et al., 2011). In both Dnm1 KO and DKO neurons there is increased 
cargo stranded on the membrane due to impaired endocytosis (Ferguson et al., 2007; 
Raimondi et al., 2011). There is an activity-dependent increase in number of 
endocytic intermediates and clathrin-coated pits accumulated in DKO neurons due to 
the impaired SV endocytosis. There is also loss of functional SVs (Raimondi et al., 
2011). This presynaptic phenotype could be reversed by silencing synaptic activity in 
culture with tetrodotoxin (TTX), perhaps suggesting a compensatory role of dyn2 in 
maintaining a low rate of SV recycling (Ferguson et al., 2007; Raimondi et al., 2011; 
Tanifuji et al., 2013). As expected, Dnm1/3 DKO neurons display a reduction in 
evoked EPSCs due to the reduced number of SVs in nerve terminals (Lou et al., 
2012; Raimondi et al., 2011). These neurons displayed decreased release probability 
rather than accelerated depression, suggesting that there are mechanisms in place to 
sustain neuronal activity in the presence of decreased SVs (Lou et al., 2012).  
 
Dnm1/2/3 conditional triple KO (cTKO) mice die a few hours after birth (Fan et al., 
2016), similar to the Dnm1/3 DKO (Raimondi et al., 2011). Dnm1/2/3 triple KO 
(TKO) mouse embryonic fibroblasts show impaired transferrin uptake suggesting 
impaired clathrin-mediated endocytosis (CME) (Park et al., 2013). These cells also 
displayed long, narrow, deeply invaginated pits (Park et al., 2013) similar to what is 
seen in Dnm1 KO and Dnm1/3 DKO nerve terminals (Ferguson et al., 2007; 
Raimondi et al., 2011). 
 
Both GTP binding and hydrolysis are required for membrane fission by dyn1, as 
using a non-hydrolisable form of GTP (GTPγS) impaired endocytosis (Marks et al., 
2001; Takei et al., 1995). However, GTP hydrolysis is not sufficient for endocytosis, 
conformational change induced by GTPase activity is also required (Damke et al., 
2001; Marks et al., 2001; Sweitzer and Hinshaw, 1998). Dyn1 GTPase activity is 
required for both CME (Hinshaw and Schmid, 1995; van der Bliek et al., 1993) and 
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activity-dependent bulk endocytosis (ADBE) (Clayton et al., 2009; Clayton et al., 
2010; Smillie and Cousin, 2012). GTP hydrolysis by the dyn1 “collar” induces 
constriction of the underlying membrane tube which then undergoes scission once it 
reaches a critically narrow radius (Dar et al., 2015).  
 
The GTPase activity of dyn1 can be differentially modulated. Dyn1 is usually present 
as homotetramers (Muhlberg et al., 1997) and can self-assemble into rings which 
stimulates its GTPase activity 5-10 fold (Hinshaw and Schmid, 1995; Warnock et al., 
1996). The self-assembly of dyn1 is mediated by the stalk domain (Ramachandran et 
al., 2007). Dyn1 also contains a GED located in the stalk (Sever et al., 2000). This 
GED functions as a GAP, since addition of an exogenous dyn1 GED increased 
unassembled dyn1’s GTPase activity 6-fold (Sever et al., 2000). Artificial templates 
such as microtubules or phospholipids also increase GTPase activity 50 fold 
(Barylko et al., 1998; Barylko et al., 2001; Lin et al., 1997; Tuma et al., 1993; Zheng 
et al., 1996). Dyn1 can bind the SH3 domains of multiple proteins through its PRD 
(Faelber et al., 2011). SH3 domains can differentially stimulate dyn1 assembly and 
GTPase activity (Gout et al., 1993; Krishnan et al., 2015). Some SH3 domains impair 
GTPase activity such as the cell division control protein 42 (Cdc42)- interacting 
protein 4 (CIP4) SH3 domain. Others enhance it including the SH3 domains of 
intersectin-1a (Krishnan et al., 2015) and amphiphysin-1 (Krishnan et al., 2015; 
Yoshida and Takei, 2005). 
 
Dyn1’s GTPase activity and subsequent conformational change is sufficient for 
membrane fission, however in vivo different functions of dyn1 are also required to 
ensure efficient SV endocytosis. The PH domain must be inserted in the plasma 
membrane to produce the membrane curvature required for dyn1 assembly in helical 
formation around budding vesicle (Ramachandran et al., 2009; Shnyrova et al., 
2013). Self-assembly of dyn1 into more complex helical structures are also required 
(Boumil et al., 2010; Ramachandran et al., 2007). Dyn1 is recruited to the clathrin 
lattice of early stage clathrin coated pits (M. J. Taylor et al., 2011; M. J. Taylor et al., 
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2012). This leads to the recruitment of more dyn1 as well as actin and the N- Bin-
amphiphysin-Rvs161/167 (BAR) proteins amphiphysin-1 and endophilin which are 
required for fission. Through a feedback loop, actin serves as a scaffold to maintain 
dynamin and N-BAR proteins at scission sites (M. J. Taylor et al., 2012).  
 
Dyn1 contains two phosphorylation sites at the C-terminus, serine 774 (S774) and 
S778 that can both be phosphorylated by Cdk5 in vitro (Tan et al., 2003). Dyn1 is 
constitutively phosphorylated in resting neurons. It becomes dephosphorylated by 
calcineurin upon depolarisation of the nerve terminal in an activity-dependent 
manner (Clayton et al., 2009). In vivo, Cdk5 phosphorylates dyn1 at S778. This 
phosphorylation primes dynamin for rephosphorylation at S774 by glycogen 
synthase kinase 3β (GSK3β) (Clayton et al., 2010). Dyn1’s dephosphorylation by 
calcineurin is required for its interaction with syndapin-1 which is required for 
ADBE but not CME (Clayton et al., 2009) (see section 1.3.2).  
 
Dyn1 phosphorylation can also be modulated by neuronal activity. For example, 
during high frequency stimulation, protein kinase B/Akt becomes activated by 
phosphorylation on Threonine 308 (T308) and S473 (Alessi et al., 1997; Sarbassov et 
al., 2005). This is indirectly mediated by phosphatidylinositol 3-kinase (PI3K) 
activation through Ca2+ microdomains due to increased neuronal activity (Nicholson-
Fish, Cousin et al., 2016; Smillie and Cousin, 2012). PI3K can then activate 
upstream activators of Akt including phosphatidylinositol-dependent kinase 1 
(PDK1) that can phosphorylate T308 and mammalian target of rapamycin (mTOR) 
complex 2 (mTORC2) that can phosphorylate S473. Additionally, the brain-derived 
neurotrophic factor (BDNF) can activate Akt through activation of PI3K (Nicholson-
Fish et al., 2016; Smillie et al., 2013). This suggests that an extracellular signalling 
molecule can affect SV endocytosis. GSK3β is inhibited by Akt phosphorylation on 
S9/21 and thus cannot phosphorylate dyn1. This allows dyn1 to be maximally 
dephosphorylated by calcineurin and allows ADBE to occur (Smillie and Cousin, 
2012). Dyn1’s activity-dependent dephosphorylation and subsequent 
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rephosphorylation (Figure 1.2) are required for correct functioning of ADBE at nerve 
terminals (Clayton et al., 2010; Smillie and Cousin, 2012).  
 
Deficits observed in patients with epileptic encephalopathy due to heterozygous 
mutations in DNM1 may result from dyn1 dysfunction impairing efficient 
neurotransmission and SV endocytosis. Thus, these models are appropriate for 
elucidating the role of defective SV recycling in neurodevelopmental disorders. 
 
 
Figure 1.4 Dyn1 dephosphorylation-rephosphorylation cycle 
Figure adapted from Smillie and Cousin (2011) 
(1) Cdk5 is constitutively active and can phosphorylate dyn1 at rest on S778. (2) Once it has 
been primed by Cdk5, constitutively active GSK3β can phosphorylate dyn1 on S778. Upon 
increased neuronal activity: (3) Ca2+ and calmodulin activate the phosphatase calcineurin 
which dephosphorylates dyn1; (4) PI3K can activate Akt which through phosphorylation 
inhibits constitutively active GSK3β allowing dyn1 to be dephosphorylated.  
GSK3β can then rephosphorylate dyn1 after it has been primed by Cdk5 phosphorylation.  
Blue arrow indicates dephosphorylation, red arrows indicate phosphorylation, grey arrows 




1.3. Synaptic vesicle (SV) recycling 
Neurotransmission allows for the transmission of information between neurons. The 
arrival of action potentials (APs) at nerve terminals lead to depolarisation of the 
nerve terminal and activation of voltage-gated Ca2+ channels. The high intracellular 
free calcium concentration ([Ca2+]i ) triggers fusion of SVs and release of 
neurotransmitters. Chemical signals received across synapses are then transformed 
into electrical currents, through signalling downstream of neurotransmitter receptors, 
to allow signal transduction across neuronal networks to sustain neuronal activity 
(Sudhof, 2004).  
 
1.3.1. SV Exocytosis 
Neurons transmit signals by release of neurotransmitters in response to APs. The 
neurotransmitters are packaged in SVs. The vacuolar H+-adenosine triphosphatase 
(ATPase) mediates the acidification of SVs which is necessary for refilling them 
with neurotransmitter. The vacuolar H+-ATPase uses energy from ATP hydrolysis to 
create an electrochemical gradient across SV membranes to drive H+ influx leading 
SVs to acidify. SVs are filled through neurotransmitter-specific transporters that can 
exchange lumenal H+ for cytoplasmic neurotransmitter (reviewed in Edwards, 2007). 
Upon AP and calcium influx, these neurotransmitter-filled SVs fuse with the 
presynaptic membrane and release their content into the synaptic cleft where they 
can bind their target receptors (Sudhof, 2004).  
 
SVs dock and fuse at the presynaptic active zone (AZ). The AZ is a large protein-
dense structure located across the synaptic cleft from PSDs. The AZ can link SVs to 
voltage-gated Ca2+ channels through its dense protein scaffolding to facilitate SV 
fusion. The AZ can also organise presynaptic receptors and membrane composition 





SV exocytosis is mediated by the soluble N-ethylmaleimide-sensitive factor (NSF)-
attachment protein receptor (SNARE) complex (reviewed in Rizo and Xu, 2015; 
Sudhof and Rizo, 2011). Synaptobrevin-2 on SVs can interact with synaptosomal-
associated protein 25 (SNAP-25) and syntaxin-1 on the plasma membrane to form 
the SNARE complex. These proteins work together to bridge the SV to the plasma 
membrane for docking. Different AZ proteins including the scaffolds piccolo and 
bassoon, Rab3-interacting molecules (RIMs) and RIM-binding proteins may also be 
involved in the SV docking process (reviewed in Rizzoli, 2014). In particular, RIMs 
may interact with SVs to ensure their docking at the AZ (Haucke et al., 2011). RIMs 
can also mediate Ca2+ channel tethering at the AZ (Kaeser et al., 2011). Therefore, 
SVs are docked in proximity to Ca2+ channels ensuring optimal Ca2+-sensing of the 
SV fusion machinery.  
 
SVs can be primed once they are docked at the AZ. Priming is essential to ensure 
SVs can undergo fusion. RIMs, mammalian uncoordinated (Munc)-13 and Munc-18 
are required for this step (reviewed in Rizo and Xu, 2015; Rizzoli, 2014). RIM can 
directly bind to Munc-13 to regulate its activity. Munc-13 and Munc-18 cooperate to 
promote correct assembly of the SNARE complex for efficient SV fusion (Lai et al., 
2017). Together, they can promote the correct assembly the syntaxin-1-SNAP-25 
sub-complex. Munc13 can additionally ensure the correct assembly of syntaxin-1-
synaptobrevin-2 sub-complex (Lai et al., 2017). Complexin can also bind the 
SNARE complex to maintain its stability and increase SV fusion probability 
(Trimbuch and Rosenmund, 2016). 
 
During evoked release, Ca2+ enters the nerve terminal and binds to the SV protein 
synaptotagmin-1 with low affinity. Ca2+-bound synaptotagmin-1 interacts with both 
the SNARE complex and the plasma membrane to promote SV fusion. 
Synaptotagmin-1 is thought to promote membrane curvature (Martens et al., 2007) to 
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bring the SV closer to the plasma membrane and leads to the opening of the fusion 
pore. The primed SV can then completely merge with the plasma membrane at the 
fusion pore to release neurotransmitters. Munc-18 and protein chaperones are also 
required for efficient SV exocytosis. After SV fusion, the zippered SNARE complex 
must be disassembled by the ATPase NSF and SNAP proteins to allow subsequent 
rounds of SV fusion (Rizo and Xu, 2015; Sudhof and Rizo, 2011).  
 
The SVs in the nerve terminal can be divided into two pools that can be mobilised by 
APs (reviewed in Alabi and Tsien, 2012; Rizzoli and Betz, 2005): the readily 
releasable pool (RRP), which, as the name states, is made up of primed SVs already 
situated near the AZ ready to be released, and the reserve pool which contains the 
SVs that are only mobilised during high intensity stimulation. There is also an 
additional pool, the resting pool, which accounts for 50 % of all the SVs in the nerve 
terminal. The SVs in this pool remain unreleased even after intense stimulation 
(Alabi and Tsien, 2012). There is evidence that this pool of SVs participates is 
spontaneous release, independent of APs (Fredj and Burrone, 2009) to modulate 
network maturation and homeostasis (Kavalali, 2015).  
 
1.3.2. SV Endocytosis 
There are a limited number of SVs in the nerve terminal (N. Harata et al., 2001). 
New SVs need to be formed to ensure that neurotransmission is continued, especially 
during sustained neuronal activity. New SVs can be formed through endocytosis of a 
portion of the plasma membrane. Once new SVs are formed, they are acidified, filled 
with neurotransmitter, as previously described, and prepared to undergo another 
round of exocytosis (H. T. McMahon and Boucrot, 2011).  
 
There are several different SV endocytosis pathways (Figure 1.5). 1- CME (section 
1.3.2.1) by which individual SVs are endocytosed by means of a clathrin coat 
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(Heuser and Reese, 1973). 2- ADBE (section 1.3.2.2) where a large invagination 
forms an endosome from the presynaptic membrane from which individual SVs can 
then be formed (Miller and Heuser, 1984). 3- Ultrafast endocytosis (section 1.3.2.3) 
occurs on the edge of the active zone where a portion of the plasma membrane is 
retrieved. This form of endocytosis occurs 200-fold faster than in CME (Watanabe, 
Liu et al., 2013; Watanabe, Rost et al., 2013). 4- Kiss-and-run is when the SV does 
not fully fuse with the synaptic membrane at the AZ and thus retrieved intact (Alabi 
and Tsien, 2013; Fesce et al., 1994; N. C. Harata et al., 2006). The mode of 
endocytosis that the SVs undergo depends on multiple factors including the nerve 
terminal, the intensity of stimulation, the duration of stimulation and the proteins 
present (reviewed in Cousin, 2017; Kononenko and Haucke, 2015; H. T. McMahon 
and Boucrot, 2011; Saheki and De Camilli, 2012; Watanabe and Boucrot, 2017). 
 
 
Figure 1.5 SV endocytosis 
Adapted from Clayton et al. (2007) 
Different modes of SV endocytosis occurring at the nerve terminal: kiss-and-run, ultrafast 
endocytosis, clathrin-mediated endocytosis (CME) and activity-dependent bulk endocytosis 
(ADBE). CME preferentially refills the RRP whereas ADBE refills the reserve pool that is only 
mobilised upon high neuronal activity. It is still unclear which pool is refilled through ultrafast 
endocytosis. CME and SV budding from ultrafast endosomes and bulk endosomes are 




1.3.2.1. Clathrin-mediated endocytosis (CME)  
CME is the major form of endocytosis that occurs after physiological stimuli 
(Granseth et al., 2006). CME can retrieve individual SVs on the order of tens of 
seconds (Granseth et al., 2006). CME is composed of different stages: nucleation, 
invagination, fission and uncoating (reviewed in H. T. McMahon and Boucrot, 2011; 
Saheki and De Camilli, 2012).  
 
Nucleation occurs in the periactive zone of synaptic terminals. Phosphatidylinositol 
4,5-bisphosphate (PIP2) initiates the nucleation process by recruiting the F-BAR 
Fer/Cip4 homology domain-only protein (FCHo) to bind it at the plasma membrane. 
FCHo can then recruit epidermal growth factor receptor substrate 15 (eps15) and 
intersectins to form the initial scaffolding around the nucleation site to recruit 
adaptor and accessory proteins (Henne et al., 2010). They can also induce curvature 
of the plasma membrane. Intersectin contains five SH3 domains through which it can 
interact with dynamin-1 and synaptojanin (Saheki and De Camilli, 2012).  
 
Adaptor protein-2 (AP-2) and AP180, as well as epsins are among the proteins that 
are recruited to the nucleated pit. These proteins bind to the plasma membrane and 
can continue to induce curvature. AP-2 can directly bind to FCHo. This interaction 
activates AP-2 through a conformational change which promotes cargo recognition 
and binding (Hollopeter et al., 2014). The adaptor proteins AP-2 and AP180 can 
recognise and recruit cargo proteins through cargo-specific amino acid motifs and 
sequences (Saheki and De Camilli, 2012).  
 
Once clathrin adaptors have been recruited, clathrin can be recruited to the plasma 
membrane invagination by AP180 and AP-2 (Ford et al., 2001). AP-2, AP180 and 
epsin then promote the clathrin cage formation (H. T. McMahon and Boucrot, 2011). 
Synaptotagmin-1 can also directly interact with AP-2 to promote clathrin cage 
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assembly (Haucke and De Camilli, 1999). Clathrin forms triskelia composed of three 
molecules of clathrin light chain (CLC) and three molecules of clathrin heavy chain 
(CHC). Once the clathrin has polymerised, it stabilises the curvature of the 
membrane and forms a clathrin-coated bud (H. T. McMahon and Boucrot, 2011).  
 
During the nucleation stage, the different proteins recruited can also start the 
invagination process by promoting membrane curvature. As previously mentioned, 
the F-BAR protein FCHo can promote membrane curvature (Saheki and De Camilli, 
2012). Epsin can also directly deform and curve the plasma membrane through 
inserting its amphipathic α-helix into the plasma membrane upon binding PIP2 (Ford 
et al., 2002). Other proteins with BAR domains have been proposed to mediate 
membrane invagination including endophilin (Verstreken et al., 2002) and 
amphiphysin-1 (Di Paolo et al., 2002). Disruption of the actin cytoskeleton impaired 
SV endocytosis and the transport of SVs into SV clusters suggesting a critical role of 
actin in CME (Shupliakov et al., 2002). Actin is proposed to serve as a scaffold 
surrounding the invaginating clathrin-coated pit. It may tether other required 
molecules in place during this process (Sankaranarayanan et al., 2003).  
 
Dyn1 is recruited by amphiphysin-1 and endophilin to the clathrin cage at the 
formation of clathrin-coated pits through its PRD domain interacting with the SH3 
domains of these BAR proteins (M. J. Taylor et al., 2011; M. J. Taylor et al., 2012). 
Dyn1 mediates the fission of the clathrin-coated vesicle from the plasma membrane. 
Dyn1 can self-assemble into helical rings “collars” around the necks of invaginating 
SVs (Sweitzer and Hinshaw, 1998; Takei et al., 1995). Dyn1 undergoes a 
conformational change mediated by GTP hydrolysis leading to constriction at the 
neck of the clathrin-coated pit and fission of the plasma membrane to form SVs 
(Damke et al., 2001; Marks et al., 2001; Sweitzer and Hinshaw, 1998). Genetic or 
pharmacological disruption of dyn1 impairs CME, suggesting that dyn1 plays a 
critical role in SV recycling through this pathway (Schmid and Frolov, 2011) (Also 




The clathrin coat is immediately disassembled by heat shock cognate 70 (HSC-70), 
auxilin, and synaptojanin following fission. Synaptojanin is recruited to clathrin-
coated SVs through its interaction with endophilin (Gad et al., 2000; Verstreken et 
al., 2003). Synaptojanin dephorylates the nucleation protein PIP2 which results in the 
removal of the adaptor and accessory proteins from the SV membrane (H. T. 
McMahon and Boucrot, 2011). Auxilin can then recruit HSC-70 to the clathrin coat 
and promote its ATPase activity. Through ATP hydrolysis, HSC-70 can disrupt 
clathrin-clathrin interactions to dissociate the clathrin coat (Lemmon, 2001). After 
uncoating, SVs recycled through CME join the RRP to undergo further rounds of 
exocytosis (Cheung et al., 2010).  
 
CME occurs during low levels of neuronal activation (Granseth et al., 2006). There is 
only enough clathrin present in nerve terminals to recycle ~7 % of SVs 
simultaneously through CME (Lopez-Murcia et al., 2014; Wilhelm et al., 2014). 
Therefore, upon elevated neuronal activity another mode of endocytosis must occur 
to ensure sustained neurotransmission.  
 
1.3.2.2. Activity-dependent bulk endocytosis (ADBE) 
ADBE occurs at synapses during high frequency stimulation (Clayton et al., 2008; 
Nguyen et al., 2012) when endocytosis of individual SVs by CME cannot maintain 
synaptic transmission. During high frequency stimulation, there is invagination of a 
large portion of the plasma membrane which goes on to form a bulk endosome. 
Individual SVs can then bud off from this large bulk endosome structure (reviewed 
in Clayton and Cousin, 2009a).  
 
ADBE is thought to be dyn1-dependent (Clayton et al., 2007; Clayton et al., 2009; 
Clayton et al., 2010; Kononenko et al., 2014; Nguyen et al., 2012). Our group has 
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shown that in order for ADBE to occur, dyn1 must undergo an activity-dependent 
dephosphorylation-rephosphorylation cycle (Clayton et al., 2007; Clayton et al., 
2009; Clayton et al., 2010). Upon high intensity stimulation, there is a large influx of 
Ca2+ in nerve terminals which activates calmodulin. Together, Ca2+ and calmodulin 
can activate the phosphatase calcineurin. Calcineurin then dephosphorylates dyn1 
allowing ADBE to occur.  
 
Dephosphorylated dyn1 can bind the SH3 domain of syndapin-1 (Anggono et al., 
2006). This interaction with syndapin-1 is required for ADBE to occur (Clayton et 
al., 2009). Syndapin-1 is a neuronal protein in the BAR family (reviewed in Quan 
and Robinson, 2013). Syndapin-1 has an F-BAR domain at it’s N-terminus (Quan 
and Robinson, 2013). F-BAR domains preferentially interact with membranes that 
have a shallow curvature (Henne et al., 2007; Shimada et al., 2007). Although the 
exact role of syndapin-1 in ADBE remains unknown, it is possible that it can bind to 
and facilitate the curvature of large bulk endosomes (Clayton et al., 2009) 
Furthermore, it may serve to recruit dephosphorylated dyn1 to large bulk endosomes. 
 
ADBE can be abolished by genetically or pharmacologically inhibiting GSK3β and 
preventing its phosphorylation of dyn1 (Clayton et al., 2010). Additionally, 
overexpressing dominant-negative mutants of dyn1 which prevent GSK3β 
phosphorylation at S774 inhibit ADBE (Clayton et al., 2009). siRNA-mediated KD 
of Dyn1 and dyn3 or dyn2 also impaired endocytic retrieval at high frequency 
stimulation, purported to be ADBE (Kononenko et al., 2014).  
 
Dyn1’s GTPase activity is also required for bulk endosome fission from the plasma 
membrane. Pharmacologically blocking dyn1’s activity with dynasore inhibited 
ADBE (Clayton et al., 2009). However, it is important to note that dynasore still 
arrests endocytosis in Dnm TKO cells, meaning that it may not be acting via dyn 
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GTPase activity (Park et al., 2013). Taken together, this provides evidence of the 
importance of dyn1 and the phosphorylation of S774 for the triggering of ADBE. 
 
Interestingly, other groups have suggested that ADBE may be dyn1-independent, as 
ADBE can still occur in Dnm1/3 DKO neurons (Wu et al., 2014). Large bulk 
endosomes could still be generated in DKO nerve terminals following depolarisation 
by high K+ concentration or high frequency electrical stimulation (Wu et al., 2014). 
Additionally, new fully functional SVs could be generated from these endosomes, 
suggesting that dyn1 does not play a role in SV budding (Wu et al., 2014). This 
would suggest that ADBE is dyn-independent. However, it is important to note that 
there are a few caveats to this study. Dnm1/3 DKO mice die shortly after birth 
however their neurons do not appear morphologically different to WT neurons in 
culture (Raimondi et al., 2011). This could suggest that there is a compensatory 
mechanism that can mediate neuronal activity in culture. This compensatory 
mechanism may act through dyn2 which is still expressed at low levels in these 
neurons (Raimondi et al., 2011). There is overlapping function between the three 
dynamin proteins (Hayashi et al., 2008; Raimondi et al., 2011). Dyn2 may be able to 
sustain neuronal activity in the absence of the other two isoforms (Ferguson et al., 
2007; Hayashi et al., 2008; Raimondi et al., 2011). Indeed, Dnm1 KO (Ferguson et 
al., 2007) and Dnm1/3 DKO neurons (Raimondi et al., 2011) can still undergo some 
CME despite its dependence on dyn1.  
 
Actin is another protein which has been proposed to modulate ADBE. Interestingly, 
the PI3K-Akt pathway that is required to mediate the dyn1 dephosphorylation-
rephosphorylation cycle required for ADBE can also promote actin remodelling in 
chicken embryo fibroblasts (Qian et al., 2004). This perhaps hints to a convergence 
of actin and dyn1 activation to promote ADBE. In retinal bipolar cells, stimulus-
dependent growth of the actin network through actin polymerisation was required for 
ADBE. The actin remodelling in this model was also dependent on Ca2+ and PI3K 
signalling (Holt et al., 2003). Actin polymerisation is proposed to be essential for the 
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budding of recyclosome vesicles from the bulk endosomes at amphibian 
neuromuscular junctions (Nguyen et al., 2012). Actin polymerisation is also required 
for ADBE in neurosecretory chromaffin cells (Gormal et al., 2015). In these cells, 
actin forms a contractile ring around the neck of large plasma membrane 
invaginations. Along with myosin-2, the actin rings can constrict the neck of the bulk 
endosome precursors. Dyn2 GTPase activity then mediates fission from the plasma 
membrane (Gormal et al., 2015). Finally, in hippocampal neurons, ADBE was 
impaired by preventing actin polymerisation by treatment with latrunculin-A 
(Kononenko et al., 2014). Therefore, actin remodelling and polymerisation may be 
required for efficient membrane retrieval by ADBE. 
 
Endophilin has also been proposed to mediate ADBE (Kononenko et al., 2014). 
Endophilin is a N-BAR domain-containing protein that can directly bind the lipid 
bilayer to promote curvature (Farsad et al., 2001). Endophilin can form complexes 
with dyn1 on lipid tubules to regulate its fission activity (Farsad et al., 2001). 
Therefore, endophilin may act to reshape the membrane to promote ADBE.  
 
After formation of the bulk endosome, budding off of individual SVs occur. These 
newly formed SVs replenish the reserve pool (Cheung et al., 2010; Cheung and 
Cousin, 2012). This process is proposed to be clathrin-dependent and cannot occur 
when endogenous clathrin is disrupted, even though bulk-endosome formation is 
clathrin-independent and can occur under these conditions (Heerssen et al., 2008; 
Kasprowicz et al., 2008; Kononenko et al., 2014). Budding of SVs from bulk 
endosomes also requires adaptor proteins (Cheung and Cousin, 2012; Kononenko et 
al., 2014) that can mediate SV formation and SV cargo retrieval (reviewed in Cousin, 
2017). The adaptor proteins AP-1 and AP-3 can both mediate SV budding suggesting 
perhaps a separate and sequential role of these two adaptor proteins in this process 
(Cheung and Cousin, 2012). Additionally, AP-2, clathrin’s major adaptor protein, is 
involved in budding as AP-2 cKO results in accumulation of bulk endosomes 




There is some evidence suggesting that the budding of SVs may be clathrin-
independent (Wu et al., 2014). In Dnm1/3 DKO neurons, lentiviral KD of CHC did 
not impair SV reformation from bulk endosomes after high frequency stimulation. In 
fact, reformation of SVs and depletion of bulk endosomes occurred to the same 
extent in both the CHC KD and control conditions (Wu et al., 2014). However as 
previously mentioned, the Dnm1/3 DKO neuron model may be flawed due to 
excessive compensation in the absence of dynamin.  
 
SV budding from bulk endosomes is also Ca2+-dependent (Cheung and Cousin, 
2013). There is fluid phase uptake of Ca2+ from the extracellular milieu into the bulk 
endosome during its formation. Acidification of the bulk endosomes through the 
vacuolar H+-ATPase leads to Ca2+ efflux from the endosome into the cytoplasm. This 
Ca2+ can then activate calcineurin which is required for SV budding (Cheung and 
Cousin, 2013). In fact, buffering intracellular or intra-endosomal Ca2+ disrupted SV 
budding from bulk endosomes. Additionally, pharmacologically inhibiting the 
vacuolar H+-ATPase or calcineurin also prevented SV budding (Cheung and Cousin, 
2013). Taken together this suggests that Ca2+ activation of the phosphatase 
calcineurin is required for ADBE both to signal bulk endosome formation and SV 
budding.  
 
Our group has also identified an ADBE-specific cargo: the vesicle-associated 
membrane protein-4 (VAMP4) (Nicholson-Fish et al., 2015). VAMP4 was found to 
be enriched on bulk endosomes and essential for efficient ADBE (Nicholson-Fish et 
al., 2015). VAMP4 had previously been reported to mediate Ca2+-dependent 
asynchronous release through interacting with a subset of SNARE proteins (Raingo 
et al., 2012). This provides further evidence for a role of ADBE for preferentially 
replenishing a pool of SVs for asynchronous release (see Bacaj et al., 2013; 
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Evstratova et al., 2014; Y. C. Li et al., 2017; Nicholson-Fish et al., 2015; Raingo et 
al., 2012).  
 
Some key molecules in ADBE have been identified, however there are still many 
unknowns regarding the trafficking of endocytic pathway including whether or not 
bulk endosomes fuse with other endosomal pathways before SV budding occurs 
(reviewed in Cousin, 2015).  
 
1.3.2.3. Ultrafast endocytosis 
Ultrafast endocytosis is a mode of endocytosis that was recently discovered at the 
neuromuscular junction of Caenorhabditis elegans and is thought to be 
evolutionarily conserved across species (Watanabe et al., 2013; Watanabe et al., 
2013). This form of endocytosis can be triggered by a single AP under 
physiologically relevant conditions in both intact Caenorhabditis elegans and 
dissociated mouse hippocampal neurons (Watanabe et al., 2013; Watanabe et al., 
2013). Interestingly, no CME is observed at physiological temperatures using these 
stimulation conditions (Watanabe et al., 2014). This suggests that ultrafast 
endocytosis may be the dominant endocytic mode during mild stimulation. Ultrafast 
endocytosis occurs on a much more rapid scale of any previously defined modes of 
endocytosis (Watanabe et al., 2013; Watanabe et al., 2013; Watanabe and Boucrot, 
2017).  
 
SV exocytosis triggered by a single pulse of blue light exciting an exogenously 
expressed channelrhodopsin triggers ultrafast endocytosis on the edge of active zones 
within 50 ms of stimulation (Watanabe et al., 2013; Watanabe et al., 2013). The 
majority of SVs are recycled through ultrafast endocytosis under these stimulation 
conditions (Watanabe et al., 2013). Addition of membrane to the nerve terminal 
through SV exocytosis is required for ultrafast endocytosis to occur. Immediately 
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following SV exocytosis (within 50-100 ms) shallow endocytic pits begin to form on 
the edge of the active zone. These shallow pits then form deeper invaginations which 
are thought to be precursors of “large vesicles”. These “large vesicles” have the 
surface area of approximately 2-4 SVs and scale with the amount of SV exocytosis 
occurring at the AZ (Watanabe et al., 2013; Watanabe et al., 2013). Within 300 ms of 
stimulation, the “large vesicles” are resolved into smaller SVs (Watanabe et al., 
2013; Watanabe et al., 2013).  
 
Ultrafast endocytosis is actin-dependent as disruption of actin polymerisation by 
latrunculin-A inhibits the formation of endocytic structures after SV exocytosis 
(Watanabe et al., 2013). Ultrafast endocytosis is also mediated by dyn1 activity. 
Genetic (Watanabe et al., 2013) or pharmacological disruption (Watanabe et al., 
2013) of dyn1 prevents the formation of “large vesicles”. Instead, there are large 
deep invaginations that remain attached to the plasma membrane. This suggests that 
perhaps dyn1’s GTPase activity is required for membrane fission in this form of 
endocytosis. Additionally, at physiological temperatures, clathrin is required for SV 
budding from endosomes, although it is not required for the formation of ultrafast 
endosomes (Watanabe et al., 2014). This is similar to; the role that clathrin is 
proposed to play in ADBE (Heerssen et al., 2008; Kasprowicz et al., 2008; 
Kononenko et al., 2014), perhaps suggesting a common underlying mechanism 
relating these two endocytic modes. 
 
1.4. Monitoring SV recycling 
Different live-cell imaging reporters can be used to measure the SV exocytosis and 
endocytosis occurring in neuronal cultures. These include styryl dyes, synaptic 
pHluorins (reviewed in Kavalali and Jorgensen, 2014; Ryan, 2001) and fluorescent 
dextrans (Clayton and Cousin, 2009b). Styryl dyes are amphipathic dyes that can 
label SV membranes. In brief, uptake of styryl dyes allow for the visualisation of SV 
trafficking through different endocytic pathways. FM dyes have different properties 
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and can thus report different modes of endocytosis with FM1-43 reporting both CME 
and ADBE, and FM2-10 only reporting CME (Clayton and Cousin, 2009b; Richards 
et al., 2000). In this work we used pHluorins (described in section 1.4.1) and 
fluorescent dextran (described in section 1.4.2) to monitor SV exocytosis and 




PHluorins are modified pH-sensitive green fluorescent proteins (GFPs), (Miesenbock 
et al., 1998). Their fluorescence is quenched by acid. Fusing pHluorins to the lumen 
of synaptic proteins allows the synaptic pHluorin to report SV recycling 
(Miesenbock et al., 1998; Sankaranarayanan et al., 2000). When the pHluorin is in 
the acidic lumen of the SV it remains quenched. It is possible to observe an 
exocytosis-dependent increase in fluorescence signal as SVs fuse with the plasma 
membrane, exposing the pHluorin to a neutral pH ~7.4 (Miesenbock et al., 1998; 
Sankaranarayanan et al., 2000; Sankaranarayanan and Ryan, 2000). After 
endocytosis, SVs are reacidified through the vacuolar H+-ATPase. This proton pump 
creates an electrochemical gradient across the SV membrane which is required for 
neurotransmitter loading into the SV (reviewed in Edwards, 2007). Once the SV has 
been reacidified after endocytosis, the pHluorin is once again quenched, therefore 
pHluorins report the reacidification of SVs. This reacidification of endocytosed SVs 
occurs on the order of ~5 s (Atluri and Ryan, 2006; see also Egashira et al., 2015), 
whereas endocytosis occurs on a slower timescale τ ~ 15 s, (Granseth et al., 2006), 
making endocytosis the rate limiting step. Thus, pHluorins provide a real-time 





1.4.1.1. Synaptophysin-pHluorin (sypHy) and vesicular glutamate transporter-pHluorin 
(vGLUT-pH) 
Both synaptophysin-pHluorin (sypHy) and vesicular glutamate transporter-pHluorin 
(vGLUT-pH) produce the characteristic fluorescence trace with increased 
fluorescence upon SV exocytosis which returns to baseline following SV endocytosis 
and subsequent reacidification (Figure 1.4). SypHy was created by fusing the 
pHluorin into the second intra-vesicular loop of synaptophysin-1 (Granseth et al., 
2006). For vGLUT-pH, the pHluorin was fused to the first lumenal loop of vGLUT 
(Voglmaier et al., 2006). These reporters are targeted to SVs and have good signal-to 
noise ratios due to low surface expression on the plasma membrane (Granseth et al., 
2006; Sankaranarayanan and Ryan, 2000; Voglmaier et al., 2006). SypHy and 
vGLUT-pH fluorescence traces were not altered in the presence of a GSK3 
antagonist CT99021 (Nicholson-Fish et al., 2015) which has previously been shown 
to impair ADBE but not CME (Clayton et al., 2010). Therefore, these two pHluorins 




Figure 1.6 Synaptic pHluorin imaging 
Figure adapted from Sankaranarayanan (2000) 
Fluorescence trace as a response to SV exocytosis and endocytosis. When the lumen of the 
SV becomes exposed to a neutral pH during exocytosis, the pH-sensitive GFP in the lumen 
of the SV becomes unquenched and fluoresces. When the SV is endocytosed and 




1.4.1.2. Vesicle-associated membrane protein-4-pHluorin (VAMP4-pH) 
A new pHluorin was recently identified as a reporter of ADBE. VAMP4-pH was the 
only reporter that showed impaired response with genetic or pharmacological block 
of ADBE compared to sypHy, vGLUT-pH, synaptobrevin-2-pHluorin and 
synaptotagmin-1-pHluorin (Nicholson-Fish et al., 2015). VAMP4-pH was created by 
fusing the pHluorin into C-terminal lumenal domain of VAMP4 (Nicholson-Fish et 
al., 2015). VAMP4 was also found to be enriched on bulk endosomes compared to 
clathrin-coated vesicles, providing further evidence that this protein is a cargo of 
ADBE (Nicholson-Fish et al., 2015).  
 
VAMP4-pH expressed in nerve terminals displays a different fluorescence response 
compared to sypHy and vGLUT-pH (Nicholson-Fish et al., 2015; Raingo et al., 
2012). The combination of fluorescence traces from all nerve terminals usually 
results in a fluorescence trace that does not significantly deviate from baseline during 
stimulation. However, when individual nerve terminals are assessed on stimulation, 
VAMP4-pH fluorescence can either increase or decrease. The decrease in 
fluorescence (“down” trace) represents the slow acidification of bulk endosomes. 
The increase in fluorescence (“up” trace) represents asynchronous release (Figure 
1.5).  
 
VAMP4-pH is more localised at the plasma membrane than sypHy or vGLUT-pH. 
More fluorescence is therefore unquenched resulting in high levels of baseline 
fluorescence. Upon high frequency stimulation, when ADBE is recruited, 
fluorescence decreases over time in line with the slow reacidification of bulk 
endosomes (Nicholson-Fish et al., 2015; Nicholson-Fish, Smillie et al., 2016). 
Although it has been demonstrated that all nerve terminals can undergo ADBE, they 
do not all undergo ADBE upon every high frequency stimulation (Nicholson-Fish et 
al., 2016). Nerve terminals that do not undergo ADBE show a slow increase in 
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fluorescence upon high frequency stimulation. This increase in fluorescence is 
proposed to be due to VAMP4-dependent asynchronous release (Raingo et al., 2012). 
The sorting of VAMP4-pH time traces into “up” or “down” traces allows for ADBE 
to be monitored at individual nerve terminals.  
 
 
Figure 1.7 VAMP4-pH imaging 
VAMP4-pH allows for ADBE recruitment to be monitored at individual nerve terminals. 
VAMP4-pH fluorescence traces can be sorted into “up” traces representing asynchronous 
release adding more VAMP4 to the plasma membrane and “down” traces representing 
ADBE and the slow reacidification of bulk endosomes. Bar indicates high frequency 
stimulation.  
 
1.4.2. Tetramethylrhodamine (TMR) dextran uptake 
Dextrans are large polysaccharides that can be used as inert fluid phase markers. 
Upon high frequency stimulation, 40 kDa fluorescent tetramethylrhodamine (TMR) 
dextran is preferentially internalised by ADBE due to its large size (Berthiaume et 
al., 1995; Clayton and Cousin, 2009b; Holt et al., 2003; Teng et al., 2007). Dextran is 
not found in SVs suggesting it is not being endocytosed via the CME pathway (Holt 
et al., 2003; Teng et al., 2007). TMR dextran fluorescence at nerve terminals does 
not correlate with the extent of ADBE occurring, perhaps due to the low number of 
bulk endosomes present at each nerve terminal and the limited number of dextran 
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particles that can fit into each bulk endosome. Background TMR puncta display 
similar fluorescence intensities to internalised TMR dextran fluorescence (Clayton 
and Cousin, 2009b). However, TMR dextran can provide information about the 
number of nerve terminals that undergo ADBE upon high frequency stimulation, 
similar to how VAMP4-pH reports ADBE (Clayton and Cousin, 2009b). Therefore, 
TMR dextran is a selective reporter for nerve terminals undergoing ADBE.  
 
1.5. Hypothesis 
ID, ASD and epilepsy are difficult to study due to the complex interplay of genetic, 
epigenetic and environmental factors underlying the disorders. A common 
mechanism is thought to underlie these three neurodevelopmental disorders, due to 
their high comorbidity. FXS, SYNGAP1 haploinsufficiency and DNM1 epileptic 
encephalopathy are monogenic diseases that can cause these disorders. Furthermore, 
they are all characterised by impaired synaptic function and there is evidence for 
presynaptic deficits in each condition. Fmr1 KO hippocampal neurons show altered 
SV recycling and SV pool sizes (Deng et al., 2011; Deng et al., 2013; Ferron et al., 
2014). During development, SynGAP1 Het mice show altered mEPSC frequency in 
the forebrain which may be a sign of altered release probability (Clement et al., 
2012). Correct functioning of dyn1 is required for SV endocytosis and thus necessary 
for maintained neurotransmission (Damke et al., 2001; Ferguson et al., 2007; Marks 
et al., 2001).  
 
Based on these findings, we hypothesize that altered SV recycling in the presynapse 
is an important pathological feature of ID, ASD and epilepsy, particularly in models 





The overarching aims of this work were to characterise SV exocytosis and 
endocytosis deficits in models of SYNGAP1 haploinsufficiency, FXS, and DNM1 
epileptic encephalopathy using synaptic pHluorins, and large fluorescent TMR 
dextran. These live-cell imaging techniques provide ways to track SV recycling 
independently through either the CME or the ADBE modes to isolate which pathway 
may be defective in these models. Additionally, these experiments can provide 
insight into the roles that these proteins and their different domains play in different 
components of SV recycling. Repeating the same imaging assay on various 
preclinical models of neurodevelopmental disorders can elucidate whether these 
disorders may all use a converging SV recycling pathway to disrupt neuronal 
development and synaptic plasticity. Furthermore, we also aimed to see whether 
some of the impaired SV recycling defects observed could be rescued with 




2. Materials and methods 
 
2.1. Materials 
Unless specified otherwise, general reagents were acquired from Sigma Aldrich 
(Gillingham, UK). All other reagents used can be found in Table 2.1. 
 
 






Hyperladder 1 kb DNA 
markers  
Bioline, London UK; 
33053 
Green Reaction Buffer  Promega, Wisconsin 
USA; M7841 






Invitrogen, Paisley UK, 
18427013 
Proteinase K Promega, Wisconsin 
USA; V3021 
RedSafe  Chembio, UK; 21141  










DMEM F12  Gibco, Paisley, UK; 
21331-020 
Poly-D-lysine  Sigma Aldrich, 
Gillingham, UK; 
P7886 
FBS BioSera, France;  
S1810-500 





Gibco, Paisley, UK; 
15140-122 
Lipofectamine 2000  ThermoFisher 
Scientific, UK; 
11668027 




Gibco, Paisley, UK; 
21090-022 




Gibco, Paisley, UK; 
41966-029 




Gibco, Paisley, UK; 
31985-047 
Laminin Sigma Aldrich, 
Gillingham, UK, 
L2020 
Trypsin Irvine Scientific, 
USA; 9342 
Site-directed mutagenesis reagents 
Pfu DNA polymerase 
10 x buffer 
Promega, Wisconsin 
USA; M7741 
Pfu DNA polymerase Promega, Wisconsin 
USA ; M7741 
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Abcam, UK; ab120271 Bafilomycin A1 Cayman Chemical 











MaxiPost Bio-Techne Ltd, UK; 
4949/90) 
Tetramethylrhodamine 
dextran, 40,000 MW  
Life Technologies, 
Paisley, UK; D1842 




Immunofluorescence staining and fixed-cell imaging reagents  
Paraformaldehyde  Sigma Aldrich, 
Gillingham, UK; 47608 
FluorSave Reagent (Calbiochem, USA; 
345789). 




GTPase assay reagents 
Protease inhibitors,  Sigma Aldrich, 
Gillingham, UK; 
P8849 




















Bradford solution  Applichem, Germany; 
A6932 
 
Table 2.1 Table of reagents with sources and catalog numbers  
 
2.2. Animals 
All procedures involving animals were carried out in accordance with the Animals 
(Scientific Procedures) Act (ASPA) 1986 under a project license and delegated 
personal licence authority. Furthermore, severity recordings were taken for each 
animal in accordance with Home Office legislation. All animals were group housed 
as recommended by ASPA 1986. Colonies were maintained in facilities with a 12:12 




2.2.1. WT mice 
WT mice on the C57BL/6J (Jackson Labs) from the in-house colony were set up for 
weekly timed matings. Embryos of either sex were used for tissue culture. 
 
2.2.2. Fmr1 KO mouse  
A breeding colony was established and maintained for the transgenic Fmr1 -/y mice. 
In these KO mouse models, exon 5 of Fmr1 was replaced with a neomycin resistance 
cassette, disrupting the gene and thus inactivating it (The Dutch-Belgian Fragile X 
Consortium, 1994). Fmr1 heterozygous females on the C57BL/6J (Jackson Labs) 
background were set up for weekly timed matings with WT males on the same 
background to produce either Fmr1-/y or wildtype males. Male embryos from 
pregnant females were used for tissue culture. 
 
2.2.3. Fmr1 KO Sprague Dawley rat 
Commercially available Fmr1 KO Sprague Dawley (Fmr1 SD) rats were obtained 
from Sigma Advanced Genetic Engineering (SAGE) Labs (St. Louis, Missouri, 
USA), now part of Horizon Discovery. These rats were generated through a zinc 
finger-mediated 122 bp deletion in Exon 8 of Fmr1 (Hamilton et al., 2014).   
 
2.2.4. Fmr1 KO Long Evans Hooded rat 
Fmr1 KO Long Evans Hooded (Fmr1 LEH) rats were designed by the Centre for 
Integrative (University of Edinburgh) and engineered by Horizon Discovery. In this 





For both Fmr1 rat models, heterozygous females were set up for weekly timed 
matings with WT males on the same background (Charles River labs) to produce 
either Fmr1-/y or wildtype males. Male embryos from were used for tissue culture. 
 
2.2.5. SynGAP1 KO mouse 
A breeding colony was established and maintained for the transgenic SynGAP-/+ 
mice. The deletion of the C2 and GAP domains were caused by the insertion of a 
hemagglutinin (HA) tag with stop codons and internal ribosomal entry site (IRES)-
lacZ-polyA · MC1neo-polyA cassette (Komiyama et al., 2002). SynGAP het males 
or females on the C57BL/6JOla (Harlan) background were bred with WT mice on 
the same background to maintain the colony.  
 
2.2.6. SynGAP1 GAP deletion Long Evans Hooded rat 
SynGAP1 GAP deletion LEH rats were designed by the Centre for Integrative 
Physiology, (University of Edinburgh) and engineered by Horizon Discovery. 
Briefly, deletion of the GAP domain was obtained by using zinc finger motifs to 
delete exons 8-12 coding for the GAP domain of the protein, resulting in a deletion 
encompassing amino acids 255 to 705.   
 
2.2.7. SynGAP1 KO Long Evans Hooded rat 
SynGAP1 KO LEH rats were designed by the centre for Integrative Physiology, 
(University of Edinburgh) and engineered by Horizon Discovery (Saint-Louis, 
Missouri). Briefly, CRISPR/Cas9 technology was used to create a 2-base insertion 




For all SynGAP animals, Het x Het crossings were set up for embryonic cultures to 
obtain WT, Het and KO embryos in the case of the KO animals and WT, Het and 




2.3.1. Fmr1 KO mouse 
For the Fmr1 mice, the HotSHOT method was used to extract genomic DNA from 
the ear notches or tail samples (Truett et al., 2000). A tissue sample was heated in 
HotSHOT lysis buffer (25 mM NaOH and 0.2 mM EDTA) at 95°C for 60 min. The 
solution was then neutralised using HotSHOT neutralisation buffer (40 mM Tris-
HCl). The supernatant was isolated by centrifugation at 1600 g for 3 min. For the 
reaction, 1 µL of supernatant was combined with the primers IMR 6735 (1600 nM), 
IMR 6734 (800 nM) and IMR 2060 (800 nM) (Eurogentec, Belgium) (sequences 
listed in Table 2.2). GoTaq DNA polymerase in Green Reaction Buffer and 200 µM 
of dNTPs were used to amplify the polymerase chain reaction (PCR) product.  
 
The cycling conditions for the PCR were 95°C for 2 min, and 35 cycles of 95°C for 
30 s, 56°C for 30 s and 72°C for 30 s, then 72°C for 5 min. To separate PCR 
products, the samples were run on a 1.2 % (w/v) agarose gel stained with RedSafe 
(1:20000) at 130 V for 30 min, in TBE buffer (44 mM Tris, 44 mM boric acid, 1.6 
mM EDTA). Samples were run against Hyperladder 1 kb DNA markers. DNA bands 
were then visualised under ultraviolet (UV) illumination. The WT product ran at 131 




2.3.2. Fmr1 KO SD rat 
The genomic DNA from Fmr1 rats was also extracted using the HotSHOT method as 
previously described (section 2.3.1). For the PCR reaction, 1 µL of extracted DNA 
was combined with the primers SDrat Fmr1 F (20 uM) and SDrat Fmr1 R (20 uM) 
(Eurogentec, Belgium) (sequences listed in Table 2.2). GoTaq Green Master Mix 
was used to amplify the PCR product. 
 
The cycling conditions for the PCR were 95°C for 5 min, and 35 cycles of 95°C for 
30 s, 60°C for 30 s and 68°C for 30 s, then 68°C for 5 min. To separate PCR 
products, the samples were run on a 2 % (w/v) agarose gel stained with RedSafe 
(1:20000) at 45 V for 35 min, in TBE buffer (44 mM Tris, 44 mM boric acid, 1.6 
mM EDTA). Samples were run against Hyperladder 1 kb DNA markers. The WT 
product ran at 400 bp and the KO product ran at 278 bp.  
 
2.3.3. SynGAP1 mouse 
Genomic DNA was extracted using the Wizard SV Genomic DNA Purification 
System (Promega, Wisconsin USA; A2360) according to manufacturer’s instructions 
for purification using a microcentrifuge. Briefly, tissue was incubated in Nuclei Lysis 
Solution, 0.5 M EDTA (pH 8.0), Proteinase K 20 mg/mL and RNase A Solution 
overnight at 55°C. After incubation, Wizard SV lysis buffer was added. The sample 
was then transferred to the Wizard SV Minicolumn Assembly and spun at 13000 g 
for 3 min. DNA was eluted using nuclease-free water.  
 
Both WT and KO PCR reactions were set up for each sample. For the WT reaction, 
4 uL of extracted DNA was combined with the primers Syn12R (800 nM) and 
Syn11> (800 nM) (Eurogentec, Belgium) (sequences listed in Table 2.2). For the KO 
reaction, 2 uL of extracted DNA was combined with primers Syn12R (800nM) and 
FCASS1a (800 nM) (Eurogentec, Belgium) (sequences listed in Table 2.2). GoTaq 
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DNA polymerase in Green Reaction Buffer and 200 µM of dNTPs were used to 
amplify the PCR product. The cycling conditions for the PCR were 95°C for 3 min, 
and 30 cycles of 94°C for 20 s, 56°C for 30 s and 68°C for 120 s, then 68°C for 3 
min followed by holding at 4°C. To separate PCR products, the samples were run on 
a 0.8 % (w/v) agarose gel stained with RedSafe (1:20000) at 140 V for 20 min, in 
TBE buffer (44 mM Tris, 44 mM boric acid, 1.6 mM EDTA). Samples were run 
against Hyperladder 1 kb DNA markers. The WT product ran at 2.5 kb and the KO 
product ran at 1 kb. 
 
2.3.4. Fmr1 KO LEH, SynGAP1 GAP deletion LEH, SynGAP1 KO LEH 
Tissue samples from Fmr1 KO LEH, SynGAP GAP LEH and SynGAP KO LEH 
were sent directly to Transnetyx (Cordova, Tennessee, USA) for genotyping. 
Genomic DNA was extracted, genotyped and sequenced using proprietary methods. 




Animal model Primer Sequence 5’-3’ 
Fmr1 KO mouse IMR 6735 CTTCTGGCACCTCCAGCTT 
Fmr1 KO mouse IMR 6734 TGTGATAGAATATGCAGCATGTGA 
Fmr1 KO mouse IMR 2060 CACGAGACTAGTGAGACGTG 
Fmr1 KO SD SDrat Fmr1 F TGGCATAGACCTTCAGTAGCC 
Fmr1 KO SD SDrat Fmr1 R TATTTGCTTCTCTGAGGGGG 
Fmr1 KO LEH  GFPF1 ACGTAAACGGCCACAAGTTC 
Fmr1 KO LEH GFPR1 ATGCCGTTCTTCTGCTTGTC 
Fmr1 KO LEH CelF1 CGAGGAAGGACGAGAAGATG 
Fmr1 KO LEH CelR1 CCGCTTCCCTGACTGAAC 
SynGAP KO mouse FCASS1a TTCATGGAGCGGGAACACCTCATAT 
SynGAP KO mouse Syn12R CATACAAGAATTGCTGCATAGAAC 
SynGAP KO mouse Syn11> TTCATGGAGCGGGAACACCTCATAT 
SynGAP GAP LEH SynGAP For  GACTCCATTATCAAGCCAGTACA 
SynGAP GAP LEH SynGAP Rev CGAGCCATGAAGGACTGAA 
SynGAP KO LEH Cel-1 F GGGAGTGGTGGACGCTATT 
SynGAP KO LEH Cel-1 R GGGGTACCACTGCTCTGTG 
Table 2.2 Genotyping primer sequences 
All primers were synthesised by Eurogentec (Belgium) 
 
2.4. Cell culture  
2.4.1. Primary neuronal cultures 
The UK Home Office Schedule 1 methods were followed for sacrifice of the 
pregnant females and embryos. At day 16.5 to 18.5 of gestation for mice and day 
18.5-19.5 of gestation for rats, pregnant females were sacrificed using cervical 
dislocation. Death of pregnant females was confirmed by onset of rigor mortis. 
Embryos were taken by caesarean section. All embryos were decapitated, and death 
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was confirmed by the destruction of brain. Tail samples were taken for genotyping 
purposes.  
 
Due to the X-linked nature of FXS, in the case of the Fmr1 KO mouse and rat, 
embryos were sexed and only males were chosen and dissected. Males could either 
have the KO or WT allele and thus could be used both for the experimental Fmr1 
KO group and WT littermate controls. To determine the sex of the embryos, the 
abdomen was dissected and the distinction between the sexes was made using the 
visible reproductive anatomy (Figure 2.1). For all other genotypes, embryos of either 
sex were dissected. 
 
 
Figure 2.1 Embryonic reproductive organs  
Figure adapted from Heikkila, 2002)  
The sexes of embryos can be determined by the location of their reproductive organs 
(highlighted in red). In males, the testes can be found adjacent to the bladder. In females, 
the ovaries are located behind the kidneys.  
 
Embryos were dissected in ice-cold phosphate buffered saline (PBS, 10 mM 
phosphate buffer, 2.7 mM KCl and 137 mM NaCl, pH 7.4). Hippocampi from each 
embryo were processed separately as to avoid contamination across genotypes. 




After the digestion, excess papain was removed and DMEM F12 supplemented with 
10 % (v/v) foetal bovine serum (FBS) and 1 % (v/v) penicillin/streptomycin was 
added to neutralise the remaining papain. Cells were triturated to form a single cell 
suspension and centrifuged at 260 g for 5 min in a Universal 32 R Hettich centrifuge 
at room temperature. Neurons were resuspended in 100 uL/head of pre-warmed 
Neurobasal (NB) medium supplemented with 2 % (v/v) B-27 supplement, 0.5 mM L-
glutamine and 1 % (v/v) penicillin/streptomycin.  
 
Cells were counted using a haemocytometer and plated at 5x 104 cells per coverslip 
in a 50 µL spot of laminin (10 µg/ mL in supplemented NB medium) for live-cell 
imaging experiments and 3.5x 104 cells per coverslip for immunofluorescence 
staining experiments. Coverslips had been coated overnight with poly-D-lysine 
(PDL) (50 µg/mL) dissolved in boric acid (100 mM, pH 8.5).  
 
After plating, cells were left to settle for 1 h, after which 2 mL of supplemented NB 
was added into each well. After 2-3 days of incubation (humidified Sanyo incubator, 
37°C, 95 % air/5 % CO2) 1 µM of cytosine arabinofuranoside (AraC) was added to 
each well to inhibit the proliferation of glia.  
 
2.4.2. Transfection of primary neuronal cultures 
High purity plasmid DNA was prepared using a HiSpeed Plasmid Maxi Kit (Qiagen, 
Hilden, Germany; 12643), according to manufacturer’s instructions, using overnight 
cultures of TOP10 Escherichia coli (E. coli). A Thermo Scientific Nanodrop 2000 
spectrophotometer was used to quantify DNA yield and purity. All plasmids used can 










Rat pEGFP-C1 1 µg Prof. L. Lagnado (LMB, University 
of Cambridge) 
mCerN1 N/A Clontech 
EGFP-N1 
Variable 
 0.3 -1 µg 
Cousin lab by replacing EGFP by 
mCer (Cheung et al., 2010) 
vGLUT-pHluorin Rat pCAGGS 1 µg Prof. R. Edwards (University of 
California, San Francisco, USA) 
mCer-Dynamin1aa 
(Dyn1) 
Rat pEGFP-N1 0.3 µg Cousin lab (Anggono et al., 2006) 
VAMP4-pHluorin Human pEGFP-N1 1 µg Cloned from viral VAMP4-pH from 
Prof. E. Kavalali (University of 
Texas South-Western Medical 
Centre, Texas, USA) (Nicholson-
Fish et al., 2015) 
shFMRP Rat pcDNA3.0 1 µg Prof. A. Dolphin (University 
College London, London, UK) 
shScr (FMRP) Rat pcDNA3.0 1 µg Prof. A. Dolphin (University 
College London, London, UK) 
mCer-Dynamin1aa 
G139R 
Rat pEGFP-N1 0.3 µg Site directed mutagenesis 
mCer-Dynamin1aa 
R237W 
Rat pEGFP-N1 0.3 µg Site directed mutagenesis 
mCer-Dynamin1aa 
I289F 
Rat pEGFP-N1 0.3 µg Site directed mutagenesis 
mCer-Dynamin1aa 
H396D 
Rat pEGFP-N1 0.3 µg Site directed mutagenesis 
mCer-Dynamin1aa 
A408T 
Rat pEGFP-N1 0.3 µg Site directed mutagenesis 
shSyndapin Rat pSuper 1 µg Cousin lab (Clayton et al., 2009) 
shScr (syndapin) Rat pSuper 1 µg Cousin lab (Clayton et al., 2009) 
Table 2.3 Plasmids used for transfections 
 
For transfection of a 6-well plate, per well, 1 µL of Lipofectamine 2000 per 1 µg of 
the plasmid DNA was incubated in Minimal Essential Medium (MEM) for a total 
volume of 100 µL. Plasmid DNA was also incubated in 100 µL of MEM. After 
5 min, both solutions were combined for a total volume of 200 µL/ well and left to 
incubate at room temperature for 20-30 min. During this incubation, growth medium 
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was removed from cells and replaced with pre-warmed and equilibrated MEM. The 
conditioned NB that was removed from the cultured neurons was conserved in the 
incubator. After incubation, the Lipofectamine 2000 and plasmid complexes were 
added dropwise to each well. The cells were left to incubate with the complexes for 
2 h at 37°C before removing the MEM and replacing with the conditioned growth 
medium. 
 
2.4.3. Cell line culture 
HEK293T cells (obtained from Prof. Luke Chamberlain, University of Strathclyde, 
Glasgow, UK) were thawed out at passage 2. The cells were grown in Dulbecco’s 
Modified Eagle Medium (DMEM) supplemented with 1 % (v/v) 
penicillin/streptomycin and 10 % (v/v) FBS and grown in T75 flasks. Cells were split 
twice a week upon confluence. Briefly, growth medium was removed from the cells 
and cells were washed with PBS. Cells were then incubated in pre-warmed (37°C) 
trypsin to detach them from growth surface. Once cells were detached, trypsin was 
quenched with pre-warmed supplemented DMEM. 1:15 of cell suspension was added 
to new flask.  
 
2.4.4. Cell line transfection 
The day prior to transfection cells were plated in 10 cm culture dishes at 80 % 
confluence. Cells were transfected using Lipofectamine 2000 according to 
manufacturer’s instructions. Briefly, per plate, 14 ug of plasmid DNA complexes 
were made up to a volume of 500 uL in Opti-MEM reduced-serum medium. Per 
dish, 28 uL of Lipofectamine 2000 was left to incubate in 472 uL of Opti-MEM at 
room temperature for 5 min. After incubation, the Lipofectamine 2000 solution was 
added to the plasmid DNA for a total volume of 1 mL/10 cm dish. This solution was 
added drop-wise to the cells. Cells were harvested 48 h later. Plasmid DNA 




2.5. Site-directed mutagenesis 
Single-base pair mutations in DNM1 were obtained from a screen of patients with 
developmental delay and/or epilepsy by the Deciphering Developmental Disorders 
Consortium and provided to us by Dr Wayne Lam (Muir Maxwell Epilepsy Centre, 
University of Edinburgh). Site-directed mutagenesis was used to introduce patient 
mutations into the mCer-Dynamin1aa plasmid (mCer-Dyn1). The spontaneous 
Dyn1A408T mutation observed in fitful mice (Boumil et al., 2010) was also generated. 
The Stratagene approach was used to make single base pair changes in the plasmid. 
For each reaction, diluted template DNA was added to Pfu DNA polymerase 10 x 
buffer, 200 µM dNTPs, 0.5 µM sense primer (see Table 2.4 for primer details), 
0.5 µM anti-sense complement primer, and 1 µL Pfu DNA polymerase. The cycling 
conditions for the PCR were were 96°C for 2 min, and 18 cycles of 96°C for 30 s, 
52°C for 10 s and 72°C for 1 min/ kb of plasmid (7 min), then 72°C for 10 min. The 
base change was confirmed by Source Bioscience Sanger Sequencing (Glasgow, 
UK). 
 
Mutation Primers 5’- 3’ 
Dyn1G139R Sense CTAGTGGACCTGCCAAGAATGACCAAGGTCCCA 
Anti-sense TGGGACCTTGGTCATTCTTGGCAGGTCCACTAG 
Dyn1R237W Sense ATTGGCGTGGTGAACTGGAGCCAGAAGGACATA 
Anti-sense TATGTCCTTCTGGCTCCAGTTCACCACGCCAAT 
Dyn1I289F Sense CAACTGACCAACCACTTCCGGGACACGCTGCCG 
Anti-sense CGGCAGCGTGTCCCGGAAGTGGTTGGTCAGTTG 
Dyn1H396D Sense GCTATCAAGAACATTGATGGCATCAGGACAGGC 
Anti-sense GCCTGTCCTGATGCCATCAATGTTCTTGATAGC 
Dyn1A408T Sense TTCACTCCTGACCTCACTTTTGAAGCCACAGTG 
Anti-sense CACTGTGGCTTCAAAAGTGAGGTCAGGAGTGAA 




2.6. Fluorescence live-cell imaging 
Transfected hippocampal neurons were imaged on day in vitro (DIV) 13-15. 
Coverslips were mounted onto an imaging chamber embedded with parallel platinum 
wires and fluid perfusion ports (Warner Instruments, CT, USA; RC-21BRFS) using 
vacuum grease. Cells were viewed using a Zeiss Axio Observer D1 inverted 
epifluorescence microscope (Zeiss, Cambridge, UK). Cells were visualised with a 
Zeiss EC Plan Neofluar 40 ×/1.30 oil immersion objective. Excitation at 500 nm was 
used to visualise pHluorins (sypHy, VAMP4-pH, vGLUT-pH) and calcium reporters 
(GCaMP6f, Fluo-5F). Excitation at 430 nm was used to visualise vectors tagged with 
mCerulean (mCer-Dyn1 constructs, mCerN1). For both these excitation wavelengths, 
515 nm dichroic filter and long-pass emission filter, >520 were used for emission 
collection. Unless otherwise specified, fluorescent images were acquired at 4 s 
intervals using an AxioCam 506 mono digital camera (Zeiss) at room temperature. 
Images were acquired using Zen Pro software (Zeiss).  
 
Neurons were field stimulated using a Digitimer LTD MultiStim system-D33 
stimulator (current output 100 mA, current width 1 ms, Hertfordshire, UK) with a 
low frequency train of 300 action potentials (APs) delivered at 10 Hz or high 
frequency train of 300 APs delivered at 50 Hz or 60 Hz, or 400 APs delivered at 40 
Hz. Imaging time courses were acquired while undergoing constant perfusion with 
imaging buffer (119 mM NaCl, 2.5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 25 mM 
HEPES, 30 mM glucose at pH 7.4, supplemented with 10 μM 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX) and 50 μM DL-2-Amino-5-phosphonopentanoic 
acid (AP-5) (Armbruster and Ryan, 2011). After stimulation, pHluorin-transfected 
neurons were left to recover before undergoing perfusion with imaging buffer 
containing 50 mM NH4Cl substituted for 50 mM NaCl. NH4Cl imaging buffer was 
used to unquench the synaptic pHluorin giving a measure of total fluorescence to 
quantify the total SV pool. The weak base NH4+ can reversibly dissociate into NH3 
and H+. NH3 is permeable and can enter the acidic SVs where it can associate with 
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the protons in the SV which alkalinises the pH of the SV lumen unquenching the 
pHluorins. 
 
2.6.1. SypHy and vGLUT-pH imaging  
For standard sypHy and vGLUT-pH experiments, cells were perfused with imaging 
buffer before being stimulated with a train of 300 APs delivered at either 10 Hz (low 
frequency), 50 Hz or 60 Hz (both high frequency). After recovery, neurons were 
perfused with NH4Cl buffer to reveal the total SV pool (Figure 2.2). Precise time 
courses for individual experiments can be found in results figures. 
 
For MaxiPost experiments, cells were incubated in imaging buffer with 0 µM, 3 µM, 
10 µM or 30 µM of MaxiPost made up in dimethyl sulfoxide (DMSO) for 2 min 
prior to the start of imaging. MaxiPost was present in the imaging buffer for the 
duration of the experiment. Total concentration of DMSO in the imaging buffer was 
kept constant across conditions.  
 
Images were analysed using the FIJI distribution of Image J (NIH). Images were 
aligned using the Rigid body model of the StackReg plugin (Thevenaz et al., 1998). 
Nerve terminal fluorescence was measured using the Time Series Analyser plugin 
(Balaji, 2007). Regions of interest (ROIs) 5 px in diameter were placed over nerve 
terminals that responded to the electrical stimulus. Per transfected axon, 10-148 ROIs 
were selected. Fluorescence intensity in these ROIs was measured across all the 
frames to produce a fluorescence time trace. The ROI Trace Selection v0.6 software 
(Stewart, 2013) was used to screen ROIs to ensure that all selected ROIs responded 
both to the electrical stimulation and NH4Cl buffer. Any traces that did not meet 
these criteria were excluded. The baseline of traces displaying fluorescence decay 
were fitted with a mono-exponential curve. This curve was then subtracted from the 




Figure 2.2 Example sypHy or vGLUT-pH trace 
Hippocampal neurons transfected with sypHy or vGLUT-pH were imaged DIV 13-15 
following the time course in a). Baseline (yellow), stimulation (red), recovery (green), NH4Cl 
buffer (blue) b) Sample fluorescence trace. Coloured arrows correspond to the different 
stages of the protocol time course. c) Example images with selected ROIs which responded 
both to electrical stimulation and NH4Cl pulse. Border colour corresponds to the different 
stages of the protocol time course. Arrow heads show responding nerve terminals    
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Data were firstly normalised to the fluorescence at baseline (F/F0), and then further 
normalised to either maximum response to stimulus to look at SV endocytosis or 
maximum fluorescence response (NH4+) to look at peak exocytosis. Fluorescence 
decay time constants (tau, τ, s) were calculated by fitting an exponential decay curve 
to data from the time point directly after the end of electrical stimulation to the point 
where the fluorescence plateaued (200 s from start of acquisition).  
 
2.6.1.1. Surface fraction 
The surface fraction assay provides a measure for how much reporter is stranded on 
the cell surface. For these imaging experiments, cells were perfused with imaging 
buffer, acid buffer (69 mM NaCl, 2.5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 25 mM 
MES, 30 mM glucose at pH 5.5) and NH4Cl buffer. The acid buffer was used to 
quench all the sypHy at the surface (Figure 2.3). The NH4Cl buffer was used to 
provide a measure for the total amount of SVs.  
 
For the surface fraction traces, sypHy fluorescence was normalised to 100 in the 
NH4Cl solution and to 0 in the acid buffer. Surface fraction was calculated for 
individual cells as a percentage of total fluorescence: 
𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 = (
baseline fluorescence − minimum fluorescence
maximum fluorescence − minimum fluorescence
) × 100 
Where the baseline fluorescence is the average fluorescence when perfused with the 
imaging buffer taken for 20 s immediately before acid pulse and 20 s immediately 
before stimulation, the minimum fluorescence is the average fluorescence obtained 
from 20 s of plateaued acid buffer and maximum fluorescence is the average 






Figure 2.3 Surface fraction assay 
Example surface fraction trace with fluorescence images from baseline fluorescence (1), 
minimum fluorescence with acid buffer (2) and maximum fluorescence with NH4Cl buffer (3). 





For reacidification experiments, surface sypHy fluorescence was quenched with a 
pulse of acid buffer during baseline. After recovery of surface fluorescence by 
perfusing over imaging buffer, cells were electrically stimulated with 300 APs at 
10 Hz. After the end of the stimulation, another pulse of acid buffer was applied to 
the culture to quench any surface stranded sypHy. The sypHy that was already 
located in SVs was not quenched as the acid buffer is impermeable. This allowed for 
the monitoring of the reacidification kinetics of the SVs separately from the 
endocytosis rates as any further decrease in fluorescence would be due to the 
acidification of the SV (Kwon and Chapman, 2011).  
 
Images were acquired every 1 s to ensure accurate monitoring of SV acidification 
which occurs on the order of ~ 5 s (Atluri and Ryan, 2006). Rate of acidification was 
calculated by fitting a mono exponential curve to the fluorescence drop after the 
second acid pulse.  
 
2.6.1.3. 37°C experiments 
For experiments conducted at 37°C, an automatic temperature controller (Warner 
Instruments, CT, USA; TC-324C) was used to heat the imaging buffers. The 
temperature controller was set at 42°C so that the temperature of the buffers when 
they were being perfused over the cells was 37°C. This was confirmed by measuring 
the temperature of the imaging solution with an electronic thermometer at the level 
of the cells.  
 
Images were acquired every 2 s during baseline, stimulation and recovery as to 
ensure accurate monitoring of SV kinetics, as the kinetics of SV recycling is faster at 





To determine exocytosis rate and total exocytosis amount we used the vacuolar-type 
H+-ATPase blocker Bafilomycin A1 to inhibit reacidification of SVs. 
Bafilomycin A1 diluted in DMSO was added to the imaging buffer for the duration 
of acquisition for a final concentration of 1 µM.  
 
The average fluorescence of the final 20 s of electrical stimulation was used to obtain 
maximum fluorescence during electrical stimulation providing a measure for total 
exocytosis. 
 
2.6.2. VAMP4-pH imaging 
VAMP4-pH imaging was conducted as previously described (Nicholson-Fish et al., 
2015; Nicholson-Fish et al., 2016). Briefly, after 19 frames of baseline, neurons were 
stimulated at 40 Hz 10 s then allowed to recover for 180 s before being perfused with 
NH4Cl buffer to reveal the total SV pool. The fluorescence decay caused by 
bleaching due to 500 nm excitation was corrected by fitting a linear function to 19 
frames of baseline and subtracting this function from each individual synaptic 
bouton’s fluorescence trace using MATLAB (MathWorks, USA). 
 
As VAMP4 is not an abundant protein, VAMP4-pH was always cotransfected with 
mCerN1 to allow for visualisation of the transfected cells. An image of the mCerN1 
transfection was also captured to allow for identification of nerve terminals. Images 
were acquired using 3 x 3 px binning performed by Zen Pro software (Zeiss) to 
increase signal intensity. ROIs 3 px in diameter were selected using this image and 
fluorescence traces were obtained by translocating these ROIs onto the VAMP4-pH 
time trace images. Images were then processed in Microsoft Excel as previously 
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described (Nicholson-Fish et al., 2016). Briefly, VAMP4-pH fluorescence traces for 
each nerve terminal were normalised to the total SV pool as revealed by NH4Cl. 
Fluorescence responses were then sorted into “up” or “down” traces depending on 
fluorescence 120 s after stimulation. If a nerve terminal’s fluorescence trace was 
above baseline by this timepoint it was categorised as “up”, whereas if the 
fluorescence trace was below baseline it was categorised as “down”. Formula for 
segregation of traces obtained from Nicholson-Fish et al. (2016).  
 
2.6.3. Calcium imaging 
Due to the rapid kinetics of the calcium reporters used, images were acquired every 
2 s. Cells were imaged in imaging buffer, however constant perfusion was not 
required for these experiments. After acquiring a 30 s baseline, neurons were 
stimulated with 300 APs delivered at either 10 Hz or 50 Hz as previous described in 
Section 2.6.1. Image processing was done as previously described in Section 2.6.1. 
Nerve terminal fluorescence was measured using the Time Series Analyser plugin 
(Balaji, 2007) to determine the fluorescence time trace of ROIs placed on synaptic 
boutons (as determined by morphology). Per transfected axon, 20-148 ROIs were 
selected. Fluorescence intensity in these ROIs was measured across all the frames to 
produce a fluorescence time trace. Only the fluorescence time traces of ROIs that 
responded to electrical stimulation were included.  
 
For Fluo-5F experiments, cultures were incubated with 10 µM of Fluo-5F in imaging 
buffer for 30 min at room temperature prior to image acquisition. Image acquisition 
occurred in imaging buffer without Fluo-5F. 
 
2.6.4. Dextran imaging 
Neurons were loaded with 50 µM of tetramethylrhodamine (TMR) dextran, 
40,000 MW in imaging buffer using 400 AP stimulation delivered at 40 Hz to elicit 
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ADBE. The dextran was then washed off with imaging buffer to remove all dextran 
that had not been taken up into ADBE endosomes. This ensured a low level of 
background fluorescence for image acquisition. Images were acquired undergoing 
constant perfusion to lower levels of background fluorescence. 
 
Dextran images were acquired using a 556/25 excitation and 630/98 emission filter 
(Zeiss). Per coverslip, 5-7 different fields of view with roughly the same number of 
axons, and few cell bodies were imaged. The n for this experiment is number of 
coverslips. The dextran puncta on each image were counted using the Analyze 
Particles plugin of Image J (NIH) to select and count particles of 4-14 px. For each 
imaging day, for each condition, at least one unstimulated coverslip was imaged. As 
there was no loading of dextran, this condition was used as a control for the 
background level of dextran. The values for number of dextran puncta obtained from 
these conditions was subtracted from all experimental (stimulated) coverslips.  
 
2.7. Immunofluorescence staining and fixed-cell imaging 
Immunofluorescence staining and analysis was performed as previously described 
(Gordon et al., 2011). Briefly, hippocampal neurons plated on PDL-coated coverslips 
were fixed with 4% paraformaldehyde (PFA) in PBS. Cells were left to incubate in 
PFA for 15 min at room temperature. PFA was then removed and cells were 
quenched 2 x 5 min with 50 mM NH4Cl in PBS. Cells were then washed 4 x 5 min 
with PBS. Fixed neurons were stored at 4°C until antibody labelling, (no longer than 
1 week). 
 
Before staining, cells were permeabilised in 1% bovine serum albumin (BSA) in 
PBS-Triton 1% for 5 min. Cells were then washed gently in PBS before being 
blocked in 1% BSA in PBS at room temperature for 1 h. After blocking, cells were 
left to incubate in primary antibody diluted in blocking solution for 30-45 min (see 
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Table 2.4 for antibodies). Following 4 x 5 min washes, cells were left to incubate in 
secondary antibody (see table 2.2 for antibodies) diluted in blocking buffer for 30-45 
min at room temperature in the dark. After washing, coverslips were mounted to 
slides using FluorSave Reagent. 
 
Alexa Fluor 488 and 568 images were acquired using a dual camera imaging system 
(Zeiss). The signal was filtered by a double band pass excitation filter (470/27 + 
556/25) with beam splitter (490 + 575) and emission filters 512/30 and 630/98 
(Zeiss) respectively. Alexa Fluor 647 was visualised with a 640 nm excitation and a 
690/50 band pass emission filter.  
 
For each image analysed, ROIs were placed over the transfected neuron, a non-
transfected neuron and the background. This allowed measurement of levels of 
overexpression of mCer-Dyn1 within neurons on the same coverslip by comparing 
the overexpression to normal expression levels. Background fluorescence was 
subtracted from all signals. For each coverslip, 4-6 fields with transfected neurons 
were acquired. The n is the number of transfected cells imaged. 
 










Anti-GFP 1:5000 Chicken Abcam ab13970 
Anti-Synaptic vesicle 
glycoprotein 2A (SV2A) 
1:200 Rabbit Abcam ab32942 










s Anti-chicken Alexa Fluor 488 1:1000 Goat Invitrogen A11039 
Anti-rabbit Alexa Fluor 568 1:1000 Goat Invitrogen A21069 
Anti-goat Alexa Fluor 647 1:1000 Donkey Invitrogen A21447 




2.8. Statistical analysis 
Microsoft Excel and Prism 6 software (GraphPad software Inc., San Diego USA) 
were used for data processing and analysis. A response trace was calculated for each 
cell by averaging the individual traces from each selected ROI.  
 
For all figures, results are presented with error bars as ± SEM, and the n in brackets 
for each condition represents the number of coverslips imaged unless otherwise 
specified. For each imaging assay, cells were obtained from at least two independent 
cultures. Mean pHluorin fluorescence differences across the time course were 
examined with two-way analysis of variance (ANOVA) with Dunnett’s post hoc test 
comparing all traces to the control condition when three or more conditions were 
present. For all other data, statistical significance between two groups was evaluated 
using two-tailed Student t-tests. Statistical significance between three or more groups 
was evaluated using a one-way ANOVA with Dunnett’s post hoc test to compare all 
results to control results unless otherwise stated. 
 
2.9. GTPase assay 
2.9.1. HEK293T lysis 
HEK293T cells that were previously transfected with mCer-Dyn1 plasmids were 
harvested 48 h after transfection. Culture media was removed, and cells were rinsed 
with PBS. Two plates transfected with the same plasmid were pooled together to 
obtain sufficient protein for the GTPase assay experiments. Cells were then washed 
off the culture dish in 1 mL of PBS and centrifuged at 250 g for 2 min at 4°C. The 
supernatant was discarded. Pelleted cells were resuspended in 1 mL of sucrose lysis 
buffer (250 mM sucrose, 3 mM imidazole pH 7.4 supplemented with 2 µL/mL 
protease inhibitors and 1 mM phenylmethane sulfonyl fluoride). Cells were then 
placed into a primed ball-bearing cell cracker (EMBL, Heidelberg, Germany) and 
forced through the chamber 30 times. The solution with the mechanically broken 
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cells was collected and centrifuged at 1500 g for 15 min at 4°C to pellet all unbroken 
cells. The supernatant was collected and used for the following assays. 
 
2.9.2. Immunoprecipitation using GFP-trap beads 
Anti-GFP VHH coupled to agarose beads for immunoprecipitation (IP) of GFP-fusion 
proteins (GFP-Trap) was used for IP of mCerN1, mCer-Dyn1WT or mutant mCer-
Dyn1. GFP-Trap buffer was made substituting KCl for NaCl for consistency with the 
GTPase assay buffer. Beads were diluted 2:1 in GFP-Trap buffer. Following 
manufacturer’s instructions, the beads were washed in GFP-Trap buffer and 
centrifuged at 2500 g for 2 min at 4°C. The mechanically lysed cells were added to 
the equilibrated GFP-trap beads and mixed top over bottom at 4°C for 1 h. Following 
the incubation, the beads and attached proteins were centrifuged at 2500 g for 2 min 
at 4°C. The supernatant was discarded. The beads were then washed 3 times as 
previously described.  
 
2.9.3. Bradford 
A Bradford assay was performed according to manufacturer’s instructions to 
determine protein concentration of GFP-Trap-bound mCerN1 or mCer-Dyn1. For the 
standard curve, BSA was dissolved in GTPase assay buffer (20 mM HEPES pH 7.5, 
50 mM KCl, 2 mM MgCl2 (Leonard et al., 2005)) to create a standard curve (0, 1, 2, 
4, 6, 8, 10 µg of BSA/ 100 µL buffer). 1 mL of Bradford solution was added to each 
concentration of the standard curve and to diluted GFP-Trap-bound protein samples. 
The absorbance of these dilutions was measured at 595 nm on a spectrophotometer 
and plotted to make a standard curve. The IP samples were diluted 1:10 in GTPase 




2.9.4. Malachite green colorimetric GTPase assay 
A colorimetric assay was used to quantify GTPase activity of the different mCer-
Dyn1 mutants (Leonard et al., 2005). The dye malachite green changes colour from 
yellow to blue-green when free inorganic phosphate is detected. This change in 
colour was then quantified using a plate reader to measure the absorbance at 650 nm. 
 
GTP was made up to a 100 mM stock in 20 mM HEPES pH 7.4, snap frozen and 
stored at -80C. For each experiment, a fresh aliquot of GTP was thawed on ice and 
diluted in GTPase assay buffer (20 mM HEPES pH 7.5, 50 mM KCl - this low salt 
concentration allows for the oligomerisation of dynamin, 2 mM MgCl2). GFP-Trap-
bound mCer-Dyn1 mutants were diluted to a concentration of 1 µM in GTPase assay 
buffer. 
All reactions were carried out on ice to limit GTP hydrolysis. For each reaction, 
20 µL of 2 mM GTP diluted in GTPase assay buffer and 20 µL of 1 µM stock of 
mCer-Dyn1 was left to incubate in a 37°C water bath for 30 min. To terminate the 
reaction 10 µL of 0.5 M EDTA pH 8.0 was added. During the incubation, the 
standards were prepared at room temperature. KH2PO4 was diluted in GTPase assay 
buffer for the standards: 0 µM, 5 µM, 10 µM, 20 µM, 50 µM, 80 µM, 100 µM, 
150 µM. After termination of the reaction, it was transferred to room temperature 
and 300 uL of filtered Malachite green solution (34 mg Malachite green carbinol 
base dissolved in 40 mL of 1 N HCl added to 1 g of ammonium molybdate 
tetrahydrate diluted in 14 mL of 4 N HCl up to 100 mL with ddH2O) was added to 
each of the reactions as well as the standards. This step was done in the dark as 
Malachite green is light-sensitive. The reactions were mixed by pipetting up and 
down and then transferred to a 96-well plate. The absorbance of the standards and 
samples were read in a plate reader at 650 nm. The amount of inorganic phosphate 




The controls included for each repeat of this experiment were: 1-GTP only reaction: 
as to measure the amount of GTP degradation occurring during the time course of the 
experiment, 2- GTPase addition after the termination of the reaction with EDTA: as 
to control for the GTPase having any effect on absorbance due to nucleotide 
contaminants, 3-No GTP for baseline inorganic phosphate levels in the reaction. 
These controls were not included in the results. Instead we used the mCerN1 reaction 
as a measure of basal release activity because it was a more accurate representation 






3. Characterisation of SV recycling defects in rodent models 
of SynGAP1 haploinsufficiency 
 
3.1.  Introduction 
Mutations in the synaptic GTPase-activating protein 1 (SYNGAP1) gene lead to non-
syndromic intellectual disability, autism spectrum disorder and epilepsy (Hamdan et 
al., 2009; Hamdan et al., 2011). The affected protein, SynGAP, is a brain-specific 
protein enriched at excitatory neuron synapses (Chen et al., 1998; J. H. Kim et al., 
1998). SynGAP is expressed in the hippocampus and cortex prenatally and 
throughout development with expression reaching its peak on post-natal day (PND) 
14 and levels decreasing into adulthood (J. H. Kim et al., 1998; Porter et al., 2005; 
Clement et al., 2012). 
 
SynGAP plays an important role in synapse formation. Firstly, it competitively binds 
the PDZ domains of PSD-95 where it can regulate the composition of the 
postsynaptic density by preventing other proteins such as neuroligin, LRRTM and 
TARP from binding (Walkup et al., 2016). Secondly, although dendritic spine 
density was unchanged between SynGAP1 heterozygous (Het) and WT dentate gyrus 
neurons, spine morphology was markedly different in Het neurons with more 
mushroom-type spines and fewer stubby-type spines (Clement et al., 2012). 
Moreover, dendritic spines in SynGAP1 Het cortical neurons mature rapidly and, by 
PND 21, they are already undergoing pruning which is characteristic of mature 
neurons (Aceti et al., 2015).  
 
SynGAP can also control synapse formation and strength through the regulation of 
protein translation in cortical neurons. It does this by suppressing the MAPK/ERK 
pathway and inhibiting protein translation (Rumbaugh et al., 2006; Wang et al., 




to increased protein synthesis rates (Wang et al., 2013). SynGAP mediates AMPAR 
trafficking and its insertion in the plasma membrane through negative regulation of 
ERK (Rumbaugh et al., 2006). SynGAP can also limit AMPAR content through 
suppression of its synthesis by inhibiting the MAPK/ERK pathway (Wang et al., 
2013). Altering the number of AMPAR at the plasma membrane directly impacts 
synaptic strength (reviewed in Anggono and Huganir, 2012). 
 
 SynGAP plays an important role in synapse formation during the critical period, in 
agreement with its pattern of expression. Het deletion of SynGAP1 results in rapid 
maturation of synapses at PND 7 (Aceti et al., 2015) and increased 
neurotransmission in the hippocampus starting at PND 14 (Clement et al., 2012). The 
increase in mEPSC frequency and amplitude seen in Het mice at PND 14 is fully 
recovered to WT levels by PND 21 (Clement et al., 2012).  
 
Although there is no direct evidence that SynGAP is localised at the presynapse 
(Moon et al., 2008) the increased mEPSC frequency in the hippocampus of Het mice 
during development (Clement et al., 2012) and in the cortex when SynGAP is 
knocked-down (Wang et al., 2013) could be due to presynaptic dysfunction. 
Furthermore, various SynGAP isoforms have been found to affect mEPSC frequency 
and amplitude differentially (McMahon et al., 2012). Additionally, overexpression of 
GFP-SynGAP in cultured neurons revealed decreased mEPSC frequency (Rumbaugh 
et al., 2006).  
 
SynGAP1 Het mice behave differently to WT littermates in various experimental 
paradigms due to deficits in synapse and circuit formation. SynGAP1 het mice 
display an anxiolytic phenotype compared to WT controls as shown by significantly 
more entries into the open arms of an elevated plus maze (Muhia et al., 2010). These 
mice also display deficits in hippocampal-dependent behaviour including no 




hippocampal independent tasks such as novel object recognition, the Het mice 
showed no impairment (Muhia et al., 2010).  
 
Thus, the highly abundant SynGAP protein plays multiple roles in synapse 
formation, protein translation, synaptic transmission and hippocampal learning. 
These roles could, in part, mediate the ASD, ID and epilepsy phenotypes observed in 
individuals with SYNGAP1 haploinsufficiency  
 
The aims of this work were to characterise SV recycling defects in preclinical models 
of SynGAP1 haploinsufficiency. Furthermore, we also wanted to determine whether 
the defects observed were due to the enzymatic GAP activity of the SynGAP protein. 
 
 
3.2.  Results 
 
3.2.1.  SynGAP1 KO mouse hippocampal neurons show increased sypHy retrieval only at 
low frequency stimulation 
The altered mEPSC described in various SynGAP haploinsufficiency models 
(Clement et al., 2012; McMahon et al., 2012; Wang et al., 2013) could suggest 
altered presynaptic function, particularly altered neurotransmitter release. To 
determine whether the mEPSC frequency phenotype was indeed due to presynaptic 
function, we used the genetically-encoded synaptic pHluorins to monitor synaptic 
vesicle recycling in a SynGAP1 haploinsufficiency mouse model (Komiyama et al., 
2002). PHluorins are pH-sensitive GFPs, which are fused to SV-associated proteins 
such as synaptophysin-pHluorin (sypHy) and located in the lumenal portion of the 
SV. When the synaptic pHluorin is exposed to an acidic pH as is the case in a SV 




extracellular milieu (pH 7.4), the pHluorin fluoresces (Ryan, 2001; 
Sankaranarayanan and Ryan, 2000). PHluorins report the reacidification of SVs after 
endocytosis which happens on the order of ~5 s (Atluri and Ryan, 2006). Thus, the 
coupling between rate-limiting slow endocytosis, τ ~ 15-60 s, (Granseth et al., 2006; 
Sankaranarayanan and Ryan, 2000) and fast acidification allow for pHluorins to 
report SV endocytosis kinetics.  
 
We first compared sypHy retrieval kinetics in dissociated hippocampal cultures from 
SynGAP1 Het, KO and WT littermate controls to determine whether either the 
absence or a reduction of SynGAP had any effect on SV recycling.  
 
As increased mEPSC frequency seen in previous studies could be due to increased 
SV fusion and neurotransmitter release, we first determined whether loss of SynGAP 
impacted SV exocytosis. SypHy time traces were normalised to the total synaptic 
vesicle pool by perfusion with NH4Cl buffer which can diffuse through the 
membrane and neutralise acidic vesicles thus allowing for complete unquenching of 
the sypHy signal (Figure 3.1b). The amount of exocytosis can then be quantified as a 
proportion of fluorescence during stimulation compared to total fluorescence as 
revealed by NH4Cl (Figure 3.1d). There were no significant differences (1-way 
ANOVA n.s. p > 0.05) in the normalised sypHy peak heights of SynGAP1 Het (0.388 
± 0.026 units, n=16) or KO (0.332 ± 0.024 units, n=11) compared to control, WT 
(0.392 ± 0.032 units, n=19). Thus, partial or complete absence of SynGAP does not 
have an effect on SV exocytosis at low frequency stimulation.    
 
Since there was no effect on SV exocytosis, we then investigated whether 
endocytosis was different across genotypes. Although all modes of SV endocytosis 
serve to replenish the SV pools, they are all distinct from each other with different 
proteins mediating the various steps of each (reviewed in Saheki and De Camilli, 




endocytic pathway without affecting another. Similarly, different SV endocytosis 
modes are triggered by discrete stimulus intensities. Thus, different stimulation 
frequencies were used to mobilise different endocytosis pathways. We first started 
with low frequency stimulation, 10 Hz 30 s (Figure 3.1) which has been shown to 
predominantly recruit the CME pathway at room temperature (Granseth et al., 2006). 
Traces were normalised to the stimulation peak to examine sypHy retrieval (Figure 
3.1c). Normalising to the peak of stimulation allows for a measurement of 
endocytosis without the confounds of exocytosis. Furthermore, it allows for 
quantification of the amount SVs endocytosed as a proportion of total amount 
exocytosed as determined by the fluorescence trace. When comparing time traces, 
sypHy retrieval was significantly different in KO hippocampal neurons compared to 
WT (2-way ANOVA using Dunnett’s multiple comparisons p < 0.01). Single-phase 
decays can also be fitted to these curves to provide the sypHy retrieval time constant 
(τ). There were no differences (1-way ANOVA n.s. p > 0.05) between the τ values of 
Het (33.42 ± 2.73 s, n=16), KO (25.19 ± 1.99 s, n=11) and WT (33.66 ± 3.10 s, 
n=19). Thus, there was enhanced sypHy retrieved during the time course in 
SynGAP1 KO hippocampal neurons compared to WT, however the rate of 
endocytosis remained constant across all genotypes.   
 
To see if we could observe a similar phenotype at high frequency, we maintained the 
same number of action potentials (300 action potentials) and increased the frequency 
of stimulation, 50 Hz for 6 s (Figure 3.2). High frequency stimulation provides a 
higher intensity stimulus load which can lead to exaggeration of defects seen at lower 
frequency stimulation. Furthermore, during high frequency stimulation ADBE is 
thought to become the more dominant endocytic mode (Clayton et al., 2008). 
Although sypHy cannot be used to monitor ADBE (Nicholson-Fish et al., 2015), 
sypHy responses can still be examined to determine whether the reported endocytosis 






Figure 3.1 Increased sypHy retrieval in SynGAP1 KO hippocampal neurons compared to WT 
at low frequency stimulation (10 Hz 30 s) 
Hippocampal neurons derived from SynGAP1 Het and KO mice and WT littermate controls 
were transfected with sypHy on DIV 7 and imaged DIV 13-15. a) Time course of experiment. 
b-c) Mean sypHy fluorescence traces of WT (white), Het (blue) and KO (grey) hippocampal 
neurons. Bars indicate the period of stimulation, 10 Hz 30 s. b) normalised to the total vesicle 
number as revealed by NH4Cl. c) normalised to the peak of stimulation. 2-way ANOVA 
** p < 0.01. d) Mean and individual stimulation peak heights obtained from individual sypHy 
traces of data in b). e) Mean and individual sypHy retrieval time constants (τ) of data plotted 
in c). d-e) n.s. non-significant p > 0.05 by 1-way ANOVA. 







Figure 3.2  No difference in exocytosis or sypHy retrieval at high frequency stimulation 
(50 Hz 6 s) of SynGAP1 Het or KO compared to WT 
Hippocampal neurons derived from SynGAP1 Het and KO mice and WT littermate controls 
were transfected with sypHy on DIV 7 and imaged DIV13-DIV15. a) Time course of 
experiment. b-c) Mean sypHy fluorescence traces of WT(white), Het (blue) and KO (grey) 
hippocampal neurons. Bars indicate the period of stimulation, 50 Hz 6 s. b) normalised to the 
total vesicle number as revealed by NH4Cl. c) normalised to the peak of stimulation. 2-way 
ANOVA n.s non-significant p > 0.05. d) Mean and individual stimulation peak heights 
obtained from individual sypHy traces of data in b). e) Mean and individual sypHy retrieval 
time constants (τ) of data plotted in c). d-e) n.s. non-significant p > 0.05 by 1-way ANOVA. 




We first examined exocytosis by looking at normalised sypHy peak heights (Figure 
3.2b,d). There were no significant differences (1-way ANOVA n.s. p > 0.05) in the 
sypHy peak heights of SynGAP1 Het (0.497 ± 0.040 units, n=13) or KO (0.532 ± 
0.029 units, n=13) compared to control, WT (0.496 ± 0.040 units, n=16) at high 
frequency stimulation. Taken together with the results from Figure 3.1, these results 
suggest that there is no effect of SynGAP1 deletion on exocytosis at either low or 
high frequency stimulation.   
 
We next examined SV endocytosis during high frequency stimulation. As done 
previously, traces were normalised to the stimulation peak (Figure 3.2c) to examine 
sypHy retrieval. There was no difference between the traces (2-way ANOVA n.s. p> 
0.05), suggesting that the amount of endocytosis occurring during the acquisition 
period was the same across all genotypes. Furthermore, there were no differences 
(1-way ANOVA n.s. p > 0.05) between the τ values of Het (50.82 ± 6.65 s, n=13), 
KO (33.01 ± 3.07 s, n=13) and WT (41.26 ± 3.51 s, n=16). Thus, sypHy retrieval is 
only affected at low frequency stimulation in SynGAP1 KO neurons whereas there is 
no difference in either amount or rate of endocytosis at high frequency.  
 
3.2.2.  There is less sypHy stranded at the cell surface in KO neurons compared WT 
littermates 
As there appeared to be more sypHy retrieval in SynGAP1 KO compared to WT 
mouse hippocampal neurons (Figure 3.1c) we then determined whether this was 
indeed due to accelerated sypHy endocytosis or rather due to faster acidification of 
the vesicle. To do this we performed a reacidification experiment to be able to 
observe the acidification of recently retrieved SVs. In order to obtain an accurate 
timescale of reacidification, images were acquired at 1 s intervals. The cell was first 
perfused with acid buffer (pH 5.5) to quench all surface sypHy, and once again 
immediately after the end of stimulation (Figure 3.3a-b). With the second acid pulse, 
all surface sypHy was quenched, so it was possible to visualise the reacidification of 




across all genotypes (Figure 3.3c). The rate of reacidification of the SVs could then 
be quantified by fitting an exponential decay to the curve for each individual 
pHluorin trace. Mean and average acidification rates are shown in Figure 3.3d). 
There was no significant difference in reacidification rates (1-way ANOVA 
n.s. p > 0.05) between Het (7.62 ± 0.71 s, n=7), KO (7.93 ± 1.30 s, n=9) and WT 
(8.28 ± 1.84 s, n=10). Taken together with the results in Figure 3.1, this would 
suggest that the accelerated sypHy retrieval is indeed due to accelerated endocytosis 
and not due to altered SV reacidification.  
 
Defects in SV endocytosis can be reflected by a change in cargo at the plasma 
membrane as the SV cargo cannot be cleared efficiently (reviewed in Cousin, 2017). 
Since we saw increased endocytosis in SynGAP1 KO hippocampal neurons 
compared to WT, we also looked at the surface fraction of sypHy to determine 
whether this defective endocytosis had an effect on the amount of sypHy at the 
surface of the plasma membrane.   
 
Using both an impermeable acid and an NH4Cl solution, it is possible to estimate the 
ratio of sypHy stranded at the surface. Perfusing on acid quenches all surface 
fluorescence whereas pulsing over NH4Cl reveals the total SV pool. To determine the 
surface fraction, the minimum fluorescence obtained by perfusing over acid buffer 
was subtracted from both the baseline fluorescence (in normal buffer) and maximum 
fluorescence (NH4Cl buffer). The ratio of corrected baseline fluorescence over 
maximum fluorescence gives the ratio of surface-to-vesicle pool fluorescence. 
Interestingly, there was a significant decrease in surface fraction between KO (8.57 ± 
0.85%, n=7) and WT (13.23 ± 1.31, n=7) (1-way ANOVA with Dunnett’s comparing 
all conditions to WT p= 0.0487), however the Het surface fraction (13.53 ± 1.73%, 
n=7) was not different from WT (1-way ANOVA with Dunnett’s n.s. p> 0.05).  
Therefore, there is less sypHy at the plasma membrane in SynGAP1 KO hippocampal 






Figure 3.3 Less sypHy stranded at membrane surface in SynGAP1 KO hippocampal 
neurons compared to WT  
Hippocampal neurons derived from SynGAP1 Het and KO mice and WT littermate controls 
were transfected with sypHy on DIV 7. a) Time course of experiment. Images were acquired 
at 1 Hz. b) Representative sypHy reacidification trace. c) Mean sypHy reacidification trace of 
WT(white), Het (blue) and KO (grey) neurons. d) Mean and individual reacidification rates 
obtained from fitting single exponential curves to fluorescence drop upon second acid pulse 
(pulse after stimulation) as shown in c). e) Mean normalised traces of sypHy fluorescence 
upon exposure to normal buffer (Norm.) 20 frames before acid pulse, acidic buffer (pH 5.5; 
0% fluorescence) 20 frames of acid plateau, and NH4Cl buffer (100% fluorescence) 
20 frames of highest fluorescence. f) Mean and individual sypHy surface fraction (formula in 
methods). d,f) 1-way ANOVA with Dunnett’s test comparing all means to WT (control 
condition).* p < 0.05; n.s. non-significant p > 0.05. 




3.2.3. Increased endocytosis in SynGAP1 KO neurons is not due to absence of GAP domain 
The GAP domain in SynGAP plays an important role in its function and is thought to 
be the functional domain responsible for most of SynGAP activity (J. H. Kim et al., 
1998). Due to the importance of this domain, we used a rat model with a deletion of 
the SynGAP GAP domain. Rats that were Het or homozygous (Hom) for this 
deletion where used to determine whether the loss of this domain would replicate the 
SV recycling phenotype seen in the SynGAP1 KO mouse model.  
 
We first compared sypHy retrieval kinetics in dissociated hippocampal cultures from 
SynGAP1 GAP Het, Hom and WT littermate controls at low frequency stimulation, 
10 Hz 30 s (Figure 3.4) since these were the stimulation conditions which revealed 
an endocytosis defect in SynGAP1 KO mice.  
 
To first check whether there was any effect on SV exocytosis, traces were 
normalised to total vesicle pool (Figure 3.4b) and sypHy peak heights were 
calculated (Figure 3.4d). There was no difference in sypHy peak heights between Het 
(0.350 ± 0.031 units, n=14), Hom (0.383 ± 0.031 units, n=14) and WT (0.382 ± 
0.033 units, n=17) (1-way ANOVA n.s. non-significant p > 0.05). Thus, there was no 
effect of partial or complete GAP domain deletion on SV exocytosis at low 
frequency stimulation.  
 
As we saw defective endocytosis in SynGAP1 KO mouse neurons, we then went on 
to examine endocytosis in the GAP deletion rat model. There was no difference in 
amount of endocytosis as revealed by normalising the traces to the stimulation peak 
(2-way ANOVA n.s. p> 0.05, Figure 3.4c). The sypHy τ (Figure 3.4e) was also not 
significantly different (1-way ANOVA n.s. p > 0.05) between Het (35.49 ± 4.47 s, 




deletion of the SynGAP1 GAP domain does not impair amount or rate of endocytosis 
at low frequency stimulation.  
 
To determine whether the SynGAP GAP domain may interfere with other endocytic 
pathways, we next looked to see if there was any effect of GAP deletion on 
exocytosis or endocytosis at high frequency stimulation 50 Hz 6 s (Figure 3.5). We 
first examined exocytosis by normalising sypHy traces to total vesicle pool (Figure 
3.2b) to calculate the normalised peak sypHy response (Figure 3.5d). There were no 
significant differences (1-way ANOVA n.s. p > 0.05) in the sypHy peak heights of 
SynGAP1 GAP Het (0.452 ± 0.029 units, n=16) or Hom (0.397 ± 0.026 units, n=15) 
compared to control, WT (0.427 ± 0.031 units, n=18) at high frequency stimulation. 
Thus, deletion of the SynGAP1 GAP domain does not affect exocytosis at high 
frequency stimulation. 
 
Mouse KO cultures display no defect in endocytosis at high frequency stimulation, 
therefore we next determined whether this was also the case for GAP domain 
deletion mutants. Traces were normalised to the stimulation peak (Figure 3.2c) to 
examine sypHy retrieval as before. There was no significant difference in amount of 
sypHy retrieved (1-way ANOVA n.s. p> 0.05) when comparing sypHy fluorescence 
traces across genotypes. There were also no differences (1-way ANOVA n.s. p > 
0.05) in the τ values between Het (40.07 ± 4.16 s, n=16), Hom (42.26 ± 4.74 s, n=15) 
and WT (41.67 ± 4.72 s, n=18). Therefore, GAP domain deletion does not alter SV 
endocytosis at high frequency stimulation. These results taken together suggest that it 
is not the loss of function of the GAP domain that is mediating the enhanced SV 







Figure 3.4 No difference in exocytosis or sypHy retrieval at low frequency stimulation (10 Hz 
30 s) in SynGAP1 GAP deletion rat model 
Hippocampal neurons derived from SynGAP1 rat GAP domain heterozygous (Het) or 
homozygous (Hom) deletion and WT littermate controls were transfected with sypHy on 
DIV 7 and imaged DIV 13-15. a) Time course of experiment. b-c) Mean sypHy fluorescence 
traces of WT (white), Het (blue) and Hom (grey) hippocampal neurons. Bars indicate the 
period of stimulation, 10 Hz 30 s. b) normalised to the total vesicle number as revealed by 
NH4Cl. c) normalised to the peak of stimulation. 2-way ANOVA n.s. non-significant p > 0.05. 
d) Mean and individual stimulation peak heights obtained from individual sypHy traces of 
data in b). e) Mean and individual sypHy retrieval time constants (τ) of data plotted in c). d-e) 
1-way ANOVA n.s. non-significant p > 0.05. 






Figure 3.5 No difference in exocytosis or sypHy retrieval at high frequency stimulation (50 Hz 
6 s) in SynGAP1 GAP deletion rat model 
Hippocampal neurons derived from SynGAP1 rat GAP domain heterozygous (Het) or 
homozygous (Hom) deletion and WT littermate controls were transfected with sypHy on 
DIV 7 and imaged on DIV 13-15. a) Time course of experiment. b-c) Mean sypHy 
fluorescence traces of WT (white), Het (blue) and Hom (grey) hippocampal neurons. Bars 
indicate the period of stimulation, 50 Hz 6 s. b) normalised to the total vesicle number as 
revealed by NH4Cl. c) normalised to the peak of stimulation. 2-way ANOVA n.s. non-
significant p > 0.05. d) Mean and individual stimulation peak heights obtained from individual 
sypHy traces of data in b). e) Mean and individual sypHy retrieval time constants (τ) of data 
plotted in c) d-e) 1-way ANOVA n.s. non-significant p > 0.05.  




3.2.4. SynGAP1 KO rat hippocampal neurons showed no effect on SV recycling  
We did not observe the enhanced endocytosis at low frequency stimulation seen in 
the mouse KO hippocampal neurons using the GAP deletion rat model. This could be 
due to the loss of the GAP domain not being involved in the defective endocytic 
phenotype observed, alternatively, it could be due to species differences between 
mice and rats. Thus, we went on to study SV recycling in a novel SynGAP1 KO rat 
model (Figures 3.6-3.8). If the enhanced SV endocytosis phenotype was seen in the 
rat KO neurons, then taken together with the results in Figure 3.4, it would suggest 
that the GAP domain is not required for SV endocytosis.  
 
A new imaging protocol was used in this model (Figure 3.6a) to extract the 
maximum amount of information from a single experiment. We perfused acid buffer 
over the cells prior to stimulation to be able to calculate sypHy surface fraction. The 
cells were then stimulated at 10 Hz 30 s to examine the effect of low frequency 
stimulation. Following a five-minute recovery, cells were stimulated again, this time 
at 40 Hz for 10 s to determine the effect of high frequency stimulation on SV 
recycling. After further recovery NH4Cl buffer was pulsed over the cells to reveal the 
total SV pool (Figure 3.6b).  
 
We first examined SV exocytosis and found that there were no differences in sypHy 
peak height at low frequency stimulation (1-way ANOVA n.s. p > 0.05) between Het 
(0.524 ± 0.029 units, n= 11), KO (0.488 ± 0.025 units, n= 12) and WT (0.461 ± 
0.030 units, n=12) (Figure 3.6c). Furthermore, there were no differences in sypHy 
peak height at high frequency stimulation (1-way ANOVA n.s. p> 0.05) between Het 
(0.401 ± 0.028 units, n=11), KO (0.427 ± 0.330 units, n=12) and WT (0.375 ± 0.024 
units, n=12) (Figure 3.6d). The lack of difference in exocytosis across genotypes 
suggests that SynGAP is not required for SV exocytosis similar to what was 





We then normalised the sypHy traces to the peak of stimulation for each stimulus 
including a 15-frame baseline for the second stimulus to examine sypHy endocytosis 
(Figure 3.7a). When comparing the time traces across genotypes, there was no 
difference in the amount of endocytosis observed during imaging (2-way ANOVA 
n.s. p >0.05). There was also no significant difference (1-way ANOVA n.s. p> 0.05) 
in sypHy retrieval rates either at low frequency (Figure 3.7b; Het: 42.98 ± 4.76 s, 
n=11; KO: 43.08 ± 5.47 s, n=12; WT: 46.61 ± 4.89 s, n=12) or at high frequency 
stimulation (Het: 48.27 ± 7.00 s, n=11; KO: 48.39 ± 6.73 s, n=12; WT 51.01 ± 
5.11 s, n=12; 1-way ANOVA n.s. p> 0.05). Thus, in this rat model of SynGAP1 
haploinsufficiency, the loss of SynGAP does not precipitate any SV recycling 
defects. 
 
As we saw decreased stranding of sypHy in the plasma membrane in SynGAP1 KO 
mouse neurons compared to WT, we looked at whether the surface fraction of sypHy 
was altered in this rat model (Figure 3.8). The surface fraction traces (Figure 3.8a) 
were obtained by using the 5 frames from the start of acquisition (20 seconds) and 5 
frames before stimulation (20 seconds) to determine baseline fluoresce levels as well 
as 5 frames of acid plateau and 5 frames of NH4Cl plateau. There was no difference 
in surface fraction between SynGAP1 Het (9.27 ± 1.52 %, n=9), KO (10.42 ± 0.84 %, 
n=8) and WT (9.90 ± 2.45 %, n=8) (1-way ANOVA n.s. p> 0.05). Taken together 
these results suggest that there is no effect of deletion of SynGAP1 on SV recycling 
in rat hippocampal neurons. This is in contrast to the results seen in mouse 
hippocampal neurons (Figure 3.1) where there was enhanced sypHy retrieval at low 









Figure 3.6 No difference in exocytosis at either low (10 Hz 30 s) or high frequency 
stimulation (40 Hz 10 s) in SynGAP1 KO rat model.  
Hippocampal neurons derived from SynGAP1 heterozygous (Het) and knockout (KO) mice 
and WT littermate controls were transfected with sypHy on DIV 7 and imaged on DIV 13-15. 
a) Time course of experiment. b) Mean sypHy fluorescence traces of WT (white), Het (blue) 
and KO (grey) hippocampal neurons normalised to the total vesicle number as revealed by 
NH4Cl. Bars indicate the period of stimulation, first bar: 10 Hz 30 s, second bar: 40 Hz 10 s. 
c) Mean and individual 10 Hz stimulation peak heights obtained from individual sypHy traces 
of data in a). d) Mean and individual 40 Hz stimulation peak heights obtained from individual 
sypHy traces of data in a). 1-way ANOVA n.s. non-significant p > 0.05. 






Figure 3.7 No difference in sypHy retrieval rate at either low (10 Hz 30 s) or high frequency 
stimulation (40 Hz 10 s) in SynGAP1 KO rat model.  
Same data as in Figure 3.6 a) Mean sypHy fluorescence traces of SynGAP1 WT (white), Het 
(blue) and KO (grey) hippocampal neurons normalised to the peak of each stimulation. Bars 
indicate the period of stimulation, first bar: 10 Hz 30 s, second bar: 40 Hz 10 s. 2-way 
ANOVA n.s. non-significant p > 0.05. b-c) Mean and individual taus b) following 10 Hz 
stimulation; c) following 40 Hz stimulation. 1-way ANOVA n.s. non-significant p > 0.05. 






Figure 3.8 No difference in surface levels of sypHy 
Data obtained from individual traces of data from figure 3.6. a) Mean normalised traces of 
sypHy fluorescence upon exposure to normal buffer (Norm.), acidic buffer (pH 5.5; 0% 
fluorescence) and NH4Cl buffer (100% fluorescence) of WT (white), Het (blue) and KO (grey) 
hippocampal neurons. f) Mean and individual sypHy surface fraction (formula in methods). 
1-way ANOVA n.s. non-significant p > 0.05. 




3.3.  Discussion 
Using the genetically encoded reporter sypHy to monitor SV recycling in different 
rodent models of SynGAP1 haploinsufficiency, we observed enhanced SV 
endocytosis at low frequency stimulation in SynGAP1 KO mouse hippocampal 
neurons compared to WT littermate controls, however the rate at which the 
endocytosis occurred was not changed. Paired with this, we also found a decreased 
proportion of sypHy stranded on the plasma membrane. Interestingly, when the 
neurons were challenged with a higher stimulus load (50 Hz 6 s or 40 Hz 10 s) to 
mobilise the whole recycling pool (Denker and Rizzoli, 2010), there were no 
differences in endocytosis amount or rate between genotypes.  
 
Previous electrophysiological evidence hinted toward a defect in presynaptic 
neurotransmitter release which could underlie the impaired mEPSC frequency in 
SynGAP1 het neurons (Clement et al., 2012; McMahon et al., 2012; Wang et al., 
2013). We used our pHluorin imaging assay to determine whether loss of SynGAP 
impaired SV exocytosis. The amount of exocytosis as a proportion of the total SV 
pool, as revealed by NH4Cl buffer, was not different between genotypes at either low 
or high frequency stimulation. This suggests that release probability is unimpaired 
with loss of SynGAP. Thus, defects in mEPSC frequency could be due to impaired 
postsynaptic function as proposed by Clement et al. (2012).   
 
SynGAP was first described as a RasGAP and most of its functions were thought to 
be mediated by its GAP activity, particularly the negative regulation of AMPAR 
trafficking to the postsynaptic membrane which mediates the altered synaptic 
plasticity observed in this model (J. H. Kim et al., 1998). However, in our GAP 
deletion rat model, we observed no SV recycling defects. This could suggest that the 
enhancement in SV endocytosis observed in SynGAP1 full KO mouse hippocampal 
neurons is not mediated by the GAP domain as homozygous deletion of the SynGAP 




species difference between mice and rats as the SynGA1P KO rat hippocampal 
neurons show no defects in SV recycling at either low or high frequency stimulation. 
 
3.3.1. Species differences 
As previously mentioned, the lack of effect of loss of SynGAP in rat KO neurons 
could suggest differing function of SynGAP across species. SynGAP may play 
different roles across species and may interact differently with other postsynaptic 
molecules which in turn could mediate the lack of SV endocytosis enhancement in 
hippocampal neurons. However, it would be highly unusual for a gene product to 
perform a completely different role within different mammalian systems.  
 
It is important to note the KO of SynGAP1 in each model was not generated the same 
way. The mouse model was created by deleting exons coding for the C2 and GAP 
domains and inserting stop codons and a neo-resistance cassette (Komiyama et al., 
2002) whereas the rat was created using CRISPR/Cas9 technology to introduce a 
2 bp deletion and 1 bp insertion at exon 8 introducing an early stop codon (Horizon 
Discovery, Saint Louis MO, USA). Although these models were generated in 
different ways, the loss of SynGAP has been verified by Western blotting in the 
mouse (Komiyama et al., 2002) and the rat (S. Basu, personal correspondence). 
SynGAP protein expression is down to 50% in Hets and absent in the KO. Although 
SynGAP expression levels have been studied extensively to characterise these 
models, it is possible that certain truncated portions of the proteins remain which 
may exert different effects on the synapse and neurotransmission and could underlie 
the differences observed across these models. To determine whether this is the case, 
an N-terminus-specific antibody to SynGAP could be used to detect the presence of a 





Another possible explanation for why the enhanced SV endocytosis phenotype was 
absent in the rat could be the difference in critical periods between the two species 
(reviewed in Pressler and Auvin, 2013). SynGAP plays an important role in synapse 
formation during critical periods, particularly through accelerating maturation of 
dendritic spines (Aceti et al., 2015; Clement et al., 2012). Early during development 
(PND 7-9) there are no deficits in dendritic spine morphology or synaptic 
transmission in SynGAP1 Het mice (Clement et al., 2012). Deficits only begin to 
appear at PND 14 where spines already have mature-like appearance (Clement et al., 
2012). At PND 14 in SynGAP1 Het mice there are fewer silent synapses (Rumbaugh 
et al., 2006) and there is altered neurotransmission (Clement et al., 2012). 
Interestingly these deficits did not persist through development. The more “mature 
synapse” phenotype was recovered by PND 60 when WT neurons reached maturity 
thus becoming comparable to the “prematurely aged” SynGAP1 Het neurons (Aceti 
et al., 2015; Clement et al., 2012). Surprisingly, the altered mEPSC frequency and 
amplitude of SynGAP1 het pyramidal neurons compared to WT observed at PND 14 
is recovered by PND 21 as now WT spines and connectivity are more mature. 
Therefore, it appears that SynGAP is essential during this critical period. More 
support for this comes from work showing that conditional expression of SynGAP1 
in het animals during adulthood is not enough to rescue behavioural deficits 
(Clement et al., 2012).  
 
The studies cited above have all examined these deficits in mice. It is possible that 
SynGAP has the same functions in rats, however the critical periods may be slightly 
shifted. A shift in critical periods could explain why there were no SV recycling 
deficits observed in both rat models (full KO and GAP deletion). It appears that loss 
of SynGAP is particularly important at PND 14. In our experiments, neurons were 
imaged at DIV 14 when synapse development has reached its peak (Kaech and 
Banker, 2006; Rao et al., 1998). This time point is roughly equivalent to this PND 14 
developmental critical period, as it marks the peak of dendritic spine formation with 
dendritic spines just starting to form around the second week in vitro (Kaech and 





The mEPSC amplitude and frequency deficits seen at PND 14 are absent at PND 7 
and have been fully recovered by PND 21. This leaves a small window for this 
critical period. There is evidence to suggest that rat hippocampal neurons do not 
mature in the same way as mouse hippocampal neurons, at least in the case neurons 
arising from adult synaptogenesis (Snyder et al., 2009). It is therefore possible that 
the critical periods are subtly shifted between species in neuronal culture. If the 
critical period is indeed shifted, even by just a few days, it may explain why no 
enhanced SV endocytosis was seen in the rat model at DIV 13-15. It would be 
interesting to repeat these experiments in both mice and rats at both an earlier time-
point such as DIV 10 and a later time-point such as DIV 21. As well as providing 
information on the role SynGAP plays in SV recycling, the results from these 
experiments could provide insight on synapse formation critical periods in rats.  
 
3.3.2. Altered surface fraction 
Cargo stranding at the plasma membrane surface can be due to multiple rounds of 
SV recycling occurring during stimulated or network activity in culture. It may also 
reflect a physiological cohort of cargo immediately available for retrieval distinct 
from the cargo released upon exocytosis of a specific SV (Fernandez-Alfonso et al., 
2006; Hua et al., 2011). In SynGAP1 KO hippocampal neurons we observed a 
decreased surface fraction of sypHy compared to WT levels. This could be due to the 
enhanced sypHy retrieval observed. If there is enhanced endocytosis, it may be 
expected that there is less sypHy on the plasma membrane or that the cargo is not 
present on the plasma membrane for as long before being retrieved to form new SVs. 
However, there was no defect in the extent of sypHy retrieval during low frequency 
stimulation, arguing against this explanation. Recent evidence suggests that the 
surface fraction of cargo proteins does not always correlate with deficits in SV 
recycling (Harper et al., 2017; Kaempf et al., 2015; Kononenko et al., 2013; Zhang et 
al., 2015). In fact, there can be more cargo stranded on the surface with faster 




Surface levels of cargo can also be unaltered when there is defective recycling 
(Harper et al., 2017; Kononenko et al., 2013). Thus, there is evidence that the surface 
stranding of SV cargo is independent of defective SV recycling.  
 
Additionally, it is necessary to determine whether the amount of all SV cargo is 
decreased on the plasma membrane or whether this is sypHy-specific. Solely less 
sypHy on the membrane could suggest that there is more sypHy in newly-formed 
SVs. More synaptophysin on SVs would also lead to more recruitment of 
synaptobrevin-2 on SVs (Gordon et al., 2011; Gordon and Cousin, 2013; Gordon et 
al., 2016). This potential alteration in the composition of SVs could impair SV 
recycling through altered stoichiometry of SV proteins leading to altered interactions 
and recruitment of SV docking machinery. Conversely, a decrease in all SV cargo at 
the plasma membrane could be due to increased number of SVs within the nerve 
terminal depleting a limited stock of SV proteins (Wilhelm et al., 2014). 
Interestingly, increased SV number and pool size has been suggested to be a 
pathological feature in FXS (Deng et al., 2011), another condition which causes 
ASD, ID and epilepsy. The sypHy reporter does not provide an accurate estimate of 
SV numbers, since the signal is normalised to the total SV pool. SV pool size can be 
estimated with sypHy by depleting the recycling pool in the presence of bafilomycin 
and then estimating the remaining resting pool via addition of NH4Cl (S. H. Kim and 
Ryan, 2013), thus stimulating neurons to depletion. Other optical approaches such as 
tracking SV numbers with FM dyes or morphological approaches will be required to 
conclusively determine alterations in absolute number of SVs inside nerve terminals 
(Deng et al 2011).    
 
3.3.3. Lack of role of GAP domain 
As previously suggested, the absence of effect of the deletion of the GAP domain on 
SV endocytosis could be due to species differences across mice and rats, as full KO 




also be the case that the GAP domain does not mediate the role that SynGAP plays in 
SV recycling. 
 
The N-terminal portion of SynGAP contains its GAP domain containing both a PH 
and C2 domain (J. H. Kim et al., 1998). SynGAP functions as a GAP that can 
negatively regulate Ras and Rap GTPases (Chen et al., 1998; Krapivinsky et al., 
2004; Pena et al., 2008). The RasGAP activity of SynGAP can also regulate F-actin 
which is a major component of stable dendritic spines (Bar et al., 2016). In the 
absence of SynGAP there is no longer any negative modulatory effect on F-actin. 
Increased levels of  F-actin can, in part, be responsible for the earlier time course of 
dendritic spine maturity observed in SynGAP1 Het neurons. F-actin is also required 
for clustering SV proteins to the presynaptic membrane (Dason et al., 2014). 
Increasing the amount of F-actin could therefore increase clustering of SV proteins 
on the plasma membrane allowing them to be more readily retrieved during 
endocytosis and thus mediating accelerated SV retrieval.  
 
Furthermore, together with the C2 domain, the GAP domain of SynGAP can take on 
a RapGAP role (Krapivinsky et al., 2004; Pena et al., 2008). Dephosphorylation 
activates SynGAP RapGAP activity which in turn inactivates Rap. With Rap 
inactivated, there is no activation of p38 MAPK which mediates AMPAR trafficking 
from the postsynaptic membrane (Krapivinsky et al., 2004; Rumbaugh et al., 2006; 
Zhu et al., 2002). SynGAP can mediate synaptic plasticity by preventing the removal 
of AMPAR from synapses. With the loss of SynGAP, there is no longer inactivation 
of Rap. This leads to increased p38 MAPK activity and removal of AMPAR from the 
postsynaptic membrane. Activation of the MAPK/ERK pathway can lead to 
increased phosphorylation of synapsin (Giachello et al., 2010) which may in part 





However, SynGAP is not just a GAP, it has other functions in the synapse. The C-
terminus of SynGAP contains a PDZ-domain ligand that mediates its binding to the 
PDZ domains of PSD-95 (J. H. Kim et al., 1998). SynGAP can competitively bind all 
three slots of PSD-95, thus preventing other molecules, including TARP complexes, 
from binding (Opazo et al., 2012; Walkup et al., 2016). SynGAP can thus alter 
synaptic strength by limiting the binding of AMPAR complexes to the plasma 
membrane. SynGAP can also prevent the cell-adhesion molecules LRRTMs and 
neuroligins from binding the PDZ domains of PSD-95. This is particularly important 
as it is through these molecules and their interactions with the presynaptic protein 
neurexin that synapses are formed (Graf et al., 2004; Levinson et al., 2005; 
Scheiffele et al., 2000). The deletion of SynGAP1 could therefore alter synapse 
composition and impair SV recycling.  
 
Based on the results from our experiments, we cannot conclude whether the GAP 
domain mediates the presynaptic SV recycling defect observed. However, as outlined 
above, the GAP domain may indirectly play a role in SV recycling through the 
activation of other important presynaptic molecules involved in SV recycling 
including F-actin and synapsin.  
 
There seems to be some redundancy across both major functions of SynGAP as it 
appears that both the GAP function and structural function of can mediate AMPAR 
localisation at the postsynapse which in turn mediates synaptic plasticity. Thus, it 
will be important to use both the SynGAP1 GAP deletion and the full deletion models 
to determine how SynGAP can mediate synaptic strength and transmission.  
 
3.3.4. Potential mechanisms for acceleration of SV endocytosis 
The observed acceleration of SV endocytosis in SynGAP1 KO neurons, specifically 




Because SynGAP is highly abundant in the PSD (Cheng et al., 2006), it can bind to 
approximately 10-15% of the PDZ domains of PSD-95 where it then determines 
synaptic composition (Walkup et al., 2016). Because of the 50 % decrease in protein 
levels duet to haploinsufficiency (Vazquez et al., 2004), SynGAP can no longer bind 
to as many PSD-95 PDZ domains and thus the composition of the synapses is altered 
(Walkup et al., 2016). In agreement, there is significantly increased binding of 
TARP, LRRTM-2, and neuroligin-2 to PSD-95, in PSD fractions from SynGAP1 Het 
neurons (Walkup et al., 2016). Of particular interest to this work is the increased 
binding of the postsynaptic cell adhesion molecules LRRTM2 and neuroligin-2. 
Altering the binding of both these proteins to PSD-95 may have varying effects on 
synaptic development and strength. 
 
LRRTMs are postsynaptic proteins that can bind PSD-95 through their cytoplasmic 
C-tail (Hung and Sheng, 2002), and presynaptic neurexins through their leucine-rich 
extracellular domains (Paatero et al., 2016). LRRTM-2 is predominantly expressed in 
the hippocampus (Lauren et al., 2003). Knocking-down LRRTM-2 in cultured 
neurons was found to decrease the number of excitatory synapses (de Wit and 
Ghosh, 2014). Although LRRTMs are postsynaptic proteins they have powerful 
synaptogenic effects. Expressing LRRTMs in non-neuronal cells elicited artificial 
synapse formation in the axons of co-cultured neurons including clustering of 
presynaptic proteins such as synaptophysin and bassoon on contacting axons 
(Linhoff et al., 2009; Siddiqui et al., 2013). It is through its binding to neurexin that 
LRRTM-2 mediates excitatory synapse development (Siddiqui et al., 2010).  
 
Like LRRTM, neuroligin-2 has strong neurogenic effects. In co-culture assays, 
neuroligin-2 was found to induce the formation of presynaptic structures in 
contacting axons. These presynaptic structures included both gamma-aminobutyric 
acid (GABA)ergic and glutamatergic SVs which could undergo turnover (Graf et al., 
2004; Scheiffele et al., 2000). Although neuroligin-2 is localised at inhibitory 




possibly through mediating its binding to the PDZ domain of PSD-95, allowing for 
more molecules to be associated with excitatory synapses (Levinson et al., 2005).  
 
LRRTM-2 and neuroligin-1 bind to an overlapping region of neurexin and thus both 
cannot bind the same neurexin molecule (Siddiqui et al., 2010). However, these 
postsynaptic proteins can cooperate in an additive manner to recruit neurexin to form 
new glutamatergic synapses (Siddiqui et al., 2010). Neurexins play important roles in 
the presynapse (reviewed in Reissner et al., 2013). Most importantly, knocking-out 
the neurexin-1α isoform has been shown to impair spontaneous neurotransmitter 
release (Etherton et al., 2009), whereas knocking-out more isoforms also impairs 
evoked release (Kattenstroth et al., 2004; Missler et al., 2003).  
 
It is therefore possible that postsynaptic SynGAP can exert an effect on presynaptic 
activity through modulating PSD composition. The SV recycling deficits observed 
with the loss of SynGAP, could be mediated by increased recruitment of neurexins to 
synapses by LRRTM-2 and neuroligin-2. This could be tested by knocking-down 
neurexin in SynGAP1 KO cultures and seeing whether this can rescue the accelerated 
endocytosis observed in these neurons.   
 
3.3.5. Limitations in experimental design 
Our results suggest a novel role for SynGAP in mediating presynaptic activity at low 
frequency stimulation in mice however, there are still certain limitations of this work 
that need to be addressed.  
 
We saw enhanced sypHy retrieval at low frequency stimulation in SynGAP1 KO 
hippocampal neurons compared to WT littermate controls. Synaptophysin is an 




general that is affected by loss of SynGAP, it would be important to repeat this 
experiment with a different synaptic pHluorin to ensure that it is not just 
synaptophysin retrieval that is defective in this model.  
 
Additionally, it would be important to determine whether this enhanced SV 
endocytosis observed is due solely to enhanced endocytosis or whether it is 
compensation for increased exocytosis. It can be difficult to determine whether SV 
deficits are due to exocytic or endocytic defects as these two processes are tightly 
coupled. Endocytosis can start to occur during exocytosis particularly during the long 
stimulus train we used to elicit this effect (10 Hz 30 s) (Sankaranarayanan and Ryan, 
2000). Using the vacuolar-type H+-ATPase proton pump blocker, Bafilomycin A1 it 
is possible to dissociate these two processes during pHluorin imaging to isolate 
exocytosis. Bafilomycin A1 prevents reacidification of the vesicles after endocytosis, 
therefore once the pHluorin is within the vesicle, its fluorescence can no longer be 
quenched. This allows each SV fusing to only be monitored once (Sankaranarayanan 
and Ryan, 2000). It would be important to use Bafilomycin A1 to examine 
exocytosis in this model to determine whether the enhanced endocytosis is a 
homeostatic compensatory effect. 
 
SynGAP is localised in the PSD of excitatory neurons (Chen et al., 1998; J. H. Kim 
et al., 1998). Although it may alter inhibitory neurotransmission through 
compensatory mechanisms (Clement et al., 2012) there is no evidence that SynGAP 
is localised in inhibitory neurons. In dissociated hippocampal cultures, there are 
various hippocampal cell-types including excitatory glutamatergic pyramidal neurons 
and inhibitory GABAergic interneurons. It is possible that some neurons sampled 
were inhibitory and thus SynGAP1 KO may not have a direct effect on a cell-type 
where it is not expressed. Although these different cell-types can be distinguished 
based on morphology, it would be interesting to repeat these experiments looking 
solely at excitatory hippocampal neurons. This could be done by labelling neurons 




excitatory markers respectively) during live-cell imaging to determine whether the 
effect of loss of SynGAP is excitatory synapse-specific (Petrini et al., 2014; Smith et 
al., 2012).  
 
SypHy is a good reporter of CME (Granseth et al., 2006) which is the dominant 
endocytic pathway in hippocampal neurons at low frequency stimulation at room 
temperature (Granseth et al., 2006). However, there are other endocytic modes that 
cannot be reported by sypHy, particularly ADBE (Nicholson-Fish et al., 2015). 
ADBE is elicited after strong stimulus trains such as 50 Hz 6 s and 40 Hz 10 s 
(Clayton et al., 2008). ADBE can be monitored using labeled-dextrans or 
VAMP4-pH. Both reporters can report the number of nerve terminals undergoing 
ADBE in neuronal cultures. Additionally, horseradish peroxidase (HRP) uptake 
assays can determine how much ADBE is occurring in each nerve terminal. As 
different modes of endocytosis are all independent and require different molecules, it 
would be interesting to see if ADBE is affected by loss of SynGAP in future. 
 
Overall, these experiments suggest a novel activity-dependent role of SynGAP in SV 
recycling. Furthermore, this novel role in SV endocytosis provides a new target for 
developing treatments for SYNGAP1 haploinsufficiency, the leading genetic cause of 









Loss of FMRP results in FXS, which is a leading monogenic cause of ID and ASD 
(Mefford et al., 2012). FMRP is expressed throughout the brain (Gholizadeh et al., 
2015) with peak expression within the first postnatal week in rodents. FMRP levels 
then decrease and reach a plateau in adulthood (Till et al., 2012; Till et al., 2015; 
Gholizadeh et al., 2015) Loss of FMRP disrupts synaptic plasticity (Harlow et al., 
2010) and synapse formation during critical periods (Doll et al., 2017).  
 
FMRP’s main role is repressing protein translation of a subset of mRNAs, 
downstream of Group1 mGluRs, through polyribosome stalling (Darnell et al., 
2011). In the absence of FMRP, there is no negative regulation of protein translation 
and the translation of Group1 mGluR-associated transcripts is upregulated (Dolen 
and Bear, 2009). The levels of several presynaptic and postsynaptic proteins are 
altered with the loss of FMRP (Zalfa et al., 2003; Osterweil et al., 2010; Darnell and 
Klann, 2013) which may in part mediate the synaptic defects observed in various 
models of FXS.  
 
FXS is a synaptopathy, a disorder of the synapse. The loss of FMRP has been widely 
studied in the postsynapse, including its impact on spine morphology and dynamics 
(Cruz-Martin et al., 2010; Comery et al., 1997; Irwin et al., 2000; Galvez and 
Greenough, 2005; Levenga et al., 2011; Wijetunge et al., 2014), mGluR-LTD (Huber 
et al., 2002), and postsynaptic protein translation (Darnell and Klann, 2013). 
However, there is also evidence for a presynaptic role of FMRP, as there is faster 
synaptic vesicle recycling in Fmr1 KO mouse hippocampal neurons as determined 




larger RRP and a larger reserve pool compared to WT littermate controls (Deng et 
al., 2011). Furthermore knocking-down FMRP in dorsal root ganglion (DRG) 
neurons and hippocampal neurons enhances SV exocytosis during high frequency 
stimulation (Ferron et al., 2014).  
 
Presynaptic defects observed in models of FXS are thought to be due to non-
canonical roles of FMRP, despite 30.4% of presynaptic proteome mRNA transcripts 
being bound by FMRP. FMRP can also directly bind presynaptic ion channels 
(reviewed in Ferron, 2016) including Slack channels (Brown et al., 2010), N-type 
calcium channels (Ferron et al., 2014) and BK channels (Deng et al., 2013; Deng and 
Klyachko, 2016). FMRP can modulate synaptic strength through binding the 
regulatory subunit of BK channels to modulate their gating. Indeed, the BK 
channel’s calcium-sensitivity is reduced in Fmr1 KO neurons (Deng et al., 2013).  
 
Thus, FMRP plays multiple pre-and post-synaptic roles in synapse and circuit 
formation and neurotransmission which may underlie the cognitive and behavioural 
deficits seen in FXS. 
 
The aims of this work were to characterise SV recycling defects in both CME and 
ADBE in preclinical models of FXS. We first wanted to replicate previous findings 
that suggested altered SV recycling through the CME pathway (Deng et al., 2011; 
Ferron et al., 2014). We also wanted to establish whether FMRP could perform a 







4.2.1. No SV exocytosis or endocytosis deficits in Fmr1 KO mouse hippocampal neurons 
FMRP is found in the presynapse (Christie et al., 2009; Akins et al., 2012) and 
regulates the translation of a third of the presynaptic proteome (Darnell et al., 2011) 
including SV recycling-related proteins such as dyn1. There is also evidence that 
FMRP plays a role in SV recycling, as FMRP KD in DRG neurons leads to increased 
exocytosis at higher frequency stimulation without any change in SV endocytosis 
rate (Ferron et al., 2014). Furthermore, SV turnover has been found to be faster in 
Fmr1 KO hippocampal neurons (Deng et al., 2011). 
 
Because of this evidence suggesting loss of FMRP may alter SV recycling, we 
decided to investigate this role further in order to establish a molecular mechanism. 
We started by using sypHy as a reporter of SV recycling. We first examined 
exocytosis, as there is evidence for increased exocytosis with FMRP KD (Ferron et 
al., 2014). Dissociated hippocampal neurons from Fmr1 KO mice and WT littermate 
controls were stimulated with a train of low frequency APs (10 Hz 30 s, Figure 4.1). 
SypHy fluorescence traces were normalised to the total SV pool to measure the 
amount of exocytosis as a proportion of the total SV pool (Figure 4.1b, d). There was 
no significant difference (Student t-test n.s. p > 0.05) between KO (0.300 ± 0.030 
units, n=16) and WT (0.342 ± 0.024 units, n=15). Thus, the loss of FMRP does not 
affect exocytosis during low frequency stimulation.  
 
We used this low-frequency stimulation paradigm to determine whether CME, the 
dominant endocytic mode in these conditions (Granseth et al., 2006), was impaired in 
this model. SypHy fluorescence traces were normalised to the peak of stimulation so 
that CME kinetics could be compared across genotypes (Figure 4.1c). There was no 
significant difference between KO and WT fluorescence traces (2-way ANOVA, n.s. 
p> 0.05). Furthermore, the sypHy retrieval time constants, τ, were not different 




4.15 s, n=15) (Figure 4.1e). Therefore, the loss of FMRP does not impair endocytosis 
at low frequency stimulation.  
 
There is evidence suggesting increased SV exocytosis at high frequency stimulation 
in hippocampal neurons with FMRP KD (Ferron et al., 2014). Additionally, the loss 
of FMRP has been found to enhance synaptic responses to high-frequency 
stimulation (Deng et al., 2011). Therefore, we next examined the effect of high-
frequency stimulation (50 Hz 6 s) on SV recycling kinetics in Fmr1 KO hippocampal 
cultures and WT controls (Figure 4.2). SypHy fluorescence traces were normalised to 
the total SV pool as revealed by NH4Cl buffer to examine the amount of exocytosis 
that occurred during stimulation as a proportion of the total SV pool (Figure 4.1b, d). 
There was no difference (Student t-test n.s. p > 0.05) between KO (0.463 ± 0.035 
units, n=17) and WT (0.431 ± 0.035 units, n=17). Taken together with the results 
from Figure 4.1, this suggests that the complete loss of FMRP does not affect SV 
exocytosis during either low- or high-frequency stimulation.  
 
We then went on to examine SV endocytosis after high-frequency stimulation 
(Figure 4.2c, e) as faster SV recycling has been observed in Fmr1 KO hippocampal 
neurons (Deng et al., 2011). There was no significant difference in sypHy 
fluorescence traces across genotypes (2-way ANOVA n.s. p> 0.05). There was also 
no difference in sypHy τ (Figure 4.2e, Student t-test n.s. p > 0.05) between KO 
(37.44 ± 5.11.s, n=17) and WT (44.71 ± 7.11 s, n=17). Taken together with the 
endocytosis findings in Figure 4.1, this suggests that loss of FMRP does not alter 
sypHy retrieval, and by extension SV endocytosis, at either low or high frequency 
stimulation. Taken all together, it appears that deletion of Fmr1 does not play a role 







Figure 4.1 No difference in exocytosis or sypHy retrieval at low frequency stimulation (10 Hz 
30 s) 
Hippocampal neurons derived from Fmr1 KO mice and WT littermate controls were 
transfected with sypHy on DIV 7 and imaged DIV 13-15. a) Time course of experiment. b-c) 
Mean sypHy fluorescence traces of WT (white) and KO (red) hippocampal neurons. Bars 
indicate the period of stimulation, 10 Hz 30 s. b) normalised to the total vesicle number as 
revealed by NH4Cl. c) normalised to the peak of stimulation. 2-way ANOVA n.s. p >0.05. 
d) Mean and individual stimulation peak heights obtained from individual sypHy traces of 
data in b). e) Mean and individual sypHy retrieval time constants (τ) of data plotted in c). d-e) 
n.s. non-significant p > 0.05 by Student t-test.  





Figure 4.2 No difference in exocytosis or sypHy retrieval at high frequency stimulation (50 Hz 
6 s)  
Hippocampal neurons derived from Fmr1 KO mice and WT littermate controls were 
transfected with sypHy on DIV 7 and imaged DIV 13-15. a) Time course of experiment. 
b-c) Mean sypHy fluorescence traces of WT (white) and KO (red) hippocampal neurons. 
Bars indicate the period of stimulation, 10 Hz 30 s. b) normalised to the total SV number as 
revealed by NH4Cl. c) normalised to the peak of stimulation; 2-way ANOVA non-significant 
n.s. p> 0.05. d) Mean and individual stimulation peak heights obtained from individual sypHy 
traces of data in b). e) Mean and individual sypHy retrieval time constants (τ) of data plotted 
in c). d-e) n.s. non-significant p > 0.05 by Student t-test. 




4.2.2. No SV exocytosis deficits in immature Fmr1 KO mouse hippocampal neurons 
Like SynGAP, FMRP plays an important role in synapse maturation and refinement 
during critical periods of circuit development (Doll et al., 2017; Harlow et al., 2010). 
FMRP expression in the brain peaks during the first postnatal week in mice and rats 
and expression levels decrease then plateau in adulthood (Till et al., 2012; Till et al., 
2015). We decided to examine SV exocytosis at DIV 7, at peak FMRP expression 
(Figure 4.3), with either low or high frequency stimulation (Figure 4.3a). This was to 
ensure that the absence of SV exocytosis phenotypes in Figures 4.1 and 4.2 was not 
due to low expression levels of FMRP in DIV 13-15 WT hippocampal neurons 
masking any differences between KO and WT. SypHy fluorescence traces were 
normalised to NH4Cl peak height (Figure 4.3b, d) to quantify exocytosis as a 
proportion of total SV pool. At low-frequency stimulation (10 Hz 30 s, Figure 4.3c), 
there was no difference (Student t-test n.s. p > 0.05) between KO (0.301 ± 0.018 
units, n=3) and WT (0.377 ± 0.050 units, n= 4). Therefore, loss of FMRP during 
peak expression does not impair SV exocytosis at low frequency stimulation. 
 
We also challenged the cells with a higher intensity stimulus load (50 Hz 6 s, Figure 
4.3d-e) and again saw no difference (Student t-test n.s. p> 0.05) between KO (0.439 
± 0.088 units, n=3) and WT hippocampal neurons (0.432 ± 0.059 units n=3). Thus, 
there are no defects in SV exocytosis during high frequency stimulation in immature 
hippocampal neurons lacking FMRP. Taken together, this suggests that loss of 
FMRP does not impact SV recycling at either low or high frequency stimulation in 
developing hippocampal neurons in culture under our experimental conditions. 
 
4.2.3. No defects in evoked synaptic calcium concentrations in Fmr1 KO mouse 
hippocampal neurons 
FMRP can directly bind to Cav2.2 (N-type) calcium channels and modulate their 
density on the plasma membrane. Ferron et al. (2014) proposed that the increased SV 




the interaction of FMRP with these presynaptic channels. When FMRP is knocked-
down, more channels can be inserted into the membrane which in turn increases 
calcium current density (Ferron et al., 2014). Increased calcium influx through N-
type and P/Q-type voltage-gated calcium channels can also be observed in mouse 
Fmr1 KO hippocampal neurons especially with high-frequency stimulation (Deng et 
al., 2011).  
 
We decided to look at presynaptic calcium concentration during our two different 
stimulation paradigms because of the altered calcium influx previously reported with 
loss of FMRP (Deng et al., 2011; Deng et al., 2013; Ferron et al., 2014). We first 
used the genetically encoded reporter GCaMP6f (Chen et al., 2013) due to its fast 
kinetics, low calcium affinity (Kd: 375 ± 14 nM) and broad dynamic range compared 
to other transfected reporters (Akerboom et al., 2012; Chen et al., 2013). We first 
examined the change in intracellular free calcium concentration ([Ca2+]i) during low 
frequency stimulation (Figure 4.4b-c). There was no difference in peak GCaMP6f 
fluorescence during stimulation (Student t-test n.s. p > 0.05) between KO (2.919 ± 
0.440 units, n=8) and WT (2.343 ± 0.400 units, n =8). Thus, there is no difference in 
evoked presynaptic [Ca2+]i across genotypes at low frequency stimulation.  
 
As exaggerated calcium influx was primarily observed during high-frequency 
stimulation (Deng et al., 2011; Deng et al., 2013; Ferron et al., 2014), we went on to 
compare evoked presynaptic [Ca2+]i  responses between Fmr1 KO and WT littermate 
control neurons during high-frequency stimulation (Figure 4.4d-e). There was no 
difference in the evoked presynaptic [Ca2+]i response between genotypes (Student 
t-test n.s. p>0.05, KO: 5.724 ± 0.350 units, n= 8; WT: 7.776 ± 1.186 units, n=7, 








Figure 4.3 No difference in exocytosis at low or high frequency stimulation at DIV 7 
Hippocampal neurons derived from Fmr1 KO mice and WT littermate controls were 
transfected with sypHy on DIV 3 and imaged at DIV 7. a) Time course of experiment. 
b) Mean sypHy fluorescence traces of WT (white) and KO (red) hippocampal neurons 
normalised to the total SV number as revealed by NH4Cl. Bar indicates period of stimulation 
(10 Hz 30 s) c) Mean and individual stimulation peak heights obtained from individual sypHy 
traces of data in b). d) Mean sypHy fluorescence traces of WT and KO hippocampal neurons 
normalised to the total vesicle number as revealed by NH4Cl. Bar indicates period of 
stimulation (50 Hz 6 s). e) Mean and individual sypHy retrieval time constants (τ) of data 
plotted in d). Student t-test n.s. non-significant p > 0.05.  





Figure 4.4 No difference in evoked presynaptic [Ca2+]i using GCaMP6f 
Hippocampal neurons derived from Fmr1 KO mice and WT littermate controls were 
transfected with GCaMP6f on DIV 7 and imaged DIV 13-15. a) Time course of experiment. 
b) Mean GCaMP6f fluorescence traces of WT (white) and KO (red) hippocampal neurons in 
response to 10 Hz 30 s stimulation. Bar indicates duration of stimulation. c) Mean and 
individual stimulation peak heights obtained from individual GCaMP6f traces of data in b). d) 
Mean GCaMP6f fluorescence traces of WT and KO hippocampal neurons in response to 
50 Hz 6 s stimulation. Bar indicates duration of stimulation. e) Mean and individual 
stimulation peak heights obtained from individual GCaMP6f traces of data in d). n.s. p > 0.05 
by Student t-test 





Figure 4.5 No difference in evoked presynaptic [Ca2+]i  using Fluo-5F 
Hippocampal neurons derived from Fmr1 KO mice and WT littermate controls were 
incubated in 10 µM Fluo-5F at room temperature for 30 min prior to imaging at DIV 13-15. a) 
Time course of experiment. b) Mean Fluo-5F fluorescence traces of WT (white) and KO (red) 
hippocampal neurons in response to 10 Hz 30 s stimulation. Bar indicates duration of 
stimulation. c) Mean and individual stimulation peak heights obtained from individual Fluo-5F 
traces of data in b). d) Mean Fluo-5F fluorescence traces of WT and KO hippocampal 
neurons in response to 50 Hz 6 s stimulation. Bar indicates duration of stimulation. e) Mean 
and individual stimulation peak heights obtained from individual Fluo-5F traces of data in d). 
n.s. non-significant p > 0.05 by Student t-test. 




We also used Fluo-5F, a fluorescent calcium-reporter dye (Scott and Rusakov, 2006), 
to examine changes in [Ca2+]i, as it has lower calcium affinity (Kd: ~2.3 µM) and 
would not saturate as readily as GCaMP6f during high frequency stimulation to 
allow [Ca2+]i to be monitored across a broader dynamic range. Once again, we 
examined the [Ca2+]i  response across genotypes using either a low frequency (Figure 
4.5b-c) or high frequency (Figure 4.5d-e) stimulation paradigm. We found no 
difference in peak Ca2+ fluorescence at low frequency stimulation using Fluo-5F 
(Student t-test n.s. p> 0.05, Figure 4.5c) KO (1.259 ± 0.134 units, n=7) and WT 
(1.106 ± 0.146 units, n=7). There was also no difference at high frequency 
stimulation (Student t-test n.s. p>0.05, Figure 4.5e) between KO (1.321 ± 
0.210 units, n=7) and WT (1.642 ± 0.196 units, n=5). Thus, loss of FMRP does not 
affect the presynaptic [Ca2+]i response to action potential stimulation.  
 
4.2.4. No effect of FMRP KD on SV exocytosis 
The increased exocytosis previously described in neurons with FMRP KD was 
reported with vGLUT-pH (Ferron et al., 2014). We therefore investigated whether 
we could replicate the increased SV exocytosis phenotype observed in FMRP KD 
hippocampal results from Ferron et al. (2014). Fmr1 KO mouse hippocampal 
neurons and WT littermate controls were transfected with vGLUT-pH and either 
shRNA against FMRP (shFMRP) or the scrambled shRNA vector (shScr). Fmr1 KO 
neurons do not contain any FMRP, however they were also transfected to determine 
if there were any off-target effects of the shRNA. Hippocampal neurons were 
stimulated at high frequency (60 Hz 5 s) to mimic the previously published 
experimental conditions and SV exocytosis was measured (Figure 4.6). There was no 
difference in SV exocytosis peak heights across all conditions (1-way ANOVA n.s. 
p> 0.05) WT shFMRP (0.435 ± 0.090 units, n=6), WT scr (0.434 ± 0.035 units, n=6), 
KO shFMRP (0.418 ± 0.048 units, n=10) and KO scr (0.389 ± 0.053 units, n=8). 






Figure 4.6 No difference in amount of SV exocytosis at high frequency stimulation (60 Hz 5 
s) with FMRP KD 
Hippocampal neurons derived from Fmr1 KO mice and WT littermate controls were 
transfected with vGlut-pH and either shFMRP or scrambled vector 4 days prior to imaging 
and imaged DIV 13-15. a) Time course of experiment, imaging frames were acquired at 2 s 
intervals. b) Mean vGlut-pH fluorescence traces of WT neurons transfected with scrambled 
vector (WT scr, white), WT neurons transfected with shFMRP (WT shFMRP, grey), KO 
neurons transfected with scrambled vector (KO scr, red) and KO neurons transfected with 
shFMRP (KO shFMRP, pink) normalised to the total SV number as revealed by NH4Cl. Bar 
indicates period of stimulation (60 Hz 5 s). c) Mean and individual stimulation peak heights 
obtained from individual vGlut-pHluorin traces of WT and KO transfected hippocampal 
neuron data in b). n.s. non-significant p > 0.05 1-way ANOVA with Bonferroni multiple 
comparisons test. 





Figure 4.7 No difference in amount of SV exocytosis at low frequency stimulation (10 Hz 
30 s) with KD of FMRP at physiological temperature 
Hippocampal neurons derived from Fmr1 KO mice and WT littermate controls were 
transfected with sypHy and either shFMRP or scrambled vector 4 days prior to imaging and 
imaged DIV 13-15. a) Time course of experiment, imaging frames were acquired at 2 s 
intervals. b) Mean sypHy fluorescence traces of WT neurons transfected with scrambled 
vector (WT scr, white), WT neurons transfected with shFMRP (WT shFMRP, grey), KO 
neurons transfected with scrambled vector (KO scr, red) and KO neurons transfected with 
shFMRP (KO shFMRP, pink) normalised to the total SV number as revealed by NH4Cl. Bar 
indicates period of stimulation (10 Hz 30 s). c) Mean and individual stimulation peak heights 
obtained from individual sypHy traces of WT and KO hippocampal neuron data in b). n.s. 
non-significant p > 0.05 1-way ANOVA Bonferroni multiple comparisons test. 




One potential reason for the discrepancy with the work of Ferron et al. (2014) was 
that their imaging studies were performed at near-physiological temperature (30°C). 
We therefore also examined SV exocytosis with FMRP KD at physiological 
temperature (37°C, Figure 4.7). In this case we used sypHy as the reporter, so the 
pHluorin kinetics would be comparable to previous data (Figure 4.1). Dissociated 
hippocampal neurons from Fmr1 KO or WT littermate controls were transfected with 
sypHy and either shFMRP or shScr. Neurons were stimulated at 10 Hz 30 s and peak 
amount of exocytosis during stimulation was quantified. There was no difference 
across conditions (1-way ANOVA n.s. p > 0.05; WT shFMRP 0.255 ± 0.028 units, 
n=6; WT scr 0.325 ± 0.027 units, n=5; KO shFMRP 0.348 ± 0.054 units, n=6; Figure 
4.7c) and KO scr (0.385 ± 0.051 units, n=8). Therefore knocking-down FMRP in 
cultured hippocampal neurons does not alter SV exocytosis at low frequency 
stimulation at physiological temperatures.  
 
4.2.5. No SV exocytosis or endocytosis deficits in mature Fmr1 KO rat hippocampal 
neurons 
We then went on to examine SV recycling at both low and high frequency 
stimulation in a rat model of FXS (Till et al., 2015) to determine whether the role (or 
absence of role) of FMRP is conserved across species. We used sypHy to examine 
both exocytosis and endocytosis. We started by examining SV recycling during low 
frequency stimulation (10 Hz 30 s, Figure 4.8) in both Fmr1 KO rat neurons and WT 
littermate controls. Fluorescence traces were normalised to the total SV pool to 
determine the amount of exocytosis as a proportion of the total SV pool (Figure 
4.8b,d). There was no difference (Student t-test n.s. p > 0.05) between KO (0.386 ± 
0.038 units, n=11) and WT (0.411 ± 0.044 units, n=9). Thus, the loss of FMRP does 
not affect SV exocytosis at low frequency stimulation in rats.  
 
We then studied SV endocytosis by examining sypHy retrieval by normalising the 
fluorescence traces to the peak of stimulation so that kinetics could be compared 




and WT (2-way ANOVA, n.s. p> 0.05). Furthermore, the sypHy τ were not different 
(Student t-test n.s. p> 0.05) between KO (33.87 ± 2.63 s, n=11) and WT (44.43 ± 
7.71 s, n=9) (Figure 4.8e). Therefore, the loss of FMRP does not impair SV 
endocytosis at low frequency stimulation in rat hippocampal neurons.  
 
As the effects of loss of FMRP are exaggerated at high frequency stimulation (Deng 
et al., 2011; Deng et al., 2013; Ferron et al., 2014; Wang et al., 2014) we challenged 
Fmr1 KO and WT littermate control neurons with high-frequency stimulation 
(50 Hz 6 s) and examined  the effects on SV recycling kinetics (Figure 4.9). When 
fluorescence traces were normalised to maximum NH4Cl fluorescence, there was no 
difference in peak exocytosis during stimulation (Student t-test n.s. p> 0.05, Figure 
4.9b,d) between KO (0.432 ± 0.034 units, n=11) and WT (0.443 ± 0.041 units, 
n=10). Thus, loss of FMRP in rat hippocampal neurons does not affect SV 
exocytosis during high-frequency stimulation.  
 
We then proceeded to examine SV endocytosis after high-frequency stimulation 
(Figure 4.9c, e). There was no difference in sypHy fluorescence traces across 
genotypes (2-way ANOVA n.s. p> 0.05). There was also no difference in sypHy τ 
(Figure 4.9e, Student t-test n.s. p > 0.05) between KO (39.58 ± 3.64 s, n=11) and WT 
hippocampal neurons (43.46 ± 4.87 s, n=17). This suggests that the loss of FMRP 
does not affect sypHy retrieval during high-frequency stimulation in this rat model. 
Taken together with Figure 4.8, these results suggest that SV recycling, as reported 
by sypHy, is not affected by the loss of FMRP in rat hippocampal neurons.  
 
4.2.6. Fewer nerve terminals undergo ADBE in Fmr1 KO rat hippocampal neurons 
SypHy is a good reporter of CME, however it cannot report ADBE (Nicholson-Fish 
et al., 2015) which is the main endocytic mode that occurs during high frequency 




ADBE, we used the fluid-phase marker TMR dextran (40 kDa) in Fmr1 KO rat 
neurons (using the novel Fmr1 LEH model). TMR dextran is a fluorescent-labeled 
hydrophilic saccharide that can be taken up into bulk endosomes in the fluid phase 
upon endocytosis. 40 kDa TMR dextran is specifically accumulated via ADBE since 
its size limits uptake via CME (Clayton and Cousin, 2009). TMR dextran was loaded 
with a train of 40 Hz 10 s action potentials, a high frequency stimulation shown to 
trigger ADBE (Cheung et al., 2010; Clayton et al., 2008; Clayton and Cousin, 2009; 
Nicholson-Fish et al., 2016). The TMR dextran was then immediately washed off. 
The remaining fluorescent puncta represent TMR dextran that has been endocytosed 
during stimulation. Fluorescent puncta were then counted to get an overview of the 
amount of ADBE occurring in culture (Clayton and Cousin, 2009). The number of 
puncta in KO cultures were normalised to the WT puncta number to compare the 
data across genotypes (Figure 4.10). There were significantly fewer TMR dextran 
puncta (Student t-test ** p=0.0054) in the Fmr1 KO hippocampal neurons (76.02 ± 
5.17% of WT levels, n=14) relative to WT littermate controls (100 ± 5.97 % of WT 
levels, n=14). Thus, there is less ADBE occurring in Fmr1 KO hippocampal neurons 
compared to WT controls. This suggests that FMRP may plays a role in ADBE as its 







Figure 4.8 No difference in exocytosis or sypHy retrieval at low frequency stimulation (10 Hz 
30 s) in Fmr1 SD rat model  
Hippocampal neurons derived from Fmr1 KO rat (SD) and WT littermate controls were 
transfected with on DIV 7and imaged DIV 13-15. a) Time course of experiment. b-c) Mean 
sypHy fluorescence traces of WT (white) and KO (red) hippocampal neurons. Bars indicate 
the period of stimulation, 10 Hz 30 s. b) normalised to the total SV number as revealed by 
NH4Cl. c) normalised to the peak of stimulation; 2-way ANOVA n.s. non-significant p> 0.05. 
d) Mean and individual stimulation peak heights obtained from individual sypHy traces of 
data in b). e) Mean and individual sypHy retrieval time constants (τ) of data plotted in c). n.s. 
non-significant p > 0.05 by Student t-test. 





Figure 4.9 No difference in exocytosis or sypHy retrieval at high frequency stimulation (50 Hz 
6 s) in Fmr1 SD rat model  
Hippocampal neurons derived from Fmr1 KO rat (SD) and WT littermate controls were 
transfected with either sypHy at DIV 7 and imaged DIV 13-15. a) Time course of experiment. 
b-c) Mean sypHy fluorescence traces of WT (white) and KO (red) hippocampal neurons. 
Bars indicate the period of stimulation, 10 Hz 30 s. b) normalised to the total SV number as 
revealed by NH4Cl. c) normalised to the peak of stimulation; 2-way ANOVA n.s. non-
significant p> 0.05. d) Mean and individual stimulation peak heights obtained from individual 
sypHy traces of data in b). e) Mean and individual sypHy retrieval time constants (τ) of data 
plotted in c) .n.s. non-significant p > 0.05 by Student t-test. 





Figure 4.10 TMR Dextran uptake is impaired in Fmr1 KO neurons in Fmr1 LEH model 
Hippocampal neurons derived from Fmr1 KO LEH rat (KO, red) and WT littermate controls 
(white) were loaded with TMR dextran during a 40 Hz 10 s action potential train and imaged 
at DIV 13-15. a-b) Representative images of TMR dextran loaded nerve terminals of a) WT 
and b) Fmr1 KO hippocampal neurons. Arrow heads indicate selected nerve terminals that 
have taken up TMR dextran. c) Mean and individual dextran puncta uptake data as a 
proportion of total WT uptake. Student t-test ** p < 0.05.  





We used a series of fluorescent reporters to examine SV recycling deficits in Fmr1 
KO neurons. In our hippocampal cultures at DIV 14 neither SV exocytosis nor SV 
endocytosis were affected by loss of FMRP. This was the case with both low and 
high frequency stimulation. We also looked at SV recycling at DIV 7, as FMRP 
expression peaks at PND 7, to ensure that we did not miss any shift in presynaptic 
activity during this synapse formation critical period. However, we did not see any 
SV exocytosis defects in immature Fmr1 KO hippocampal neurons at either 
frequency. 
 
We also measured presynaptic [Ca2+]i to determine whether there was an effect of 
loss of FMRP as FMRP has been found to directly bind to N-type calcium channels 
(Ferron et al., 2014). We did not see any difference in evoked calcium concentration 
at the presynapse using the calcium reporters GCaMP6f or Fluo5f.  
 
Impaired pHluorin recycling kinetics have been observed with FMRP KD at near 
physiological temperatures (Ferron et al., 2014). We attempted to replicate this 
phenotype in our own hippocampal cultures. However, there was no effect on SV 
exocytosis of FMRP KD during high frequency stimulation. We then examined the 
effect of physiological temperatures on SV exocytosis. We found no difference in 
exocytosis between Fmr1 KO and WT neurons at low frequency stimulation.  
 
We then monitored SV recycling kinetics in a rat model of Fmr1 KO to determine 
whether there was a converging role of FMRP across species as there is some 
evidence that suggests a different role of FMRP across mouse and rat models. 
Specifically, loss of FMRP in both mouse and rat models leads to altered synaptic 
plasticity, particularly exaggerated protein synthesis-independent mGluR-LTD 




KO SD rats show impaired hippocampal-dependent spatial learning, whereas Fmr1 
KO mice do not (Till et al., 2015). However, there were no differences in SV 
exocytosis or endocytosis across genotypes at either high or low frequency 
stimulation. 
 
Finally, using a different rat model, Fmr1 KO LEH, we discovered ADBE deficits in 
Fmr1 KO hippocampal neurons compared to WT. There were fewer KO nerve 
terminals that underwent ADBE as determined by fewer fluorescent dextran puncta 
compared to WT littermate controls.  
 
4.3.1. No SV exocytic defects at high frequency stimulation 
4.3.1.1. Total vs partial loss of FMRP 
Previous work has suggested that loss of FMRP can impair SV recycling, 
demonstrated by altered SV release kinetics using FM dyes (Deng et al., 2011) and 
increased vGLUT-pH exocytosis upon high frequency stimulation (Ferron et al., 
2014). Ferron et al. found that partial loss of FMRP led to increased exocytosis in 
DRG neurons at high frequency stimulation. This also appeared to be the case in 
preliminary studies in FMRP KD hippocampal neurons (Ferron et al., 2014). 
Unfortunately, we could not replicate these findings in our cultures. In our shFMRP 
experiments, FMRP was knocked down at DIV 9-11 and imaged 4 days later 
consistent with experiments reported in Ferron et al. (2014). Synapse formation has 
already started to occur in hippocampal cultures at this stage (Kaech and Banker, 
2006). It is therefore possible that synaptic plasticity may no longer be as reliant on 
FMRP as it is during synapse formation and neurite outgrowth (reviewed in Pfeiffer 
and Huber, 2009) which occurs earlier at DIV 4-7 in hippocampal cultures (Kaech 
and Banker, 2006). As well, it is important to note that this protocol was optimised 
for DRG neurons, it is possible that a 4-day KD of FMRP is insufficient to achieve 
optimal FMRP depletion in hippocampal neurons. The efficiency of FMRP KD 




KD could explain the discrepancy between our work and what has previously been 
published by Ferron et al. (2014).  
 
Furthermore, we do not see an SV exocytosis defect in Fmr1 KO hippocampal 
neurons. This could be due to the role that FMRP plays in development. FMRP plays 
an important role in synapse formation during critical periods (Cruz-Martin et al., 
2010; Doll et al., 2017). FMRP expression peaks early in development at PND 7 (Till 
et al., 2012; Till et al., 2015) when it is required for synapse pruning and 
maintenance (Pfeiffer et al., 2010). This is why we also looked at SV exocytosis in 
developing neurons at DIV 7, in the case where a SV recycling phenotype would be 
exaggerated. This was not the case, there were no SV exocytosis defects in Fmr1 KO 
hippocampal neurons compared to WT.  
 
A possible explanation for the lack of effect of the complete loss of FMRP could be 
due to homeostatic compensation for the absence of the protein. In its absence, 
different pathways may be upregulated or downregulated to compensate for loss of 
FMRP activity. FMRP is involved in multiple cellular processes. Because of this, it 
is perhaps not unsurprising that the defects observed in FXS can be rescued by 
targeting multiple different molecules and pathways (reviewed in Wijetunge et al., 
2013). In fact, all or a subset of the following pathophysiological phenotypes: 
dendritic spine morphology, increased protein translation, audiogenic seizures, and 
impaired synaptic plasticity can be rescued by altering BK channel opening 
pharmacologically (Hebert et al., 2014) or genetically (Deng and Klyachko, 2016), 
inhibiting mGluR activity pharmacologically (Chuang et al., 2005; Suvrathan et al., 
2010; Yan et al., 2005) or genetically (Dolen et al., 2007), targeting the mammalian 
target of rapamycin (mTOR) pathway pharmacologically (Osterweil et al., 2013) or 
repressing protein synthesis of FMRP-target mRNAs pharmacologically (Gkogkas et 
al., 2014). Thus, there is considerable overlap between these pathways. This suggests 
that there may already be endogenous mechanisms in place that can compensate for 




proteins that may be up-regulated or down-regulated in the absence of FMRP 
(Klemmer et al., 2011; Tang et al., 2015). We prepared synaptosomes from 
hippocampi and cortices isolated from adult Fmr1 KO mice and WT littermate 
controls. These synaptosomes were then analysed by quantitative mass spectrometry 
(Prof Matthias Trost, Newcastle University, UK) to determine whether there was 
alteration in expression of any key presynaptic proteins (data not shown). We found 
a significant decrease in endophilin levels in both the hippocampal and cortical 
synaptosomes of the Fmr1 KO brains compared to WT. This decrease in endophilin 
levels could potentially be responsible for the deficit in ADBE observed.   
 
With a 4-day FMRP KD, FMRP levels are reduced by half in non-neuronal tsA-201 
cells (Ferron et al., 2014). There may still be sufficient levels FMRP present in this 
model, therefore there would be no need for any compensatory mechanisms to be put 
in place. This could explain why there is deficient SV recycling with FMRP KD but 
not with complete loss of the protein. Indeed, it is interesting that a 50 % depletion of 
FMRP resulted in significantly increased exocytosis whereas we did not observe any 
defects in Fmr1 KO neurons, This is especially surprising, since both mouse and 
human Fmr1 Het females show milder FXS phenotypes compared with KO males 
(Clifford et al., 2007; Gauducheau et al., 2017).  
 
Taken all together, our results suggest that FMRP may not play any role in SV 
recycling by the CME pathway.  
 
4.3.1.2. Presynaptic calcium concentration 
Another widely observed phenotype with loss of FMRP is increased calcium currents 
in the presynapse. FMRP binds to N-type calcium channels and, through this 
interaction, can modulate their density at the plasma membrane. This could partially 




hippocampal neurons (Deng et al., 2011; Deng et al., 2013; Ferron et al., 2014). 
However we did not observe any increased in [Ca2+]i at the presynapse using the 
genetically encoded reporter, GCaMP6f. This reporter was chosen for its rapid 
kinetics, however it appeared our fluorescence signal was being saturated, as addition 
of ionomycin to the cells was not able to further increase fluorescence signal. 
Ionomycin is used to raise [Ca2+]i and thus should cause an increase in reporter 
fluorescence due to the increased [Ca2+]i present. We then went on to use Fluo-5F. 
Fluo-5F is a calcium indicator dye that increases fluorescence upon binding calcium. 
It was chosen since it had a lower affinity for calcium and it did not saturate during 
high frequency stimulation as application of ionomycin was able to increase 
fluorescence signal.   
  
It should be noted that these reporters are not exclusively presynaptic and therefore 
do not exclusively report changes in presynaptic calcium levels. When we used the 
presynaptic calcium reporter SyGCaMP5f (GCaMP5f fused to synaptophysin, data 
not shown) we observed a significant trafficking of the reporter molecule from the 
presynapse which confounded our results (data not shown). Therefore we monitored 
presynaptic [Ca2+]i using Fluo-5F selecting ROIs based on nerve terminal 
morphology.   
 
The changes in presynaptic [Ca2+]i previously reported were changes in Ca2+ currents 
measured through electrophysiological patch clamping onto the neuron or through 
two-photon imaging (Deng et al., 2011; Deng et al., 2013; Ferron et al., 2014). These 
recording techniques have better spatial resolution than epi-fluorescence microscopy 
and thus may be more sensitive to slight variations in calcium concentration at the 
AZ. It is possible that this increased [Ca2+]i is very localised, and a cytosolic reporter 
may not report these minor fluctuations in calcium currents at least under our 





4.3.2. Role for FMRP in ADBE  
Although we saw no effect of loss of FMRP on SV exocytosis or CME, we did 
observe fewer nerve terminals undergoing ADBE in Fmr1 KO rat (Fmr1 KO LEH) 
neurons as compared to WT controls. VAMP4-pH could also be used to confirm this 
phenotype as VAMP4 preferentially found as cargo on bulk endosomes (Nicholson-
Fish et al., 2015). It is important to note that the dextran assay used to report ADBE 
only reports the number of nerve terminals undergoing ADBE, not the extent to 
which it happens in each nerve terminal (Clayton and Cousin, 2009). Therefore, it 
would also be important to perform an HRP uptake assay to label endosomes and 
SVs at the presynapse and image them using electron microscopy to determine how 
much ADBE is occurring at each nerve terminal (Cheung et al., 2010).  
 
4.3.2.1. Translational effects 
Our group has previously found that FMRP is enriched on bulk endosomes (Kokotos 
et al, unpublished data), therefore it may play an important role in this endocytic 
mode. FMRP may regulate ADBE through translational regulation of molecules 
involved in the pathway. FMRP’s main function is to block protein translation 
downstream of mGluRs through repression of transcription initiation (Napoli et al., 
2008) and elongation (Darnell et al., 2011). In its absence, there is increased 
translation of its target mRNAs (Darnell and Klann, 2013). A third of the presynaptic 
proteome is an FMRP target (Darnell et al., 2011). Increased translation and 
expression of these proteins may impair SV recycling by ADBE, especially since, in 
normal conditions, the number of proteins within a synaptic bouton are tightly 
regulated and present in limited amounts (Wilhelm et al., 2014). Mass spectrometry 
analyses performed by us and others confirm that there are indeed increased levels of 
presynaptic proteins important for SV recycling in Fmr1 KO mouse brains including, 
amphiphysin-1 which has been found to be overexpressed in Fmr1 KO mice during 
development (Tang et al., 2015). Amphiphysin-1 is only present in low levels on 




is possible that altered levels of this protein can impair endocytosis, particularly by 
biasing the nerve terminal to undergo CME rather than ADBE.  
 
4.3.2.2. -Actin dynamics 
FMRP can regulate protein synthesis by forming an inhibitory complex with CYFIP1 
and eIF4E to suppress protein synthesis initiation (Napoli et al., 2008). Along with 
being an eIF4E-binding protein, CYFIP1 can also regulate actin remodelling. In the 
absence of FMRP, CYFIP1 preferentially takes on its role as a promoter of actin 
remodelling (Santini et al., 2017). FMRP and CYFIP1 act antagonistically on the 
mTOR pathway to maintain effective neurotransmission through regulation of 
dendritic spines (Abekhoukh et al., 2017). In the absence of FMRP, there is an 
increase in number of dendritic spines and altered morphology (Abekhoukh et al., 
2017) similar to what is seen with overexpression of CYFIP1 (Pathania et al., 2014). 
Thus, FMRP plays an important role in synapse formation at the structural level. 
Furthermore, disruption of actin dynamics through loss of FMRP may mediate the 
decreased levels of ADBE occurring in this model as ADBE is actin-dependent 
(Kononenko et al., 2014) (see section 1.3.2.2).  
 
4.3.2.3. Modulation of APs through presynaptic ion channels 
Alternatively, FMRP could also be regulating ADBE through modulation of ion 
channel activity (Ferron, 2016). There is evidence that dysregulation of the Slack and 
N-type calcium channels may in part mediate the presynaptic deficits observed in 
FXS, however there is considerable evidence that defects in SV recycling are due to 
the loss of FMRP regulation of BK channels (Deng et al., 2013; Deng and Klyachko, 
2016). In Fmr1 KO neurons, there is no repression of the BK channel β4 subunit by 
FMRP binding (Deng et al., 2013). This leads to broader action potentials which in 
turn increases neurotransmission, enhances SV recycling as reported by FM1-43 
recycling and increases seizure susceptibility in KO neurons (Deng et al., 2011; 




neurons was able to rescue all the pathogenic phenotypes previously described (Deng 
and Klyachko, 2016). Administration of a BK channel opener to Fmr1 KO mice 
rescued dendritic spine and behavioural phenotypes (Hebert et al., 2014). Therefore, 
it is highly probable that it is through this interaction that FMRP modulates 
presynaptic activity including SV recycling. Although currently there is no evidence 
tying BK channels to different modes of endocytosis, there is evidence that ion 
channels can differentially regulate both CME and ADBE (Yao et al., 2017). 
 
4.3.2.4. Association with the endosomal sorting complex required for transport (ESCRT) 
Another way in which FMRP could regulate ADBE is through its interaction with the 
endosomal sorting complex required for transport (ESCRT) complex. In Drosophila 
melanogaster, FMRP binds to the protein Shrub (CHMP4 in mammals) and can 
negatively regulate its expression during an early critical period (Vita and Broadie, 
2017). Shrub is a core protein of the ESCRT-III complex. In endosomes, the 
ESCRT-III complex forms invaginated buds that trap important cargo protein. These 
invaginations can then form intraluminal vesicles through abscission of the 
endosomal membrane by the unfolding of the ESCRT-III by other ESCRT pathway 
proteins (reviewed in Williams and Urbe, 2007). Interestingly, in Drosophila, when 
Shrub was overexpressed, there was arrested membrane trafficking in synapses, 
including more endosomal structures and bigger intraluminal vesicle area. (Vita and 
Broadie, 2017). The same trafficking defects were seen in the Drosophila FXS 
model. Thus, the absence of FMRP could mediate defects in ADBE by loss of 
suppression of ESCRT-III complex activity.  
 
4.3.3. Limitations 
A key factor that should not be overlooked when comparing our results to the 
published work by Ferron et al. (2014) is the temperature at which we imaged our 
cells. All imaging experiments, other than those described in Figure 4.7, were 




pathway at room temperature in hippocampal neurons (Granseth et al., 2006), 
however there is some debate as to whether these imaging parameters are 
physiologically relevant. At higher temperatures, the kinetics of SV recycling are 
accelerated and allow for faster replenishment of SV pools (Fernandez-Alfonso and 
Ryan, 2004; Renden and von Gersdorff, 2007). Physiological temperatures can also 
recruit different endocytic modes that do not occur at room temperature including 
ultrafast endocytosis (Watanabe et al., 2013) which occurs on faster timescales than 
CME. Thus, imaging at 37°C may be a more physiologically relevant imaging 
paradigm and may provide more insight into what actually occurs at functioning 
synapses in the brain. It is important to note that we did not observe any effect of 
FMRP KD with low frequency stimulation at physiological temperatures. No effect 
of FMRP KD has previously been reported in DRG neurons in these same conditions 
(Ferron et al., 2014). It would be important to repeat these experiments with high 
frequency stimulation as this should reveal any deficits due to the loss of FMRP 




5. Characterisation of SV recycling defects associated with 
de novo mutations in DNM1 linked to epileptic 
encephalopathy 
 
5.1.  Introduction 
Dynamin-1 (dyn1) is a large brain-specific GTPase. It is located in presynaptic nerve 
terminals, where it plays an essential role in SV recycling. Dyn1 is composed of a 
GTPase domain, a BSE, the stalk, a PH domain, and a PRD (Figure 5.1a). Dyn1 
forms helical oligomers that wrap themselves around the neck of endocytic pits and 
upon GTP hydrolysis, dyn1 constricts the membrane and fission occurs (reviewed in 
Antonny et al., 2016). After fission, the dyn1 oligomer helices disassemble. Dyn1 
GTPase activity plays essential roles in both CME and ADBE (reviewed in Rizzoli, 
2014).  
 
The PRD of dyn1 contains the S774 and S778 phosphorylation sites which are 
phosphorylated by GSK3β and Cdk5 respectively, and dephosphorylated by Ca2+-
dependent calcineurin (Clayton et al., 2009; Clayton et al., 2010). Mutating these 
residues has revealed additional roles of dyn1 in endocytosis including mediating the 
activity-dependent acceleration phase of endocytosis (Armbruster et al., 2013) and 
mediating ADBE (Clayton et al., 2009; Clayton et al., 2010). Activity-dependent 
dephosphorylation of dyn1 allows for it to interact with syndapin-1 which mediates 
endocytosis via ADBE (Clayton et al., 2009).  
 
Recently, large-scale exome sequencing studies have revealed de novo mutations in 
DNM1 to be important risk factors for neurodevelopmental disorders 
(EuroEPINOMICS-RES Consortium et al., 2014; von Spiczak et al., 2017). We have 




(patient information acquired from the DDD consortium and provided by Dr Wayne 
Lam). These patients have one WT and one mutant allele of DNM1, suggesting that 
these mutants all express dominant-negative function. Epileptic encephalopathy 
presents itself with childhood-onset epilepsy associated with cognitive and 
behavioural deficits due to the seizures. It is often comorbid with moderate to severe 
intellectual disability and autism spectrum disorders (Epi4K Consortium et al., 2013; 
EuroEPINOMICS-RES Consortium et al., 2014; von Spiczak et al., 2017). Mutations 
human DNM1 result in severe phenotypes including Lennox-Gastaut syndrome, 
severe intellectual disability, and dystonia (EuroEPINOMICS-RES Consortium et 
al., 2014; von Spiczak et al., 2017). Three of the mutations that are investigated in 
this chapter are novel, and one, R237W, has been characterised previously and 
appears to be a recurrent mutation appearing in multiple unrelated patients 
(EuroEPINOMICS-RES Consortium et al., 2014; von Spiczak et al., 2017). Three of 
the mutations are in the GTPase domain (G139R, R237W, I289F) and one in the 
stalk domain (H396D) (Figure 5.1a).  
 
Dyn1 is necessary for sustained neurotransmission upon stimulation (Ferguson et al., 
2007). Although Dnm1 KO mice were viable and did not show any defects at birth, 
KO pups died within 2 weeks of birth (Ferguson et al., 2007). Dnm1 KO cortical 
neurons could still undergo a few rounds of SV recycling, after which endocytic 
capacity became saturated (Ferguson et al., 2007). The KO nerve terminals exhibited 
accumulations of interconnected clathrin-coated buds and very few formed SVs 
(Ferguson et al., 2007), providing evidence that dyn1 is necessary for SV formation 
through endocytosis. It is important to note that Dnm1,3 double KO (DKO) mice die 
within a few hours of birth and cultured neurons show significantly more SV 
endocytosis impairment than either Dnm1 KO or Dnm3 KO neurons (Ferguson et al., 
2007; Raimondi et al., 2011). This suggests that the dynamins have some functional 
overlap which can explain why correctly formed SVs are still present in Dnm1 KO 





In our studies, we also looked at the Dnm1 ftfl (Dyn1A408T) mutation which 
spontaneously arose in mice that displayed non-lethal seizures (Boumil et al., 2010). 
Mice with heterozygous expression of this mutant allele displayed recurrent 
generalised tonic-clonic seizures. Mice homozygous for Dyn1A408T had lethal 
seizures by 3 weeks of age (Boumil et al., 2010). Dyn1A408T has also been found to 
have defective self-assembly (Boumil et al., 2010), a function which is critical for 
GTPase activity and membrane fission (Hinshaw and Schmid, 1995; Warnock et al., 
1996). Dyn1A408T shows impaired endocytosis as measured by disrupted transferrin 
uptake in COS-7 fibroblast cells overexpressing this mutant. This can be rescued 
when Dyn1A408T is co-expressed with Dyn1WT (Asinof et al., 2016; Boumil et al., 
2010).   
 
The aim of this work was to determine whether these de novo mutations impaired SV 
recycling in cultured hippocampal neurons. This work could also provide 
mechanistic data which may explain the patient phenotypes. Studying the effect of 
these mutants on SV endocytosis could also provide insights on dyn1 function as the 
mutations are located within different protein functional domains. Additionally, we 




5.2.1.  Overexpression of mutant mCer-Dyn1 impairs CME 
De novo mutations in both the GTPase domain and stalk domain of dyn1 (Figure 
5.1a) were found in patients suffering from neurodevelopmental disorders (Table 
5.1). Due to the important role of dyn1 in both CME and ADBE, we decided to study 
the effects of these mutations on SV recycling through both of these pathways. We 




mimic the heterozygous condition found in patients, we transfected these mutants 
into WT mouse hippocampal neurons.  
 
Human mutations 
Linked disorders Predicted effects based on 




G139R c.415G>A Seizures and developmental 
delay 
Highly likely deleterious, 
destabilising 
R237W c.709C>T Seizures and developmental 
delay 
Highly likely deleterious, 
destabilising 
I289F c.865A>T Seizures Highly likely deleterious, 
destabilising 
H396D c.1186C>G Developmental delay Likely deleterious 
Table 5.1 Dyn1 mutations identified by the DDD Consortium  
Mutations were provided to us by Dr Wayne Lam (Muir Maxwell Epilepsy Centre, University 
of Edinburgh). In silico modelling was performed by Dr Dinesh Soares (American Chemical 
Society) See section 5.3.1 
 
To mimic the patient condition as closely as possible, we attempted to titrate 
exogenous dyn1 levels to be equivalent to the endogenous isoform. All mutants 
except one (mCer-Dyn1I289F) were significantly overexpressed when compared to 
endogenous dyn1 levels (1-way ANOVA with Dunnett’s test comparing to mCerN1 
empty vector 1.000 ± 0.089 fold overexpression, n=16); mCer-Dyn1WT (2.663 ± 
0.402 fold overexpression, n=10, **p= 0.003), mCer-Dyn1K44A (2.397 ± 0.353 fold 
overexpression, n=10, *p= 0.014), mCer-Dyn1G139R (2.800 ± 0.369 fold 
overexpression, n=14, ***p= 0.0003), mCer-Dyn1R237W (2.759 ± 0.536 fold 
overexpression, n=9, **p= 0.002), mCer-Dyn1I289F (1.433 ± 0.189 fold 
overexpression, n=18, n.s. p> 0.05), mCer-Dyn1H396D (2.736 ± 0.447 fold 
overexpression, n=10, **p= 0.002), mCer-Dyn1A408T (2.147± 0.258 fold 
overexpression, n=21, *p= 0.019). Thus, transfection of the mCer-Dyn1 vectors 
under these conditions provided an overexpression of exogenous dyn1 in an 





Since a number of human dyn1 mutants have alterations in their GTPase domains, 
we first examined the effects of overexpression of the well-characterised Dyn1K44A 
mutant on SV recycling using our sypHy imaging assay (Figure 5.2a). The Dyn1K44A 
mutation impairs both the GTPase activity of dyn1 and its ability to bind GTP 
(Damke et al., 1994; Damke et al., 2001). Previous studies using this mutant have 
revealed impaired transferrin uptake in HeLa cells, indicating an arrest of receptor-
mediated endocytosis (Damke et al., 1994). However, to our knowledge, the effect of 
this mutation on CME has not been directly investigated in primary neuronal 
cultures. We first monitored the effect of mCer-Dyn1K44A on sypHy retrieval after 
low frequency stimulation (10 Hz 30 s), as this frequency evokes dyn1-dependent 
CME. We observed significant impairment in sypHy retrieval in neurons expressing 
the mCer-Dyn1K44A mutant (Figure 5.2b, 2-way ANOVA with Dunnett’s test 
comparing to WT * p< 0.05, ** p< 0.01, **** p< 0.0001). In contrast, 
overexpression of mCer-Dyn1WT did not impair sypHy retrieval compared to 
mCerN1 empty vector (2-way ANOVA n.s. p> 0.05). Therefore, overexpression of 
mCer-Dyn1K44A impairs CME in primary neuronal cultures.  
 
There is some evidence that dyn1 may play a role in hormone secretion in adrenal 
chromaffin cells, particularly through regulating the size of the fusion pore (Fulop et 
al., 2008). Dyn1 has also been proposed to regulate the kinetics of exocytic vesicle 
fusion pores in astrocytes (Lasic et al., 2017). Therefore, we also examined SV 
exocytosis by normalising the fluorescence trace to the fluorescence of the total 
vesicle pool (traces not shown). We observed no difference in SV exocytosis 
between the empty vector (mCerN1, 0.439 ± 0.036 units, n=9), mCer-Dyn1K44A 
(0.502 ± 0.028 units, n= 17) and mCer-Dyn1WT (0.553 ± 0.044 units, n=10). This 
suggests that mCer-Dyn1K44A mutant impairs SV endocytosis but not SV exocytosis.  
 
We then determined whether overexpression of the other human dyn1 mutants or the 
Dyn1A408T mutant impacted SV endocytosis using the same imaging assay (Figure 






Figure 5.1 Overexpression of mCer-Dyn1 mutants in hippocampal cultures 
a) Schematic representation of the different functional domains of dyn1 and the location of 
the dyn1 mutations. b) Level of expression of dyn1 as a fold overexpression of mCerN1 
(empty vector). Hippocampal neurons derived from wildtype mouse embryos were 
transfected with mCerN1(grey), or mCer-Dyn1WT (WT, white) or dyn1 mutants: mCer-
Dyn1K44A (red), mCer-Dyn1G139R (green), mCer-Dyn1R237W (turquoise), mCer-Dyn1I289F (blue), 
mCer-Dyn1H396D (purple), mCer-Dyn1A408T (magenta) 2 days prior to fixing at DIV 13-14. 
Neurons were immunolabeled with anti-GFP to locate the transfected cells, anti-SV2A to 
locate synapses and anti-dyn1 for quantification. 1-way ANOVA with Dunnett’s multiple 
comparison comparing values to mCerN1: * p < 0.05; ** p < 0.01; *** p < 0.001; n.s. p > 0.05. 






Figure 5.2  Dyn1K44A dominant negative mutant inhibits sypHy retrieval 
Hippocampal neurons derived from WT mouse cultures were transfected with sypHy and 
mCerN1 (grey), or mCer-Dyn1WT (WT; white) or mCer-Dyn1K44A (K44A; red) 2 days prior to 
imaging at DIV13-14. a) Time course of experiment b) Mean sypHy fluorescence traces 
normalised to the peak of stimulation. Bar indicates duration of stimulation, 10 Hz 30 s. 
2-way ANOVA with Dunnett’s multiple comparisons test comparing each trace to the 
mCer-Dyn1WT trace * p < 0.05; ** p < 0.01; **** p<0.0001. c) Mean and individual stimulation 
peak heights measuring exocytosis as a proportion of total SV pool revealed by NH4Cl. 
1-way ANOVA n.s. p > 0.05.  




any phenotype was due to the overexpression of the mutant copy of dyn1 and not due 
to excess dyn1 (Figure 5.3b). There was no significant difference in fluorescence 
traces after stimulation between mCer-Dyn1G139R or mCer-Dyn1A408T and mCer-
Dyn1WT (Figure 5.3b,c,g, 2-way ANOVA with Dunnett’s test comparing to mCer-
Dyn1WT: n.s. p > 0.05), however there was a significant difference in sypHy 
fluorescence traces post-stimulation between the mCer-Dyn1R237W, mCer-Dyn1I289F 
and mCer-Dyn1H396D mutations compared to mCer-Dyn1WT (Figures 5.3b,d-f, 2-way 
ANOVA with Dunnett’s test comparing to mCer-Dyn1WT : * p< 0.05, ** p< 0.01, 
*** p < 0.001, **** p < 0.0001). Of note, sypHy τ was not calculated as the 
fluorescence decay could not be fit by an either a single or double exponential curve. 
Thus, overexpression of mCer-Dyn1R237W, mCer-Dyn1I289F or mCer-Dyn1H396D 
impairs SV endocytosis at low frequency stimulation. 
 
We also examined SV exocytosis in neurons expressing these mutants, because 
endocytosis and exocytosis are tightly coupled, and a defect in one may produce 
deficits in the other. We compared peak sypHy fluorescence during stimulation 
across mutants after normalisation to the total SV pool using NH4Cl (Figure 5.4). 
There was a significant difference in peak sypHy fluorescence during stimulation 
(1-way ANOVA with Dunnett’s test comparing to mCer-Dyn1WT: * p = 0.02) 
between mCer-Dyn1H396D (0.3043 ± 0.028 units, n=10) and mCer-Dyn1WT (0.475 ± 
0.042 units, n=16). However, there were no differences in sypHy peak height (1-way 
ANOVA: n.s. p > 0.05) between any of the other mutants (mCer-Dyn1G139R: 0.589 ± 
0.064 units, n=5; mCer-Dyn1R237W: 0.427 ± 0.042 units, n=8; mCer-Dyn1I289F: 
0.414 ± 0.049 units, n=11; mCer-Dyn1A408T: 0.479 ± 0.041 units, n=12) and 
mCer-Dyn1WT. Therefore, the Dyn1H396D mutation in the stalk domain appears to 
impair SV exocytosis, whereas the other dyn1 mutations only appear to produce 
endocytic defects.  
 
There is constant need for SV endocytosis to replenish SV pools to maintain 




starts to occur during our electrical stimulation protocol. The decreased peak height 
observed with mCer-Dyn1H396D overexpression may reflect accelerated SV 
endocytosis, rather then decreased SV exocytosis. We investigated these neurons in 
the presence of Bafilomycin A1 (Sankaranarayanan et al., 2000) to determine 
whether the decreased sypHy peak height during stimulation is an endocytic or 
exocytic defect. Bafilomycin A1 uncouples the reporting of SV endocytosis and 
exocytosis by inhibiting the vacuolar-type H+-ATPase that acidifies SVs after 
endocytosis. Therefore, once the sypHy on SVs has been exposed to the neutral pH 
upon exocytosis, it can no longer be quenched. SV exocytosis can be visualised 
without the confounds of SV endocytosis using this approach. Neurons expressing 
sypHy and either mCerN1, mCer-Dyn1WT or mCer-Dyn1H396D were stimulated at 
10 Hz for 90 s to release the total recycling pool. There was no significant difference 
in amount of exocytosis (1-way ANOVA: n.s. p> 0.05; Figure 5.5c) between 
mCerN1 (0.516 ± 0.023 units, n= 11), mCer-Dyn1WT (0.500 ± 0.033 units, n=11) and 
mCer-Dyn1H396D (0.507 ± 0.028 units, n=7). Additionally, there was no difference in 
the rate of exocytosis (1-way ANOVA: n.s. p> 0.05; Figure 5.5d) between mCerN1 
(0.017 ± 0.003 s, n=11) or mCer-Dyn1H396D (0.021 ± 0.004 s, n=7) and mCer-
Dyn1WT (0.013 ± 0.002 s, =11). Taken together with the results from Figure 5.4, this 
suggests that the decreased exocytosis observed with overexpression of mCer-
Dyn1H396D is not due to an exocytic defect, but rather an endocytic defect.  
 
5.2.2. Overexpression of mCer-Dyn1K44A and mCer-Dyn1H396D impair ADBE 
Thus far we have shown that dyn1 mutations identified in human patients result in a 
series of defects in SV recycling through CME. We next determined whether these 
dyn1 mutants also impacted on ADBE, as dyn1 may also play an important role in 
this endocytic mode (Clayton et al., 2009; Clayton et al., 2010; Nguyen et al., 2012; 
see also Y. Wu et al., 2014). To do this, we utilised the genetically-encoded reporter 
of ADBE: VAMP4-pH (Nicholson-Fish et al., 2015). Like TMR dextran, 
VAMP4-pH can provide a measure of the proportion of nerve terminals undergoing 






Figure 5.3 Overexpression of mCer-Dyn1R237W, mCer-Dyn1I289F, or mCer-Dyn1H396D 







Cultured hippocampal neurons derived from WT mice were transfected with sypHy and 
either mCer-Dyn1WT (WT, black) or dyn1 mutants: mCer-Dyn1K44A (red), mCer-Dyn1G139R 
(green), mCer-Dyn1R237W (turquoise), mCer-Dyn1I289F (blue), mCer-Dyn1H396D (purple), 
mCer-Dyn1A408T (magenta) 2 days prior to imaging on DIV 13-14. a) Time course of 
experiment b) Mean sypHy fluorescence traces normalised to the peak of 10 Hz 30 s 
stimulation for all mutations. Error bars were excluded for clarity but can be seen in c-g) Bar 
indicates duration of stimulation, 10 Hz 30 s. 2-way ANOVA with Dunnett’s multiple 
comparisons test comparing each trace to the WT trace * p < 0.05; ** p < 0.01; *** p < 0.001; 
**** p < 0.0001. c-g) Mean sypHy traces from each mutant in b) plotted against WT sypHy 
trace c) G139R, d) R237W, e) I289F, f) H396D, g) A408T. Bars indicate duration of 
stimulation. Significance obtained from analysis in b).  







Figure 5.4 Altered sypHy fluorescence peak height with overexpression of mCer-Dyn1H396D 
Data obtained from fluorescence traces in Figure 5.3. a) Time course of experiment. b) Mean 
and individual stimulation peak heights measuring exocytosis as a proportion of total SV pool 
revealed by NH4Cl. 1-way ANOVA with Dunnett’s test comparing values to mCer-Dyn1WT 
(white). * p < 0.05; n.s. p > 0.05.  






Figure 5.5 No impaired exocytosis with mCer-Dyn1H396D overexpression 
Cultured hippocampal neurons derived from WT mice were transfected with sypHy and 
either mCerN1 (grey), mCer-Dyn1WT (WT, white) or mCer-Dyn1H396D mutant dyn1 (purple) 
2 days prior to imaging on DIV 13-14. Imaging was performed in the presence of the 
vacuolar-type H+-ATPase inhibitor Bafilomycin A1. a) Time course of experiment. b) Mean 
mCerN1, WT and H396D sypHy fluorescence traces normalised to the peak of 10 Hz 90 s 
stimulation. Bar indicates duration of stimulation, 10 Hz 90 s. c) Mean and individual 
stimulation peak heights measuring exocytosis as a proportion of total SV pool revealed by 
NH4Cl buffer. d) Mean and individual exocytosis rates of data in b) obtained by calculating 
the slope of a linear regression fit to the first 3 timepoints after the start of stimulation. c-d) 
1-way ANOVA n.s. p> 0.05. 




Neurons expressing VAMP4-pH, mCerN1 and either mCer-Dyn1WT or mutant 
mCer-Dyn1 were challenged with high frequency stimulation to trigger ADBE. The 
fluorescence of each terminal was then sorted into “up” and “down” traces 
depending on the fluorescence 120 s after stimulation, as previously described 
(Nicholson-Fish et al., 2015; Nicholson-Fish et al., 2016). “Down” traces represent 
nerve terminals undergoing ADBE as the bulk endosomes slowly acidify over time 
quenching the VAMP4-pH. The proportion of “down” traces in mCer-Dyn1K44A 
expressing neurons (5.728 ± 1.456 %, n=12) was significantly different from 
mCer-Dyn1WT overexpression (1-way ANOVA with Dunnett’s test comparing 
mCer-Dyn1K44A and mCerN1 17.660 ± 2.699 %, n=11 to mCer-Dyn1WT 18.800 ± 
3.228 %, n=11; ** p= 0.002, n.s. p> 0.05; Figure 5.6a). The proportion of “down” 
traces with mCer-Dyn1H396D overexpression (8.714 ± 2.411 %, n=10) was also 
significantly different from mCer-Dyn1WT (Student t-test: * p= 0.021; Figure 5.6e). 
The proportion of “up” and “down” traces of all other mutants was not significantly 
different from WT (Student t-test: n.s. p> 0.05). This suggests that overexpression of 
mCer-Dyn1K44A and mCer-Dyn1H396D can decrease the number of nerve terminals 
undergoing ADBE.  
 
We wanted to ensure that these differences were not due to differences in 
transfection conditions and overexpression of VAMP4-pH, since we observed lower 
levels of ADBE than previously reported by our group using this approach (~20% of 
nerve terminals performing ADBE in contrast to ~40% in Nicholson-Fish et al. 
(2015)). We transfected VAMP4-pH and mCerN1 for 7 days (17.210 ± 3.449 % 
down traces , n=7) or for 2 days prior to imaging (15.02 ± 3.415 % down traces, n=8) 
and saw no difference in the proportion of nerve terminals undergoing ADBE across 
transfection conditions (Student t-test: n.s. p > 0.05; Figure 5.7a). Thus, the number 
of days for which VAMP4-pH is expressed in hippocampal cultures does not alter 






As a positive control, we also determined whether the proportion of ADBE occurring 
could be altered by knocking-down syndapin-1 (Figure 5.7b). Syndapin-1 is a 
neuronal protein in the BAR family that can interact with dyn1 through its 
C-terminal SH3 domain (reviewed in Quan and Robinson, 2013). In fact, the 
interaction between dyn1 and syndapin-1 is essential for ADBE (Clayton et al., 
2009). Therefore, we predicted that knocking down syndapin-1 in our cultures should 
impair ADBE (Clayton et al., 2009). Indeed, there was a significantly lower 
proportion of WT hippocampal nerve terminals undergoing ADBE when transfected 
for 3 days with shRNA against Syndapin-1 (Syndapin KD: 9.773 ± 2.032 %, n=14) 
compared to the scrambled control (Scrambled: 22.110 ± 4.124 %, n=11; Student t-
test: ** p= 0.009). These data show that an impairment in ADBE caused by 
knocking-down an essential component of this endocytic method can be observed 
using VAMP4-pH. This suggests that it is possible to impair ADBE by genetically 
interfering with proteins that are essential for its function.  
 
5.2.3. BK channel opener may be able to rescue the endocytic defect observed in Dyn1R237W 
mutant 
BK channels have long been proposed to be promising targets for treatment of 
epilepsy (reviewed in Leo et al., 2015; N'Gouemo, 2011), particularly because they 
can modulate action potential broadening and thus alter SV exocytosis and synaptic 
plasticity (Deng et al., 2013; Deng and Klyachko, 2016; Griguoli et al., 2016). There 
is evidence suggesting that a BK channel opener MaxiPost, can rescue both spine 
defects and behavioural deficits in a mouse model of FXS, a disorder in which 
epilepsy is often comorbid (Hebert et al., 2014). Furthermore, dyn1 has been found 
to associate with BK channels in vivo (Gorini et al., 2010). Thus, we decided to test 
whether modulation of BK channels could rescue the defective SV recycling 







Figure 5.6 Overexpression of mCer-Dyn1K44A or mCer-Dyn1H396D decreases the proportion of 
nerve terminals undergoing ADBE  
Hippocampal neurons derived from WT mice were transfected with mCerN1, VAMP4-pH and 
either WT or mutant mCer-Dyn1, 2 days prior to imaging. a-f) The percentage of up and 
down VAMP4-pH responses in individual nerve terminals are displayed plotted against 
mCer-Dyn1WT a) mCer-Dyn1K44A (K44A, red) and mCerN1 empty vector 1-way ANOVA with 
Dunnett’s test comparing values to WT: n.s. p> 0.05, ** p < 0.01. b) mCer-Dyn1G139R 
(G139R, green), c) mCer-Dyn1R237W (R237W, turquoise), d) mCer-Dyn1I289F (I289F, blue),  
e) mCer-Dyn1H396D (H396D, purple), f) mCer-Dyn1A408T (A408T, magenta). Down responses 
represent ABDE. Neurons were stimulated 40 Hz 10 s. Following stimulation, for each cell, 
fluorescence of each nerve terminals was measured and sorted if increased “up trace”; if 
decreased “down trace”. “Down” traces are a measure of a nerve terminal undergoing 
ADBE. b-f) n.s. non-significant p > 0.05 by Student t-test, * p < 0.05.  







Figure 5.7 Proportion of nerve terminals undergoing ADBE can be genetically altered 
a) Hippocampal neurons derived from WT mice were transfected with mCerN1 and VAMP4-
pH either 7 days or 2 days prior to imaging on DIV 13-14. Neurons were stimulated 40 Hz 
10 s. Following stimulation, for each cell, fluorescence of each nerve terminals was 
measured and sorted into “up” or “down” traces. The percentage of up and down VAMP4-pH 
responses in individual nerve terminals. Down traces indicate the proportion of nerve 
terminals undergoing ADBE. b) Hippocampal neurons derived from wildtype cultures were 
transfected with mCerN1 and VAMP4-pH and either syndapin KD vector or scrambled vector 
3 days prior to imaging. a-b) n.s. non-significant p > 0.05, * p< 0.05 by Student t-test.  




We initially characterised the effect of different doses of the BK channel opener 
MaxiPost on SV recycling in WT hippocampal neurons using our sypHy imaging 
assay. WT neurons were transfected with sypHy and incubated in either DMSO, 
3 µM, 10 µM or 30 µM MaxiPost for 120 s prior to imaging and throughout imaging. 
The neurons were stimulated at low frequency (300 action potentials, 10 Hz; Figure 
5.8a). We first looked at SV exocytosis, since BK channels can modulate fusion of 
SVs through control of AP duration. SypHy fluorescence time traces were 
normalised to the total SV pool revealed by NH4Cl buffer to examine exocytosis 
(Figure 5.8b). The amount of exocytosis was quantified as a proportion of total SV 
pool fluorescence (Figure 5.8d). There was a significant difference (1-way ANOVA 
with Dunnett’s test comparing to DMSO: ** p=0.003) between MaxiPost 30 µM 
(0.239 ± 0.028 units, n=8) and DMSO (0.378 ± 0.021 units, n=10). There was no 
difference in peak exocytosis amount (1-way ANOVA with Dunnett’s test 
comparing to DMSO: n.s. p> 0.05) between MaxiPost 3 µM (0.389 ± 0.036 units, 
n= 7), MaxiPost 10 µM (0.332 ± 0.028, n= 10) and DMSO. Thus, high doses of 
MaxiPost can decrease the amount of SV exocytosis occurring during low frequency 
stimulation, in agreement with its action at BK channels. 
 
We then investigated whether endocytosis was altered with MaxiPost treatment. 
SypHy fluorescence traces were normalised to the stimulation peak to examine 
sypHy retrieval (Figure 5.8c). The fluorescence traces of 10 µM and 30 µM 
MaxiPost were significantly different (2-way ANOVA with Dunnett’s to compare to 
DMSO: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001). Single-phase decay 
curves were also fit to the traces to provide the sypHy τ (Figure 5.8e). There was a 
significant difference (1-way ANOVA with Dunnett’s test comparing to DMSO 
control) between 10 µM MaxiPost (29.800 ± 2.345 s, n=10; * p= 0.012), 30 µM 
MaxiPost (21.560 ± 2.671 s, n=8; *** p = 0.0005) and DMSO (46.830 ± 6.091 s, 
n=10). However, there was no significant difference with 3 µM MaxiPost (35.650 ± 
3.637 s, n=7; n.s. p > 0.05). Therefore, MaxiPost can accelerate SV endocytosis in 






Figure 5.8 Effects of BK channel opener molecule MaxiPost on sypHy exocytosis and 
endocytosis at low frequency stimulation (10 Hz 30 s) 
Hippocampal neurons derived from WT mice were transfected with sypHy on DIV 7. Cells 
were perfused with DMSO (vehicle) or various MaxiPost concentrations for 120 s prior to 
imaging. Imaging was also performed in the presence of MaxiPost on DIV 13-15. a) Time 
course of experiment. b-c) Mean sypHy fluorescence traces of hippocampal neurons treated 
with DMSO (white), MaxiPost 3 µM (yellow),10 µM (blue), 30 µM (red). Bars indicate the 
period of stimulation, 10 Hz 30 s. b) normalised to the total SV number as revealed by 
NH4Cl. c) normalised to the peak of stimulation. 2-way ANOVA with Dunnett’s multiple 
comparisons test comparing each trace to the DMSO trace * p < 0.05; ** p < 0.01; *** p < 
0.001; **** p < 0.0001 d) Mean and individual stimulation peak heights obtained from 
individual sypHy traces of data in b). e) Mean and individual sypHy retrieval time constants 
(τ) of data plotted in c). d-e) 1-way ANOVA with Dunnett’s test comparing all means to 
DMSO (control condition): * p < 0.05; ** p < 0.01; *** p < 0.001; n.s. p > 0.05.  





Figure 5.9 Effects of BK channel opener molecule MaxiPost on sypHy exocytosis and 
endocytosis at high frequency stimulation (50 Hz 6 s) 
Hippocampal neurons derived from WT mice were transfected with sypHy on DIV 7. Cells 
were perfused with DMSO (vehicle) or various MaxiPost concentrations for 120 s prior to 
imaging. Imaging was also performed in the presence of MaxiPost at DIV 13-15. a) Time 
course of experiment. b-c) Mean sypHy fluorescence traces of hippocampal neurons treated 
with DMSO (white), MaxiPost 3 µM (yellow), 10 µM (blue), 30 µM (red). Bars indicate the 
period of stimulation, 50 Hz 6 s. b) normalised to the total SV number as revealed by NH4Cl. 
c) normalised to the peak of stimulation. 2-way ANOVA n.s. p> 0.05. d) Mean and individual 
stimulation peak heights obtained from individual sypHy traces of data in b). e) Mean and 
individual sypHy retrieval time constants (τ) of data plotted in c). d-e) 1-way ANOVA n.s. 
p > 0.05.  





We then repeated these experiments at high frequency stimulation to determine 
whether the effect of MaxiPost was frequency-dependent. Once again, WT neurons 
transfected with sypHy were incubated in either DMSO or 3 µM, 10 µM or 30 µM of 
MaxiPost for 120 s prior to imaging and imaged in the presence of MaxiPost. The 
neurons were stimulated at high frequency (50 Hz 6 s; Figure 5.9a). SypHy 
fluorescence time traces normalised to the total SV pool (Figure 5.8b) were used to 
determine the amount of exocytosis that occurred during stimulation (Figure 5.8d). 
There were no significant differences (1-way ANOVA n.s. p > 0.05) in the 
normalised sypHy peak heights of across MaxiPost doses (3 µM: 0.494 ± 
0.052 units, n=7; 10 µM: 0.391 ± 0.042 units, n=11; 30 µM: 0.501 ± 0.031 units, 
n=8) and DMSO (0.480 ± 0.029 units, n=10). Thus, MaxiPost does not alter SV 
exocytosis at high frequency stimulation. 
 
To determine whether endocytosis upon high frequency stimulation (50 Hz 6 s) was 
affected by MaxiPost, we normalised the traces to the peak of stimulation and saw no 
differences between MaxiPost traces and DMSO sypHy trace (2-way ANOVA n.s. 
p> 0.05; Figure 5.9c). We then calculated the sypHy τ and again found no 
differences between treatment conditions compared to DMSO (1-way ANOVA n.s. 
p> 0.05; 3 µM: 42.930 ± 2.874 s, n=7; 10 µM: 48.370 ± 8.262 s, n=11; 30 µM: 
33.220 ± 5.511 s, n=8; DMSO: 49.860 ± 8.860 s, n=10; Figure 5.9e). Thus, treatment 
with MaxiPost does not alter SV endocytosis during high frequency stimulation. 
Taken all together, these data show that treatment with MaxiPost decreases SV 
exocytosis and accelerates SV endocytosis in a dose-dependent manner at low 
frequency stimulation.    
 
We then investigated whether the decrease in SV exocytosis seen with high doses of 
MaxiPost treatment was due to the drug affecting SV exocytosis or due to the faster 
SV endocytosis seen with this concentration of MaxiPost. We used Bafilomycin A1 
to uncouple exocytosis from endocytosis to determine the total amount of SV 





Figure 5.10 BK channel opener molecule MaxiPost impairs sypHy exocytosis at high doses  
Hippocampal neurons derived from WT mice were transfected with sypHy on DIV 7. Cells 
were perfused with Bafilomycin and either DMSO or various MaxiPost concentrations for 
120 s prior to and for the duration of imaging. Neurons were imaged at DIV 13-15. a) Time 
course of experiment. b) Mean sypHy fluorescence traces of hippocampal neurons treated 
with DMSO (white), MaxiPost 10 µM (blue), 30 µM (red) normalised to the total SV number 
as revealed by NH4Cl. Bar indicates the period of stimulation, 10 Hz 90 s. c) Mean and 
individual stimulation peak heights obtained from individual sypHy traces of data in b). 
d) Mean and individual exocytosis rates of data in b) obtained by calculating the slope of a 
linear regression fit to the first 3 timepoints after the start of stimulation. c-d) 1-way ANOVA 
with Dunnett’s test comparing values to DMSO: * p < 0.05, n.s. p> 0.05.  




WT neurons transfected with sypHy were incubated in Bafilomycin A1 and either 
DMSO, 10 µM or 30 µM MaxiPost for 120 s and then imaged undergoing perfusion 
with imaging buffer containing these drugs (Figure 5.10a,b). Both concentrations of 
MaxiPost were used as they were both able to accelerate endocytosis upon low 
frequency stimulation. Although there was no difference in exocytic rate (1-way 
ANOVA: n.s. p> 0.05; 10 µM: 0.018 ± 0.002 s, n=8; 30 µM: 0.016 ± 0.002 s, n=10; 
DMSO: 0.019 ± 0.002 s, n=12; Figure 5.10d), there was a significant difference in 
amount of exocytosis (1-way ANOVA with Dunnett’s test comparing to DMSO) 
with 30 µM (0.466 ± 0.035 units, n=10, * p= 0.0101) compared to DMSO (0.583 ± 
0.017 units, n=12) but not with 10 µM (0.549 ± 0.034 units, n=8; n.s. p> 0.05). 
Therefore, a treatment with 30 µM MaxiPost impairs SV exocytosis and this is not 
due to the accelerated SV endocytosis observed in Figure 5.8c,e.  
 
We determined that MaxiPost impairs CME, as sypHy retrieval was accelerated at 
low frequency stimulation which preferentially recruits this endocytosis mode in 
cultured hippocampal neurons (Granseth et al., 2006). We also wanted to investigate 
whether MaxiPost could alter ADBE. We transfected WT hippocampal neurons with 
VAMP4-pH to examine the impact of MaxiPost treatment on ADBE. Neurons were 
incubated in MaxiPost or DMSO for 120 s prior to imaging and imaged in their 
presence. Nerve terminals were divided into “up” or “down” traces depending on 
fluorescence signal following stimulation (40 Hz 10 s; Figure 5.11). There was no 
difference (1-way ANOVA n.s. p> 0.05) in the proportion of “down” traces 
representing ADBE between MaxiPost-treated (10 µM: 12.640 ± 2.009 %, n=4; 30 
µM: 16.240 ± 4.610 %, n=4) and DMSO treated neurons (19.590 ± 5.113 %, n=6). 
Therefore, treatment with MaxiPost does not affect ADBE.  
 
MaxiPost treatment with both 10 µM and 30 µM concentrations appears to enhance 
SV endocytosis, particularly CME, at low frequency stimulation. Therefore, we 
investigated whether treatment with MaxiPost could rescue the endocytic defect seen 





Figure 5.11 No effect of BK channel opener molecule MaxiPost on proportion of VAMP4-pH 
down traces 
Hippocampal neurons derived from WT mice were transfected with mCerN1 and VAMP4-pH, 
2 days prior to imaging. Cells were perfused with DMSO (black) or MaxiPost 10 µM (blue), 
30 µM (red) for 120 s prior to imaging. Imaging was also performed in the presence of 
MaxiPost at DIV 13-14. a) The percentage of up and down VAMP4-pH responses in 
individual nerve terminals after 40 Hz 10 s stimulation are displayed.1-way ANOVA n.s. 
p> 0.05. Down responses represent ABDE. Neurons were stimulated 40 Hz 10 s. Following 
stimulation, for each cell, fluorescence of each nerve terminals was measured and sorted if 
increased “up”; if decreased “down”. Down traces represent nerve terminals undergoing 
ADBE.  





We first determined whether MaxiPost could accelerate endocytosis when 
mCer-Dyn1WT was overexpressed. We used the same protocol as previously 
described in Figure 5.8 (Figure 5.12a). WT hippocampal neurons overexpressing 
mCer-Dyn1WT and sypHy were treated with either DMSO or MaxiPost prior to and 
for the duration of imaging. SypHy fluorescence time traces were normalised to the 
peak of stimulation to look at endocytosis by comparing fluorescence traces (Figure 
5.12b). There was a significant difference in the fluorescence trace (2-way ANOVA 
with Dunnett’s comparing to DMSO: * p< 0.05) of 30 µM MaxiPost but not with 10 
µM MaxiPost. Thus, high concentrations of MaxiPost can enhance SV endocytosis 
in neurons overexpressing mCer-Dyn1WT.  
 
We then looked at peak sypHy exocytosis during stimulation by normalising traces 
to the total SV pool fluorescence revealed by NH4Cl (traces not shown). There was a 
significant difference (1-way ANOVA with Dunnett’s test comparing to DMSO 
condition) in peak sypHy fluorescence during stimulation with 30 µM MaxiPost 
treatment (0.294 ± 0.046 units, n=6; * p=0.022) but not with 10 µM MaxiPost 
treatment (0.424 ± 0.074 units, n=8; n.s. p> 0.05) compared to DMSO (0.512 ± 
0.367 units, n= 10). Therefore, high concentrations of MaxiPost (30 µM) decrease 
SV exocytosis in neurons overexpressing mCer-Dyn1WT, as was the case in WT 
neurons (Figures 5.8, 5.10). Taken together, these data suggest that mCer-Dyn1WT 
overexpression does not impair MaxiPost treatment from altering both SV 
endocytosis and exocytosis at high concentration.  
 
We next attempted to rescue the severe SV endocytosis impairment seen with 
overexpression of mCer-Dyn1R237W in our cultures (Figure 5.3b,d). We chose this 
mutant because it is a recurrent dyn1 mutation associated with a very severe seizure 
phenotype (EuroEPINOMICS-RES Consortium et al., 2014; von Spiczak et al., 
2017). Furthermore, our assays show that this mutation only appeared to impair 
CME and not ADBE (Figure 5.4c). As we have found that MaxiPost only alters 





Figure 5.12 Effect of BK channel opener molecule, MaxiPost, on SypHy retrieval in 
hippocampal neurons overexpressing the mCer-Dyn1R237W mutant 
a) Time course of experiment. Cells were perfused with DMSO (vehicle) or MaxiPost for 
120 s prior to imaging at DIV 13-14. Imaging was also performed in the presence of 
MaxiPost. b) Hippocampal neurons derived from WT mice were transfected with sypHy and 
mCer-Dyn1WT (WT) 2 days prior to imaging. Mean sypHy fluorescence traces of 
hippocampal neurons treated with DMSO (white), MaxiPost 10 µM (blue) or 30 µM (red). Bar 
indicates the period of stimulation, 10 Hz 30 s. 2-way ANOVA with Dunnett’s multiple 
comparisons test comparing each trace to the DMSO trace * p < 0.05. c) Mean and 
individual stimulation peak heights obtained from individual sypHy traces of data in b). 
d) Hippocampal neurons derived from wildtype cultures were transfected with sypHy and 
mCer-Dyn1R237W 2 days prior to imaging. Mean sypHy fluorescence traces of hippocampal 
neurons treated with DMSO (turquoise), MaxiPost 10 µM (blue) or 30 µM (red). Bar indicates 
the period of stimulation, 10 Hz 30 s. e) Mean and individual stimulation peak heights 
obtained from individual sypHy traces of data in d). c,e) 1-way ANOVA with Dunnett’s test 
comparing all means to DMSO (control condition): * p < 0.05; n.s. p > 0.05.  




We repeated our MaxiPost imaging assay in neurons overexpressing mCer-
Dyn1R237W and sypHy. There was no significant difference in fluorescence traces 
across treatments (2-way ANOVA n.s. p> 0.05) however, there was a trend toward 
enhanced SV endocytosis with both MaxiPost concentrations tested. Therefore, 
although MaxiPost could not rescue the defect in SV endocytosis observed with 
overexpression of mCer-Dyn1R237W at the concentrations tested. The trend toward 
enhanced SV endocytosis observed suggest that these experiments should be 
repeated to reveal whether there is indeed a significant difference in fluorescence 
traces between treatment conditions. 
 
We then looked at SV exocytosis during stimulation as a proportion of the total SV 
pool. Interestingly, there was no difference in sypHy exocytosis peak heights (1-way 
ANOVA: n.s. p> 0.05; 10 µM: 0.0425 ± 0.041 units, n=12; 30 µM: 0.481 ± 
0.050 units, n=12; DMSO: 0.531 ± 0.050 units, n=11), suggesting that MaxiPost 
cannot affect SV exocytosis in the presence of this mutant.  
 
5.2.4. Impaired GTPase activity of mCer-Dyn1K44A, mCer-Dyn1G139R and mCer-Dyn1R237W 
mutants 
Dyn1 mediates membrane fission during SV endocytosis through its GTPase activity 
(Antonny et al., 2016). The mutations studied were all predicted by in silico 
modelling to have deleterious effects on SV endocytosis (D. Soares personal 
correspondence). Specifically, Dyn1G139R and Dyn1R237W were predicted to impair 
GTPase activity of dyn1. We purified mCer-Dyn1WT and mutant mCer-Dyn1 to 
perform a GTPase assay to determine whether defective GTPase activity is 
responsible for the SV recycling deficits observed in our assays.  
 
HEK293T cells were transfected with either mCerN1, mCer-Dyn1WT or mutant 




mCer-Dyn1WT was isolated by immunoprecipitation. Isolated proteins were then used 
for a colorimetric Malachite green GTPase assay which detects the release of 
inorganic phosphates (Pi). MCer-Dyn1K44A (93.630 ± 7.158 µM, n=4, 1-way 
ANOVA with Dunnett’s test comparing to mCer-Dyn1WT: * p= 0.014) had 
significantly less Pi release as compared to mCer-Dyn1WT (119.600 ± 5.840 µM, 
n=4; Figure 5.13a) in agreement with its inability to hydrolyse GTP. As predicted by 
in silico modelling, the mCer-Dyn1G139R (103.500 ± 7.796 µM, n=3, * p= 0.031) and 
mCer-Dyn1R237W (102.800 ± 3.943 µM, n=3, * p= 0.026) had significantly reduced 
Pi release compared to mCer-Dyn1WT (123.200 ± 2.706 µM, n=3). The mCer-
Dyn1I289F mutant’s Pi release was comparable to mCer-Dyn1WT levels (131.000 ± 
0.887 µM, n=3, n.s. p > 0.05; Figure 5.13b). As expected, the mutations in the stalk 
did not impair Pi release compared to WT (1-way ANOVA n.s. p> 0.05, mCer-
Dyn1H396D: 122.700± 4.646 µM, n=3; mCer-Dyn1A408T: 122.500 ± 1.185 µM, n=3; 
Figure 5.13c). For all experiments the mCerN1 vector produced significantly less Pi 
release than WT dyn1 control (1-way ANOVA with Dunnett’s test **** p< 0.0001). 
Therefore, this condition represents basal Pi release in this assay. These data show 
that the mCer-Dyn1K44A mutant displays reduced GTPase activity, as previously 
reported (Damke et al., 1994). Furthermore, two GTPase domain mutants, mCer-
Dyn1G139R and mCer-Dyn1R237W also impair GTPase activity, whereas the mCer-







Figure 5.13 G139R and R237W mutations impair GTPase activity as predicted by in silico 
modelling 
HEK293T cells were transfected with mCerN1 empty vector (grey), mCer-Dyn1WT (WT, 
white) or mutant mCer-Dyn1K44A (K44A, red), mCer-Dyn1G139R (G139R, green), 
mCer-Dyn1R237W (R237W, turquoise), mCer-Dyn1I289F (I289F, blue), mCer-Dyn1H396D 
(H396D, purple), mCer-Dyn1A408T (A408T, magenta) 48 h prior to lysis. Mutant proteins were 
isolated and GTPase activity was determined using a colorimetric GTPase assay based on 
the detection of free inorganic phosphate. a) GTPase deficient mCer-Dyn1K44A dominant 
negative mutant. b) mutations in dyn1 GTPase domain. c) mutations in dyn1 stalk domain. 
1-way ANOVA with Dunnett’s test comparing values to WT. * p < 0.05; **** p < 0.0001; n.s. 
p > 0.05.  




5.3.  Discussion 
In this work, we studied the effects of a series of dyn1 mutants on SV recycling, to 
determine whether any defects observed could be responsible for manifestation of the 
observed developmental disorders. We first characterised the Dyn1K44A mutation in 
dissociated primary neuronal cultures. This mutation was designed to impair both the 
binding of GTP and its hydrolysis (Damke et al., 1994) and impairs endocytosis in 
non-neuronal cell lines (Damke et al., 1994; Damke et al., 2001). The de novo 
Dyn1G139R, Dyn1R237W, Dyn1I289F and Dyn1H396D mutations were identified in patients 
suffering from seizures and/or developmental delay (DDD Consortium and W. Lam 
personal correspondence, Table 5.1). We also chose to investigate the effect of the 
Dyn1A408T ftfl mutation which spontaneously arose in mice and led to seizure 
phenotypes. We found that the de novo patient mutations had different effects on 
both CME and ADBE. 
 
5.3.1. Modelling de novo dyn1 mutations 
The crystal structure of dyn1 has been resolved (Faelber et al., 2011), therefore it is 
possible to use in silico modelling to predict whether de novo dyn1 mutations can 
impair its function. Previous studies have already predicted which functional defects 
may arise from de novo dyn1 mutations linked to epileptic encephalopathy. The 
predictions in these studies were based on their location in the protein and the amino 
acid substitution (von Spiczak et al., 2017). Our collaborator, Dr Dinesh Soares 
(American Chemical Society), used in silico pathogenicity detectors to determine 
whether the de novo mutations studied were likely to be deleterious to dyn1 function. 
Dyn1G139R, Dyn1R237W, Dyn1I289F were highly likely to be deleterious, whereas 
Dyn1H396D was predicted to be deleterious by PolyPhen-2 (Adzhubei et al., 2010) 
analysis but benign by SIFT analysis (Kumar et al., 2009) (D. Soares, personal 
correspondence). FoldFX forcefield was used to assess whether the mutations in the 
G domain destabilise the structure of dyn1. This analysis predicted that all mutations 
would be destabilising consistent with the non-conservative nature of the amino acid 




predicted to impair GDP and GTP binding due to their proximity to the GDP binding 
site (D. Soares, personal correspondence). This work, therefore, was to determine 
whether these predicted deleterious mutations would impair SV recycling.  
 
5.3.2. Effects of mutant dyn1 on SV recycling 
5.3.2.1. Mutations in the GTPase domain 
We found that Dyn1K44A impaired CME as determined by defective sypHy retrieval. 
Our results agree with what has previously been reported in non-neuronal cell lines, 
where Dyn1K44A impairs transferrin uptake (Damke et al., 1994; Damke et al., 2001). 
Furthermore, Dyn1K44A also impaired ADBE as determined by fewer VAMP4-pH 
“down” traces. These results were expected as this mutation impairs dyn1 GTPase 
activity which is essential for mediating membrane fission in both CME (Hinshaw 
and Schmid, 1995) and ADBE (Clayton et al., 2009). As for the mutations in the 
GTPase domain, Dyn1R237W and Dyn1I289F mutants severely impaired sypHy retrieval 
without having any effect on the proportion of nerve terminals undergoing ADBE. 
Interestingly, Dyn1G139R did not impair SV recycling through either mode of 
endocytosis. We also measured basal GTPase activity of these dyn1 mutants. We 
found that Dyn1G139R and Dyn1R237W mutants showed decreased GTPase activity as 
predicted by FoldX forcefield modelling (D. Soares, personal correspondence). This 
was expected as these residues are both in close proximity to where GDP binds, with 
R237 directly participating in GDP binding.  
 
Our data suggest that defective basal GTPase activity is not sufficient to impair 
endocytosis as Dyn1G139R with defective GTP hydrolysis does not impair SV 
endocytosis. This lends support to previous work that shows that both effective GTP 
hydrolysis and a conformational change of dyn1 are required for endocytosis to 
occur (Damke et al., 2001; Marks et al., 2001). It was somewhat puzzling that 
Dyn1G139R mutation did not impair either form of endocytosis even though its 




Dyn1G139R way impaired, it is possible that evoked GTPase activity is not impaired. 
As previously described, self-assembly, phospholipid-binding and interactions with 
other the SH3 domain of other proteins can improve dyn1’s GTPase activity. 
Therefore, it is possible that in vivo these factors can act together to promote GTPase 
activity for efficient membrane fission and SV endocytosis. Additionally, it is 
possible that Dyn1G139R dimerises with Dyn1WT in vivo. Dyn1WT present in cultures 
may be sufficient to rescue any SV recycling phenotype as what has been shown 
with Dyn1A408T (Asinof et al., 2016).  
 
Dyn1I289F showed GTPase activity comparable to WT levels (Figure 5.13b), however 
SV endocytosis was impaired even though it was not significantly overexpressed 
(Figure 5.1b). Intact GTPase activity is not sufficient for dyn1-mediated endocytosis, 
dyn1 must also undergo a conformational for endocytosis to occur (Damke et al., 
2001; Marks et al., 2001). Indeed, a previously characterised Dyn1K142A mutation 
showed mildly impaired GTPase activity but could still strongly inhibit transferrin 
endocytosis in COS-7 fibroblasts (Marks et al., 2001). Therefore, it is possible that 
the Dyn1I289F mutant is unable to change conformation upon GTP hydrolysis thus 
impairing SV endocytosis. This mutation was predicted to destabilise dyn1 structure 
but not affect GDP/GTP binding. Destabilising dyn1’s structure may impair its 
interactions with phospholipids or with SH3 domains. This could prevent it from 
being recruited to endocytic pits by amphiphysin-1 and endophilin. Super resolution 
imaging of nanobodies to dyn1 could be used to determine whether this mutant can 
be targeted to invaginating endosome’s necks. Mislocalisation of mCer-Dyn1I289F 
could explain why SV endocytosis is impaired in this model. 
 
5.3.2.2. Mutations in the stalk domain 
Dyn1H396D located in the stalk domain was the only de novo mutation that impaired 
both forms of SV endocytosis. This mutation corresponds to the Dyn1G397D mutation 




The Dyn1G397D mutant was unable to form helical structures in the presence of lipid 
nanotubules which suggests that it may not be able to mediate efficient endocytosis 
(Ford et al., 2011). Dyn1H396D’s inability to oligomerise may contribute to the 
defective SV recycling seen in this mutant. To determine whether this could be the 
case, we could generate the previously characterised Dyn1G397D mutant and 
determine whether we observe impaired CME and ADBE as observed with 
overexpression of mCer-Dyn1H396D. This would provide confirmation as to whether 
defective dyn1 self-assembly can impair SV endocytosis. 
 
Interestingly, we also observed increased endocytosis during exocytosis with this 
mutant. At physiological temperatures, there are two phases of endocytosis: an initial 
activity-dependent acceleration phase, followed by a slower endocytosis phase 
(Armbruster et al., 2013). These two phases may also be present at room 
temperature, but harder to dissociate. Dephosphorylation of dyn1 at S774 and S778 
by calcineurin mediates this initial acceleration phase of endocytosis (Armbruster et 
al., 2013). The change from the positively charged histidine to the negatively charged 
aspartic acid in this mutation could impair dyn1 folding (Ford et al., 2011). We 
hypothesise that this change in folding could reveal the S774 and S778 residues and 
allow them to be readily dephosphorylated thus mediating the enhanced endocytosis 
seen during exocytosis without altering the later slow phase of endocytosis as seen in 
our model.  
 
We also looked at the spontaneously occurring Dyn1A408T ftfl mutation. We did not 
observe any SV recycling defects in this model through either CME or ADBE. 
GTPase activity was comparable to Dyn1WT levels. Dyn1A408T has been previously 
described to show defective transferrin uptake when overexpressed in a COS-7 cell 
line (Boumil et al., 2010). Interestingly, there was also increased tubular networks 
connected to the plasma membrane in these cells (Boumil et al., 2010). These 
membrane tubules were similar to those that had been previously described when 




This suggests that Dyn1A408T is unable to induce membrane fission despite being able 
to be recruited to the neck of invaginating pits (Takei et al., 1995). It is important to 
note, however, that this endocytic defect observed in COS-7 cells expressing 
Dyn1A408T could be rescued with Dyn1WT expression (Asinof et al., 2016) as this 
mutant can dimerise with Dyn1WT (Boumil et al., 2010). In our assay, we 
overexpressed Dyn1A408T in hippocampal neurons which already endogenously 
expressed Dyn1WT. Therefore, in our hippocampal cultures, Dyn1A408T may be 
dimerising with the endogenous Dyn1WT to maintain efficient SV endocytosis. This 
may explain why we do not observe any endocytosis deficits with this mutant.  
 
5.3.3. Rescue of endocytosis with MaxiPost 
BK channels play an important role in SV recycling, particularly in SV exocytosis 
(reviewed in Griguoli et al., 2016). BK channels located in the presynapse colocalise 
with N-type and P/Q-type voltage-gated Ca2+ channels (Indriati et al., 2013; Loane et 
al., 2007). Upon depolarisation, the voltage-gated Ca2+ channels open and allow 
entry of Ca2+ into the cell. This is crucial for SV exocytosis as Ca2+ binding 
synaptotagmin-1 is essential for SV fusion. Ca2+ can then bind BK channels with 
high affinity which consequently lowers the [Ca2+]i to subthreshold levels for 
neurotransmitter release (reviewed in Griguoli et al., 2016). Moreover, opening of 
the BK channel hyperpolarises the cell, further preventing neurotransmission by 
closing voltage-gated Ca2+ channels. Thus, BK channels can negatively regulate SV 
exocytosis.  
 
We have shown that treatment of our hippocampal cultures with the BK channel 
fluoro oxindole opener molecule, MaxiPost, (Gribkoff et al., 2001), decreased 
exocytosis in a dose-dependent manner at low frequency stimulation (Figures 5.8, 
5.10). This was expected as the opening of the BK channel would allow for an efflux 
of K+ which would hyperpolarise the nerve terminal and close voltage-gated Ca2+ 




present at high frequency stimulation. We propose that the absence of an effect on 
peak sypHy exocytosis was due to the short duration of stimulation in this condition 
rather than the frequency. This could be tested by stimulating at high frequency for a 
longer duration to see whether MaxiPost can still impair both SV exocytosis and 
endocytosis.  
 
Our results suggest that BK channels may also play a role in SV endocytosis. It was 
surprising to us that MaxiPost had such a marked effect on CME in hippocampal 
neurons (Figure 5.8) as shown by significantly accelerated sypHy retrieval. There is 
a large body of evidence that BK channels play an important role in 
neurotransmission in drosophila, c. elegans and mice (Griguoli et al., 2016). 
However, as previously discussed, it mediates neurotransmitter release by 
modulation of AP length. It is possible that MaxiPost modulates SV endocytosis by 
regulating [Ca2+]i through BK channel opening. There is no clear consensus as to 
whether increased [Ca2+]i accelerates (Armbruster et al., 2013; Sankaranarayanan and 
Ryan, 2001) or slows endocytosis (Balaji et al., 2008; Cousin and Robinson, 2000; 
Leitz and Kavalali, 2011; Marland et al., 2016; Sankaranarayanan and Ryan, 2000). 
The localisation of presynaptic [Ca2+]i can also determine how it affects SV 
endocytosis. There is evidence suggesting that prolonged, small increases in global 
Ca2+ can inhibit SV endocytosis, while transient, large increases in Ca2+ 
microdomains can trigger SV endocytosis (X. S. Wu and Wu, 2014). If it is indeed 
through modulating [Ca2+]i that MaxiPost affects SV endocytosis, our data would 
suggest that decreased [Ca2+]i accelerates endocytosis because the hyperpolarisation 
induced by the open BK channels would cause Ca2+ channels to close. To test this 
theory, we could increase [Ca2+]i to determine whether it could slow SV endocytosis 
even further in this model.  
 
Another possibility is that the interaction between dyn1 and the BK channel may 




channels co-precipitates with dyn1 (Gorini et al., 2010). However, it remains unclear 
how this interaction mediates the activity of either component.  
 
Alternatively, MaxiPost may have an off-target effect that modulates SV 
endocytosis. This could be tested by investigating whether another BK channel 
opener produces the same CME acceleration observed with MaxiPost treatment. It 
would also be interesting to determine whether a BK channel blocker such as 
paxilline or iberiotoxin would have the opposite effect and lead to a slowing of SV 
endocytosis. 
 
MaxiPost can also activate non-inactivating potassium KCNQ channels (Jensen, 
2002). These channels can regulate excitability of neurons and their response to 
synaptic input (reviewed in Jentsch, 2000). However as with the BK channels, there 
is no evidence that these channels can directly modulate SV endocytosis (Jentsch, 
2000). It is important to note that MaxiPost cannot affect the number of nerve 
terminals undergoing ADBE (Figure 5.11). This may suggest that BK and KCNQ 
channels cannot modulate this endocytic mode. This work lends further support for 
different endocytic pathways having distinct regulatory mechanisms as 
pharmacological treatment can impair one mode but not another. 
 
5.3.4. Different roles of dyn1 in CME and ADBE 
Most studies looking at the effect of mutant dyn1 on endocytosis are performed in 
non-neuronal cell lines (Asinof et al., 2016; Boumil et al., 2010; Damke et al., 1994; 
Damke et al., 2001; Marks et al., 2001). Therefore, it was important to determine 
whether mutations known (Dyn1K44A, Dyn1A408T) or predicted (Dyn1G139R, 
Dyn1R237W, Dyn1I289F, Dyn1H396D) to impact GTP hydrolysis or dynamin self-




differentially impacted the CME or ADBE modes of endocytosis suggesting that 
different roles of dyn1 may regulate different modes of SV endocytosis.  
 
Dyn1 can play multiple roles in SV endocytosis. Its different roles have been 
elucidated through the generation of a Dnm1 KO mouse model (Ferguson et al., 
2007) and by studying various mutations in different functional domains (Armbruster 
et al., 2013; Asinof et al., 2016; Baba et al., 1995; Boumil et al., 2010; Clayton et al., 
2009; Damke et al., 1994; Damke et al., 2001; Marks et al., 2001).  
 
Dyn1 can be recruited at the early stages of clathrin-coated pit formation where it can 
recruit more dyn1 to the forming pits to ensure efficient membrane fission through its 
GTPase activity (Taylor et al., 2012). Dyn1 is recruited to the neck of membrane 
invaginations in both CME (Hinshaw and Schmid, 1995) and ADBE (Clayton et al., 
2009) where it can produce membrane fission through GTP hydrolysis and a 
subsequent conformational change (Damke et al., 2001; Marks et al., 2001). 
GTP-bound dyn1 is required for regulating clathrin-coated pit formation which is a 
rate limiting step in CME (Sever et al., 2000). In the absence of GTP, dyn1 forms a 
long scaffold around the necks of the invaginating clathrin-coated pits which 
stabilises their structure and prevents fission (Shnyrova et al., 2013). However, dyn1 
bound to the non-hydrolisable GTPγS was also able to form stable scaffolds around 
the neck of invaginated membranes (Takei et al., 1995) which suggests that it may be 
the absence of GTP hydrolysis rather than the absence of GTP-binding that promotes 
dyn1 oligomerisation to form stable scaffolds. These findings suggest opposing roles 
of dyn1 depending on GTP-binding and hydrolysis.  
 
In certain non-neuronal cell-lines that endogenously express dyn1, GSK3β 
phosphorylation of dyn1 can regulate the rate and formation of clathrin-coated pits 




compensatory rapid CME (Reis et al., 2015). This suggests that over-activation of 
dyn1 can dysregulate SV endocytosis at least in non-neuronal cells.  
 
The other functional domains of dyn1 can also mediate efficient SV endocytosis. 
Dyn1 self-assembly via its stalk is required for SV endocytosis since Dyn1A408T 
located in the stalk domain impairs endocytosis in a transferrin uptake assay (Boumil 
et al., 2010). Additionally, Dyn1G397D impaired liposome-invoked GTPase activity 
which is required for SV endocytosis (Ford et al., 2011).  
 
Dyn1’s interactions with other proteins is also required for efficient SV endocytosis. 
The SH3 domains of different proteins can interact with the PRD domain of dyn1 to 
mediate its stability and GTPase activity to varying extents (Krishnan et al., 2015). 
To trigger ADBE, a dephosphorylation-rephosphorylation cycle of dyn1 is required 
in addition to GTPase activity for induction of membrane fission (Clayton et al., 
2009). Dyn1 must be dephosphorylated in order to interact with the SH3 domain of 
syndapin which is required for this mode of endocytosis (Clayton et al., 2009).  
 
These distinct functions of dyn1 may explain why the de novo mutations studied had 
varying effects on SV endocytosis. Dyn1K44A and Dyn1H396D impair both CME and 
ADBE perhaps by preventing efficient GTP hydrolysis in vivo which is required for 
both modes of endocytosis. Dyn1R237W and Dyn1I289F mutants only impair CME and 
not ADBE. These mutants are both predicted to destabilise dyn1 structure. It is 
possible that this unstable mutant dyn1 can no longer interact with the SH3 domains 
of amphiphysin-1 and endophilin and thus cannot be efficiently recruited to clathrin-
coated pits. However, Dyn1R237W and Dyn1I289F may still retain the ability to interact 
with the SH3 domain of syndapin-1 which is required for ADBE. Interaction with 
syndapin-1’s SH3 domain has been found to increase dyn1’s assembly and GTPase 
activity (Krishnan et al., 2015) which may explain why ADBE is not affected despite 




unstable dyn1 preferentially forms long scaffold structures around the neck of 
clathrin-coated pits to prevent membrane fission, thus impairing CME.  
 
5.3.5. Limitations 
There are a few limitations of this work. Firstly, VAMP4-pH, like TMR dextran, 
does not provide a measure of the amount of ADBE occurring at nerve terminals 
(Nicholson-Fish et al., 2015). Therefore, although we have shown that ADBE still 
occurs at the same proportion of nerve terminals when overexpressing mutant 
mCer-Dyn1G139R, mCer-DynR237W, mCer-Dyn1H396D, there may be less ADBE 
occurring at individual nerve terminals compared to WT. The VAMP4-pH assay 
cannot be used to investigate this. The amount of ADBE occurring in nerve terminals 
can be measured by using an HRP uptake assay to observe the number of bulk 
endosomes in nerve terminals (described in Section 4.3.3).  
 
Endocytic membrane tubule structures have been observed when dyn1 GTP 
hydrolysis is impaired (Damke et al., 1994; Damke et al., 2001; Marks et al., 2001; 
Takei et al., 1995). It would be interesting to use electron microscopy to evaluate 
endosomal structures and determine whether we observe the same phenotype when 
overexpressing our mCer-Dyn1 mutants. It would be especially interesting to fix the 
cells after high frequency stimulation to observe the intermediary bulk endosome 
structures. This could determine whether it is indeed defective GTP hydrolysis in 
vivo that is mediating the SV recycling defects.  
 
It is interesting to note that the patient with Dyn1H396D was the only patient to exhibit 
only developmental delay and not seizures. Moreover, this was the only de novo 
mutant to impair both modes of SV endocytosis studied. Therefore, it would be 
interesting to determine whether there is a correlation between patient phenotype 




for compensation by other molecular components of SV endocytosis, particularly in 
the case of the Dyn1G139R mutant where we do not observe any defects in SV 






In this work, we have studied SV recycling in three monogenic conditions that lead 
to ID, ASD and epilepsy. Using live-cell fluorescence imaging, we have shown that 
impaired SV endocytosis is a common feature across models of SYNGAP1 
haploinsufficiency, FXS and DNM1 epileptic encephalopathy. Furthermore, the 
altered SV endocytosis observed in these models may contribute to the impaired 
synaptic function observed in these disorders.    
 
We observed enhanced SV endocytosis in a mouse model of SynGAP1 
haploinsufficiency. SynGAP1 KO hippocampal neurons showed enhanced sypHy 
retrieval only at low frequency stimulation, suggesting that CME is enhanced. 
SynGAP is enriched at excitatory PSDs where it can control synapse structure. PSD 
protein composition is altered in SynGAP1 Het mice (Walkup et al., 2016). We 
propose that it is through altering protein composition at the postsynapse, including 
the localisation of the cell adhesion molecules neuroligin-2 and LRRTM, that 
SynGAP can enhance SV recycling. Interestingly, rat SynGAP1 KO neurons did not 
display enhanced SV endocytosis, perhaps due to the altered time course of 
development between these rodent species.  
 
SypHy retrieval was not altered with either low or high frequency stimulation in 
either a mouse or rat model of FXS compared to WT controls, suggesting that CME 
is not impaired. We did observe that fewer nerve terminals took up fluorescent TMR 
dextran in rat Fmr1 KO hippocampal neurons compared to WT. These results 
suggest an impairment in ADBE, with fewer nerve terminals able to take part in this 
form of SV endocytosis. FMRP plays multiple roles in both the presynapse and the 






De novo mutations in DNM1 associated with epileptic encephalopathy (DDD 
Consortium and DR. W. Lam, University of Edinburgh) had differential effects on 
both modes of SV endocytosis studied. Interestingly, deficits in GTPase activity were 
not always correlated with SV endocytosis deficits. Dyn1G139R showed impaired 
GTPase activity without impairing CME or ADBE. Dyn1R237W, Dyn1I289F and 
Dyn1H396D all showed impaired sypHy retrieval compared to Dyn1WT with 
significantly less SV endocytosis occurring in these models. Dyn1H396D also impaired 
ADBE with fewer nerve terminals expressing this mutant undergoing ADBE as 
determined by fewer VAMP4-pH “down” traces. We also found that a BK channel 
opener can accelerate CME and thus may be able to rescue the impaired SV 
endocytosis caused by a subset of these mutants.  
 
6.1. Axis of pathophysiology 
Auerbach et al. (2011) proposed an axis of pathophysiology that could explain 
models of neurodevelopmental disorders. They proposed that decreased activity and 
increased activity of mGluRs fell on either side of an inverted U-shaped curve with 
optimal activity located at the peak (Auerbach et al., 2011). Evidence for this model 
was provided by the offspring of a genetic cross between Fmr1 KO mice, that 
display increased mGluR activity, and Tsc2 Het mice, that show decreased mGluR 
activity. The offspring carrying both mutations (Fmr1-/y Tsc2+/-) displayed optimal 
mGluR activity with mGluR-LTD resembling WT mGluR-LTD (Auerbach et al., 
2011). This suggests that there is an optimal level of mGluR activity required for 
efficient neural performance and deviation from this optimal level may lead to the 
phenotypes observed in both the Fmr1 KO and Tsc2 Het models (Auerbach et al., 
2011).  
 
Although the pathway was first suggested for mGluR activity, we propose that SV 




endocytosis leading to impaired neurotransmission and synaptic dysfunction (Figure 
6.1). Dyn1R237W, Dyn1I289F and Dyn1H396D mutations and FXS fall to one side of an 
inverted U-shaped curve with impaired SV endocytosis observed in these models. On 
the other side of the curve, there is SYNGAP1 haploinsufficiency and CDKL5 
disorder which both show enhanced SV endocytosis. CDKL5 disorder is another 
monogenic cause of ID and epilepsy (Kalscheuer et al., 2003). Our group has 
observed that more hippocampal nerve terminals undergo ADBE upon high 
frequency stimulation in this model compared to WT (E. Davenport, unpublished).   
 
 
Figure 6.1 SV endocytosis axis of pathophysiology 
Adapted from Auerbach et al. (2011) 
Different monogenic causes of neurodevelopmental disorders have been placed on an 
inverted U-shaped curve with optimal SV endocytosis designated by WT (black). There are 
decreased levels of SV endocytosis in DNM1 epileptic encephalopathy (turquoise) and FXS 
(red). There is enhanced SV endocytosis in SYNGAP1 haploinsufficiency (blue) and CDKL5 
disorder (green; E. Davenport unpublished). 
 
6.2. Dysfunctional SV endocytosis and dysfunctional synapses 
We propose that deviation from the optimal amount of SV endocytosis can impair 
neural performance through impairing synapse function. As previously mentioned, 
SV recycling is necessary for efficient neurotransmission, especially during 




could lead to enhanced synaptic depression as new SVs cannot be formed to maintain 
neuronal activity (Chen et al., 2003; Shupliakov et al., 1997). This could lead to 
deficits in synaptic plasticity such as the exaggerated mGluR-LTD observed in FXS 
(Huber et al., 2002). In addition, neurotransmission failure could ultimately lead to 
death as is the case with the Dnm1/3 DKO mouse that cannot undergo efficient CME 
following neuronal stimulation (Raimondi et al., 2011).  
 
Altering SV endocytosis may also change synapse composition, however this is not 
always the case (Harper et al., 2017; Kaempf et al., 2015; Kononenko et al., 2013; 
Zhang et al., 2015). SVs fuse at the protein-dense presynaptic AZ. The protein 
composition of the AZ is tightly controlled to maintain efficient neurotransmission 
and ensure neurotransmitter release is performed at the right speed (reviewed in 
Sudhof, 2012). Addition of SV cargo to the active zone without SV endocytosis 
removing it may result in an unbalance in membrane homeostasis which could 
dysregulate synaptic function.  
 
Alternatively, enhanced endocytosis may also alter presynaptic membrane 
composition, destabilising the finely-tuned balance of exocytosis and endocytosis. In 
the case of the SynGAP1 KO mice, there is less cargo stranded at the plasma 
membrane which may also destabilise synaptic membrane homeostasis. This could 
be further exaggerated if exocytosis did not occur on a matching timescale. It would 
be important to use Bafilomycin A1 to determine both the rate and amount of 
exocytosis occurring during stimulation to better determine the extent of SV 
exocytosis and endocytosis uncoupling in this model.  
 
Enhanced SV recycling, as observed in the SynGAP1 KO mouse may suggest that 
neuronal activity cannot become as easily saturated during stimulation, since new 




synaptic depression which, in turn, could impair circuit remodelling resulting in 
altered network connectivity (Cohen et al., 2017).  
 
6.3. Future directions 
We have found that impaired SV endocytosis is a common feature across three 
different models of neurodevelopmental disorders. Mutations in other genes involved 
in synapse regulation including DYRK1A and STXBP1 have also been linked to 
neurodevelopmental disorders (Deciphering Developmental Disorders Study, 2015). 
Using the live-cell imaging assays described, it would be possible to screen other 
models of neurodevelopmental disorders to determine whether impaired SV 
endocytosis is indeed a common feature across all these models. This would thus 
provide a pathway that could be used as a target when developing new treatments for 
ID, ASD and epilepsy. 
 
Furthermore, we have also found that a BK channel opener, MaxiPost, may be able 
to rescue the decreased CME observed with overexpression of Dyn1R237W. This drug 
was developed as a treatment for acute ischemic stroke, however it did not increase 
patient outcomes compared to control treatment in a phase 3 clinical trial (Gribkoff et 
al., 2001; Jensen, 2002). However, these studies did show that this drug was safely 
tolerated in subjects. Its safety may provide an additional incentive for MaxiPost to 
be studied further in the context of neurodevelopmental disorders especially as it 
may be able to rescue some of the synaptic dysfunction. There is also evidence that 
MaxiPost administration can rescue neurodevelopmental disorder-associated 
behavioural phenotypes in mice. Treatment of Fmr1 KO mice with MaxiPost rescued 
cognitive and social behavioural deficits (Hebert et al., 2014). However, it is 
important to note that FMRP directly binds BK channels, therefore these results may 





In conclusion, SYNGAP1 haploinsufficiency and FXS are both synaptopathies. Based 
on our results, DNM1 epileptic encephalopathy can probably also be characterised as 
a disorder of the synapse based on the requirement of dyn1 for SV endocytosis. We 
propose that altered SV recycling may lead to the synaptic dysfunction observed in 
these models. This work provides a convergent mechanism underlying the various 
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